Q25|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q25 /* inversive Verknüpfung" */
Q28|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q28 /* inversive Verknüpfung" */
Q12|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q12 /* inversive Verknüpfung" */
Q17|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q17 /* inversive Verknüpfung" */
Q16|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q16 /* inversive Verknüpfung" */
Q20|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q20 /* inversive Verknüpfung" */
Q26|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q26 /* inversive Verknüpfung" */
Q19|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q19 /* inversive Verknüpfung" */
Q27|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q27 /* inversive Verknüpfung" */
Q10|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q10 /* inversive Verknüpfung" */
Q8|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q8 /* inversive Verknüpfung" */
Q24|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q24 /* inversive Verknüpfung" */
Q29|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q29 /* inversive Verknüpfung" */
Q13|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q13 /* inversive Verknüpfung" */
Q21|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q21 /* inversive Verknüpfung" */
Q14|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q14 /* inversive Verknüpfung" */
Q11|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q11 /* inversive Verknüpfung" */
Q23|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q23 /* inversive Verknüpfung" */
Q9|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q9 /* inversive Verknüpfung" */
Q22|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q22 /* inversive Verknüpfung" */
Q18|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q18 /* inversive Verknüpfung" */
Q15|P2|Q1 /* Verknüpfung Verhütung mit "Verhütungsmittel" */
Q1|P25|Q15 /* inversive Verknüpfung" */
Q208|P2|Q2 /* Verknüpfung einzelner "Geschlechter mit Geschlecht" */
Q2|P25|Q208 /* inversive Verknüpfung" */
Q207|P2|Q2 /* Verknüpfung einzelner "Geschlechter mit Geschlecht" */
Q2|P25|Q207 /* inversive Verknüpfung" */
Q203|P2|Q2 /* Verknüpfung einzelner "Geschlechter mit Geschlecht" */
Q2|P25|Q203 /* inversive Verknüpfung" */
Q227|P2|Q4 /* Verknüpfung einzelner Arten mit "Art des Verhütungsmittels" */
Q4|P25|Q227 /* inversive Verknüpfung" */
Q217|P2|Q4 /* Verknüpfung einzelner Arten mit "Art des Verhütungsmittels" */
Q4|P25|Q217 /* inversive Verknüpfung" */
Q223|P2|Q4 /* Verknüpfung einzelner Arten mit "Art des Verhütungsmittels" */
Q4|P25|Q223 /* inversive Verknüpfung" */
Q221|P2|Q4 /* Verknüpfung einzelner Arten mit "Art des Verhütungsmittels" */
Q4|P25|Q221 /* inversive Verknüpfung" */
Q209|P2|Q4 /* Verknüpfung einzelner Arten mit "Art des Verhütungsmittels" */
Q4|P25|Q209 /* inversive Verknüpfung" */
Q17|P2|Q4 /* Verknüpfung einzelner Arten mit "Art des Verhütungsmittels" */
Q4|P25|Q17 /* inversive Verknüpfung" */
Q213|P2|Q4 /* Verknüpfung einzelner Arten mit "Art des Verhütungsmittels" */
Q4|P25|Q213 /* inversive Verknüpfung" */
Q215|P2|Q4 /* Verknüpfung einzelner Arten mit "Art des Verhütungsmittels" */
Q4|P25|Q215 /* inversive Verknüpfung" */
Q201|P2|Q3 /* Verknüpfung einzelner Materialien mit "Material des Verhütungsmittels" */
Q3|P25|Q201 /* inversive Verknüpfung" */
Q198|P2|Q3 /* Verknüpfung einzelner Materialien mit "Material des Verhütungsmittels" */
Q3|P25|Q198 /* inversive Verknüpfung" */
Q195|P2|Q3 /* Verknüpfung einzelner Materialien mit "Material des Verhütungsmittels" */
Q3|P25|Q195 /* inversive Verknüpfung" */
Q205|P2|Q3 /* Verknüpfung einzelner Materialien mit "Material des Verhütungsmittels" */
Q3|P25|Q205 /* inversive Verknüpfung" */
Q200|P2|Q3 /* Verknüpfung einzelner Materialien mit "Material des Verhütungsmittels" */
Q3|P25|Q200 /* inversive Verknüpfung" */
Q218|P2|Q3 /* Verknüpfung einzelner Materialien mit "Material des Verhütungsmittels" */
Q3|P25|Q218 /* inversive Verknüpfung" */
Q226|P2|Q3 /* Verknüpfung einzelner Materialien mit "Material des Verhütungsmittels" */
Q3|P25|Q226 /* inversive Verknüpfung" */
Q216|P2|Q3 /* Verknüpfung einzelner Materialien mit "Material des Verhütungsmittels" */
Q3|P25|Q216 /* inversive Verknüpfung" */
Q197|P2|Q3 /* Verknüpfung einzelner Materialien mit "Material des Verhütungsmittels" */
Q3|P25|Q197 /* inversive Verknüpfung" */
Q212|P2|Q3 /* Verknüpfung einzelner Materialien mit "Material des Verhütungsmittels" */
Q3|P25|Q212 /* inversive Verknüpfung" */
Q211|P2|Q5 /* Verknüpfung einzelner Angaben mit "Häufigkeit der Einnahme / Applikation" */
Q5|P25|Q211 /* inversive Verknüpfung" */
Q204|P2|Q5 /* Verknüpfung einzelner Angaben mit "Häufigkeit der Einnahme / Applikation" */
Q5|P25|Q204 /* inversive Verknüpfung" */
Q202|P2|Q5 /* Verknüpfung einzelner Angaben mit "Häufigkeit der Einnahme / Applikation" */
Q5|P25|Q202 /* inversive Verknüpfung" */
Q222|P2|Q5 /* Verknüpfung einzelner Angaben mit "Häufigkeit der Einnahme / Applikation" */
Q5|P25|Q222 /* inversive Verknüpfung" */
Q199|P2|Q5 /* Verknüpfung einzelner Angaben mit "Häufigkeit der Einnahme / Applikation" */
Q5|P25|Q199 /* inversive Verknüpfung" */
Q204|P2|Q5 /* Verknüpfung einzelner Angaben mit "Häufigkeit der Einnahme / Applikation" */
Q5|P25|Q204 /* inversive Verknüpfung" */
Q220|P2|Q5 /* Verknüpfung einzelner Angaben mit "Häufigkeit der Einnahme / Applikation" */
Q5|P25|Q220 /* inversive Verknüpfung" */
Q214|P2|Q5 /* Verknüpfung einzelner Angaben mit "Häufigkeit der Einnahme / Applikation" */
Q5|P25|Q214 /* inversive Verknüpfung" */
Q224|P2|Q5 /* Verknüpfung einzelner Angaben mit "Häufigkeit der Einnahme / Applikation" */
Q5|P25|Q224 /* inversive Verknüpfung" */
Q196|P2|Q5 /* Verknüpfung einzelner Angaben mit "Häufigkeit der Einnahme / Applikation" */
Q5|P25|Q196 /* inversive Verknüpfung" */
Q8|P3|Q207|S24|Q62 /* Spermizid → P3 → Weiblich */
Q8|P3|Q208|S24|Q62 /* Spermizid → P3 → Männlich */
Q8|P3|Q203|S24|Q62 /* Spermizid → P3 → Intersexuell */
Q8|P4|Q227 /* Spermizid → P4 → chemisch */
Q8|P5|Q226|S24|Q60|S24|Q61|S24|Q63|S24|Q64 /* Spermizid → P5 → medizinische Substanz */
Q8|P6|"Nein" /* Spermizid → P6 → Nein */
Q8|P7|"28" /* Spermizid → P7 → 28 */
Q8|P8|"18" /* Spermizid → P8 → 18 */
Q8|P9|"82%"|S24|Q58|S24|Q59|S24|Q65|S24|Q66 /* Spermizid → P9 → 82% */
Q8|P10|"3-12" /* Spermizid → P10 → 3-12 */
Q8|P11|Q204 /* Spermizid → P11 → bei Bedarf */
Q8|P12|Q206 /* Spermizid → P12 → ungewollte Schwangerschaft */
Q8|P13|"Spermicidal Foam & Suppositories.png" /* Spermizid → P13 → Spermicidal Foam & Suppositories.png */
Q8|P14|"https://www.profamilia.de/themen/verhuetung/chemische-verhuetungsmittel" /* Spermizid → P14 → https://www.profamilia.de/themen/verhuetung/chemische-verhuetungsmittel */
Q9|P3|Q207|S24|Q73|S24|Q74 /* Hormonpflaster → P3 → Weiblich */
Q9|P4|Q221 /* Hormonpflaster → P4 → hormonell */
Q9|P5|Q226|S24|Q70|S24|Q71|S24|Q72 /* Hormonpflaster → P5 → medizinische Substanz */
Q9|P5|Q198|S24|Q70|S24|Q71|S24|Q72 /* Hormonpflaster → P5 → Pflaster */
Q9|P6|"Ja" /* Hormonpflaster → P6 → Ja */
Q9|P7|"7" /* Hormonpflaster → P7 → 7 */
Q9|P8|"0.03" /* Hormonpflaster → P8 → 0.03 */
Q9|P9|">99%"|S24|Q67|S24|Q68|S24|Q69 /* Hormonpflaster → P9 → >99% */
Q9|P10|"0.72-0.9" /* Hormonpflaster → P10 → 0.72-0.9 */
Q9|P11|Q214 /* Hormonpflaster → P11 → wöchentlich */
Q9|P12|Q206 /* Hormonpflaster → P12 → ungewollte Schwangerschaft */
Q9|P13|"BirthControlPatch.JPG" /* Hormonpflaster → P13 → BirthControlPatch.JPG */
Q9|P14|"https://www.profamilia.de/themen/verhuetung/verhuetungspflaster" /* Hormonpflaster → P14 → https://www.profamilia.de/themen/verhuetung/verhuetungspflaster */
Q10|P3|Q207|S24|Q75|S24|Q76|S24|Q83 /* Gestagenpille (Minipille) → P3 → Weiblich */
Q10|P3|Q203|S24|Q75|S24|Q76|S24|Q83 /* Gestagenpille (Minipille) → P3 → Intersexuell */
Q10|P4|Q221 /* Gestagenpille (Minipille) → P4 → hormonell */
Q10|P5|Q226 /* Gestagenpille (Minipille) → P5 → medizinische Substanz */
Q10|P6|"Ja" /* Gestagenpille (Minipille) → P6 → Ja */
Q10|P7|"7"|S24|Q79|S24|Q80 /* Gestagenpille (Minipille) → P7 → 7 */
Q10|P8|"0.3" /* Gestagenpille (Minipille) → P8 → 0.3 */
Q10|P9|">99%"|S24|Q81|S24|Q82 /* Gestagenpille (Minipille) → P9 → >99% */
Q10|P10|"0.5-3"|S24|Q229|S24|Q78 /* Gestagenpille (Minipille) → P10 → 0.5-3 */
Q10|P11|Q224 /* Gestagenpille (Minipille) → P11 → täglich */
Q10|P12|Q206 /* Gestagenpille (Minipille) → P12 → ungewollte Schwangerschaft */
Q10|P13|"Pilule contraceptive.jpg" /* Gestagenpille (Minipille) → P13 → Pilule contraceptive.jpg */
Q10|P14|"https://www.profamilia.de/themen/verhuetung/pille" /* Gestagenpille (Minipille) → P14 → https://www.profamilia.de/themen/verhuetung/pille */
Q11|P3|Q207|S24|Q84|S24|Q85|S24|Q86|S24|Q87 /* Vaginalring → P3 → Weiblich */
Q11|P4|Q221 /* Vaginalring → P4 → hormonell */
Q11|P5|Q226|S24|Q88|S24|Q89|S24|Q90 /* Vaginalring → P5 → medizinische Substanz */
Q11|P5|Q197|S24|Q88|S24|Q89|S24|Q90 /* Vaginalring → P5 → Kunststoff */
Q11|P6|"Ja" /* Vaginalring → P6 → Ja */
Q11|P7|"7" /* Vaginalring → P7 → 7 */
Q11|P8|"0.03" /* Vaginalring → P8 → 0.03 */
Q11|P9|">99%"|S24|Q91|S24|Q92|S24|Q93|S24|Q94|S24|Q95 /* Vaginalring → P9 → >99% */
Q11|P10|"0.4-0.65" /* Vaginalring → P10 → 0.4-0.65 */
Q11|P11|Q202 /* Vaginalring → P11 → monatlich */
Q11|P12|Q206 /* Vaginalring → P12 → ungewollte Schwangerschaft */
Q11|P13|"Anillo anticonceptivo.JPG" /* Vaginalring → P13 → Anillo anticonceptivo.JPG */
Q11|P14|"https://www.profamilia.de/themen/verhuetung/vaginalring" /* Vaginalring → P14 → https://www.profamilia.de/themen/verhuetung/vaginalring */
Q12|P3|Q207|S24|Q96|S24|Q97|S24|Q98 /* Dreimonatsspritze → P3 → Weiblich */
Q12|P4|Q221 /* Dreimonatsspritze → P4 → hormonell */
Q12|P5|Q226|S24|Q99 /* Dreimonatsspritze → P5 → medizinische Substanz */
Q12|P5|Q195|S24|Q99 /* Dreimonatsspritze → P5 → medizinischer Eingriff */
Q12|P6|"Ja" /* Dreimonatsspritze → P6 → Ja */
Q12|P7|"3" /* Dreimonatsspritze → P7 → 3 */
Q12|P8|"0.05" /* Dreimonatsspritze → P8 → 0.05 */
Q12|P9|">99%"|S24|Q100|S24|Q101|S24|Q228 /* Dreimonatsspritze → P9 → >99% */
Q12|P10|"0.3-0.88" /* Dreimonatsspritze → P10 → 0.3-0.88 */
Q12|P11|Q220 /* Dreimonatsspritze → P11 → quartalweise */
Q12|P12|Q206 /* Dreimonatsspritze → P12 → ungewollte Schwangerschaft */
Q12|P13|"Prikpil.JPG" /* Dreimonatsspritze → P13 → Prikpil.JPG */
Q12|P14|"https://www.profamilia.de/themen/verhuetung/depot-spritze" /* Dreimonatsspritze → P14 → https://www.profamilia.de/themen/verhuetung/depot-spritze */
Q13|P3|Q207|S24|Q104 /* Hormonspirale → P3 → Weiblich */
Q13|P4|Q221 /* Hormonspirale → P4 → hormonell */
Q13|P5|Q226|S24|Q103|S24|Q107|S24|Q109 /* Hormonspirale → P5 → medizinische Substanz */
Q13|P5|Q197|S24|Q103|S24|Q107|S24|Q109 /* Hormonspirale → P5 → Kunststoff */
Q13|P5|Q195|S24|Q103|S24|Q107|S24|Q109 /* Hormonspirale → P5 → medizinischer Eingriff */
Q13|P6|"Ja" /* Hormonspirale → P6 → Ja */
Q13|P7|"0.7" /* Hormonspirale → P7 → 0.7 */
Q13|P8|"0.5" /* Hormonspirale → P8 → 0.5 */
Q13|P9|">99%"|S24|Q105|S24|Q106|S24|Q108|S24|Q110 /* Hormonspirale → P9 → >99% */
Q13|P10|"0.16" /* Hormonspirale → P10 → 0.16 */
Q13|P11|Q211 /* Hormonspirale → P11 → alle 3-5 Jahre */
Q13|P12|Q206 /* Hormonspirale → P12 → ungewollte Schwangerschaft */
Q13|P13|"Mirena IUD.jpg" /* Hormonspirale → P13 → Mirena IUD.jpg */
Q13|P14|"https://www.profamilia.de/themen/verhuetung/spirale" /* Hormonspirale → P14 → https://www.profamilia.de/themen/verhuetung/spirale */
Q14|P3|Q207|S24|Q129|S24|Q133|S24|Q136|S24|Q138|S24|Q139 /* Kombinierte orale Kontrazeptiva (Pille) → P3 → Weiblich */
Q14|P4|Q221 /* Kombinierte orale Kontrazeptiva (Pille) → P4 → hormonell */
Q14|P5|Q226|S24|Q130|S24|Q134|S24|Q135|S24|Q137|S24|Q140 /* Kombinierte orale Kontrazeptiva (Pille) → P5 → medizinische Substanz */
Q14|P6|"Ja" /* Kombinierte orale Kontrazeptiva (Pille) → P6 → Ja */
Q14|P7|"7" /* Kombinierte orale Kontrazeptiva (Pille) → P7 → 7 */
Q14|P8|"0.3" /* Kombinierte orale Kontrazeptiva (Pille) → P8 → 0.3 */
Q14|P9|">99%" /* Kombinierte orale Kontrazeptiva (Pille) → P9 → >99% */
Q14|P10|"0.1-0.9"|S24|Q128|S24|Q131|S24|Q132 /* Kombinierte orale Kontrazeptiva (Pille) → P10 → 0.1-0.9 */
Q14|P11|Q224 /* Kombinierte orale Kontrazeptiva (Pille) → P11 → täglich */
Q14|P12|Q206 /* Kombinierte orale Kontrazeptiva (Pille) → P12 → ungewollte Schwangerschaft */
Q14|P13|"Combined oral contraceptive pill (2).JPG" /* Kombinierte orale Kontrazeptiva (Pille) → P13 → Combined oral contraceptive pill (2).JPG */
Q14|P14|"https://www.profamilia.de/themen/verhuetung/pille" /* Kombinierte orale Kontrazeptiva (Pille) → P14 → https://www.profamilia.de/themen/verhuetung/pille */
Q15|P3|Q207|S24|Q119 /* Hormonimplantat (Hormonstäbchen) → P3 → Weiblich */
Q15|P4|Q221 /* Hormonimplantat (Hormonstäbchen) → P4 → hormonell */
Q15|P5|Q226|S24|Q121|S24|Q124|S24|Q125|S24|Q127 /* Hormonimplantat (Hormonstäbchen) → P5 → medizinische Substanz */
Q15|P5|Q197|S24|Q121|S24|Q124|S24|Q125|S24|Q127 /* Hormonimplantat (Hormonstäbchen) → P5 → Kunststoff */
Q15|P5|Q195|S24|Q121|S24|Q124|S24|Q125|S24|Q127 /* Hormonimplantat (Hormonstäbchen) → P5 → medizinischer Eingriff */
Q15|P6|"Ja" /* Hormonimplantat (Hormonstäbchen) → P6 → Ja */
Q15|P7|"0.1" /* Hormonimplantat (Hormonstäbchen) → P7 → 0.1 */
Q15|P8|"0.1" /* Hormonimplantat (Hormonstäbchen) → P8 → 0.1 */
Q15|P9|">99%"|S24|Q122|S24|Q123|S24|Q126 /* Hormonimplantat (Hormonstäbchen) → P9 → >99% */
Q15|P10|"0-0.08"|S24|Q120 /* Hormonimplantat (Hormonstäbchen) → P10 → 0-0.08 */
Q15|P11|Q222 /* Hormonimplantat (Hormonstäbchen) → P11 → alle 3 Jahre */
Q15|P12|Q206 /* Hormonimplantat (Hormonstäbchen) → P12 → ungewollte Schwangerschaft */
Q15|P13|"Implanon 04.jpg" /* Hormonimplantat (Hormonstäbchen) → P13 → Implanon 04.jpg */
Q15|P14|"https://www.profamilia.de/themen/verhuetung/hormonimplantat" /* Hormonimplantat (Hormonstäbchen) → P14 → https://www.profamilia.de/themen/verhuetung/hormonimplantat */
Q16|P3|Q207 /* Keine Verhütung → P3 → Weiblich */
Q16|P3|Q208 /* Keine Verhütung → P3 → Männlich */
Q16|P3|Q203 /* Keine Verhütung → P3 → Intersexuell */
Q16|P4|Q215 /* Keine Verhütung → P4 → keine Verhütungsmethode */
Q16|P6|"Nein" /* Keine Verhütung → P6 → Nein */
Q16|P7|"85" /* Keine Verhütung → P7 → 85 */
Q16|P8|"85" /* Keine Verhütung → P8 → 85 */
Q16|P9|"15%" /* Keine Verhütung → P9 → 15% */
Q16|P10|"85" /* Keine Verhütung → P10 → 85 */
Q16|P11|Q224 /* Keine Verhütung → P11 → täglich */
Q16|P12|Q206 /* Keine Verhütung → P12 → ungewollte Schwangerschaft */
Q17|P3|Q207|S24|Q117 /* Kupferspirale → P3 → Weiblich */
Q17|P4|Q17 /* Kupferspirale → P4 → Kupferspirale */
Q17|P4|Q227 /* Kupferspirale → P4 → chemisch */
Q17|P5|Q197|S24|Q112|S24|Q113|S24|Q118 /* Kupferspirale → P5 → Kunststoff */
Q17|P5|Q200|S24|Q112|S24|Q113|S24|Q118 /* Kupferspirale → P5 → Kupfer */
Q17|P5|Q195|S24|Q112|S24|Q113|S24|Q118 /* Kupferspirale → P5 → medizinischer Eingriff */
Q17|P6|"Ja" /* Kupferspirale → P6 → Ja */
Q17|P7|"0.8" /* Kupferspirale → P7 → 0.8 */
Q17|P8|"0.6" /* Kupferspirale → P8 → 0.6 */
Q17|P9|">99%"|S24|Q111|S24|Q114|S24|Q115|S24|Q116 /* Kupferspirale → P9 → >99% */
Q17|P10|"0.3-0.8" /* Kupferspirale → P10 → 0.3-0.8 */
Q17|P11|Q199 /* Kupferspirale → P11 → alle 5-10 Jahre */
Q17|P12|Q206 /* Kupferspirale → P12 → ungewollte Schwangerschaft */
Q17|P13|"Multiload-Gynefix-Paragard.jpg" /* Kupferspirale → P13 → Multiload-Gynefix-Paragard.jpg */
Q17|P14|"https://www.profamilia.de/themen/verhuetung/spirale" /* Kupferspirale → P14 → https://www.profamilia.de/themen/verhuetung/spirale */
Q18|P3|Q207|S24|Q143|S24|Q151 /* Kondom für Frauen (Femidom) → P3 → Weiblich */
Q18|P3|Q203|S24|Q143|S24|Q151 /* Kondom für Frauen (Femidom) → P3 → Intersexuell */
Q18|P4|Q217 /* Kondom für Frauen (Femidom) → P4 → mechanisch */
Q18|P5|Q216 /* Kondom für Frauen (Femidom) → P5 → Latex */
Q18|P5|Q197 /* Kondom für Frauen (Femidom) → P5 → Kunststoff */
Q18|P6|"Nein" /* Kondom für Frauen (Femidom) → P6 → Nein */
Q18|P7|"21"|S24|Q144 /* Kondom für Frauen (Femidom) → P7 → 21 */
Q18|P8|"5" /* Kondom für Frauen (Femidom) → P8 → 5 */
Q18|P9|"95%"|S24|Q141|S24|Q142|S24|Q150 /* Kondom für Frauen (Femidom) → P9 → 95% */
Q18|P10|"5-25" /* Kondom für Frauen (Femidom) → P10 → 5-25 */
Q18|P11|Q204 /* Kondom für Frauen (Femidom) → P11 → bei Bedarf */
Q18|P12|Q206 /* Kondom für Frauen (Femidom) → P12 → ungewollte Schwangerschaft */
Q18|P12|Q219 /* Kondom für Frauen (Femidom) → P12 → sexuell übertragbare Erkrankungen */
Q18|P13|"Préservatif féminin.jpg" /* Kondom für Frauen (Femidom) → P13 → Préservatif féminin.jpg */
Q18|P14|"https://www.profamilia.de/themen/verhuetung/frauenkondom" /* Kondom für Frauen (Femidom) → P14 → https://www.profamilia.de/themen/verhuetung/frauenkondom */
Q19|P3|Q207 /* Diaphragma (Pessar) → P3 → Weiblich */
Q19|P3|Q203 /* Diaphragma (Pessar) → P3 → Intersexuell */
Q19|P4|Q217 /* Diaphragma (Pessar) → P4 → mechanisch */
Q19|P5|Q216|S24|Q148 /* Diaphragma (Pessar) → P5 → Latex */
Q19|P5|Q212|S24|Q148 /* Diaphragma (Pessar) → P5 → medizinisches Selikon */
Q19|P5|Q205|S24|Q148 /* Diaphragma (Pessar) → P5 → Hartgummi */
Q19|P6|"Nein" /* Diaphragma (Pessar) → P6 → Nein */
Q19|P7|"12"|S24|Q146|S24|Q147 /* Diaphragma (Pessar) → P7 → 12 */
Q19|P8|"4-8" /* Diaphragma (Pessar) → P8 → 4-8 */
Q19|P9|"92-96%"|S24|Q145 /* Diaphragma (Pessar) → P9 → 92-96% */
Q19|P10|"1-20"|S24|Q149 /* Diaphragma (Pessar) → P10 → 1-20 */
Q19|P11|Q204 /* Diaphragma (Pessar) → P11 → bei Bedarf */
Q19|P12|Q206 /* Diaphragma (Pessar) → P12 → ungewollte Schwangerschaft */
Q19|P13|"Contraceptive Diaphragm side view.jpg" /* Diaphragma (Pessar) → P13 → Contraceptive Diaphragm side view.jpg */
Q19|P14|"https://www.profamilia.de/themen/verhuetung/diaphragma" /* Diaphragma (Pessar) → P14 → https://www.profamilia.de/themen/verhuetung/diaphragma */
Q20|P3|Q207|S24|Q152|S24|Q156|S24|Q159 /* Kondom für Männer → P3 → Weiblich */
Q20|P3|Q208|S24|Q152|S24|Q156|S24|Q159 /* Kondom für Männer → P3 → Männlich */
Q20|P3|Q203|S24|Q152|S24|Q156|S24|Q159 /* Kondom für Männer → P3 → Intersexuell */
Q20|P4|Q217 /* Kondom für Männer → P4 → mechanisch */
Q20|P5|Q216|S24|Q160|S24|Q161|S24|Q162 /* Kondom für Männer → P5 → Latex */
Q20|P5|Q197|S24|Q160|S24|Q161|S24|Q162 /* Kondom für Männer → P5 → Kunststoff */
Q20|P6|"Nein" /* Kondom für Männer → P6 → Nein */
Q20|P7|"13"|S24|Q155 /* Kondom für Männer → P7 → 13 */
Q20|P8|"2" /* Kondom für Männer → P8 → 2 */
Q20|P9|"98%"|S24|Q154|S24|Q157|S24|Q158 /* Kondom für Männer → P9 → 98% */
Q20|P10|"2-12"|S24|Q153 /* Kondom für Männer → P10 → 2-12 */
Q20|P11|Q204 /* Kondom für Männer → P11 → bei Bedarf */
Q20|P12|Q206 /* Kondom für Männer → P12 → ungewollte Schwangerschaft */
Q20|P12|Q219 /* Kondom für Männer → P12 → sexuell übertragbare Erkrankungen */
Q20|P13|"Kondom.jpg" /* Kondom für Männer → P13 → Kondom.jpg */
Q20|P14|"https://www.profamilia.de/themen/verhuetung/kondom" /* Kondom für Männer → P14 → https://www.profamilia.de/themen/verhuetung/kondom */
Q21|P3|Q207|S24|Q164 /* Portiokappe → P3 → Weiblich */
Q21|P3|Q203|S24|Q164 /* Portiokappe → P3 → Intersexuell */
Q21|P4|Q217 /* Portiokappe → P4 → mechanisch */
Q21|P5|Q216 /* Portiokappe → P5 → Latex */
Q21|P5|Q212 /* Portiokappe → P5 → medizinisches Selikon */
Q21|P5|Q205 /* Portiokappe → P5 → Hartgummi */
Q21|P6|"Nein" /* Portiokappe → P6 → Nein */
Q21|P7|"17-23"|S24|Q166|S24|Q167 /* Portiokappe → P7 → 17-23 */
Q21|P8|"4-8" /* Portiokappe → P8 → 4-8 */
Q21|P9|"92-96%"|S24|Q163|S24|Q165|S24|Q168 /* Portiokappe → P9 → 92-96% */
Q21|P10|"6" /* Portiokappe → P10 → 6 */
Q21|P11|Q204 /* Portiokappe → P11 → bei Bedarf */
Q21|P12|Q206 /* Portiokappe → P12 → ungewollte Schwangerschaft */
Q21|P13|"Cape cervicale.jpg" /* Portiokappe → P13 → Cape cervicale.jpg */
Q21|P14|"https://www.profamilia.de/themen/verhuetung/verhuetungskappen" /* Portiokappe → P14 → https://www.profamilia.de/themen/verhuetung/verhuetungskappen */
Q22|P3|Q207|S24|Q170 /* Verhütungsschwamm → P3 → Weiblich */
Q22|P3|Q203|S24|Q170 /* Verhütungsschwamm → P3 → Intersexuell */
Q22|P4|Q217 /* Verhütungsschwamm → P4 → mechanisch */
Q22|P4|Q227 /* Verhütungsschwamm → P4 → chemisch */
Q22|P5|Q197|S24|Q171|S24|Q174|S24|Q175|S24|Q176 /* Verhütungsschwamm → P5 → Kunststoff */
Q22|P5|Q226|S24|Q171|S24|Q174|S24|Q175|S24|Q176 /* Verhütungsschwamm → P5 → medizinische Substanz */
Q22|P6|"Nein" /* Verhütungsschwamm → P6 → Nein */
Q22|P7|"12-24" /* Verhütungsschwamm → P7 → 12-24 */
Q22|P8|"9-20" /* Verhütungsschwamm → P8 → 9-20 */
Q22|P9|"80-91%" /* Verhütungsschwamm → P9 → 80-91% */
Q22|P10|"5-10"|S24|Q169|S24|Q172|S24|Q173 /* Verhütungsschwamm → P10 → 5-10 */
Q22|P11|Q204 /* Verhütungsschwamm → P11 → bei Bedarf */
Q22|P12|Q206 /* Verhütungsschwamm → P12 → ungewollte Schwangerschaft */
Q22|P13|"Éponge spermicide.jpg" /* Verhütungsschwamm → P13 → Éponge spermicide.jpg */
Q23|P3|Q207|S24|Q177|S24|Q179|S24|Q180 /* Coitus interruptus → P3 → Weiblich */
Q23|P3|Q208|S24|Q177|S24|Q179|S24|Q180 /* Coitus interruptus → P3 → Männlich */
Q23|P3|Q203|S24|Q177|S24|Q179|S24|Q180 /* Coitus interruptus → P3 → Intersexuell */
Q23|P4|Q209 /* Coitus interruptus → P4 → natürlich */
Q23|P6|"Nein" /* Coitus interruptus → P6 → Nein */
Q23|P7|"20" /* Coitus interruptus → P7 → 20 */
Q23|P8|"4" /* Coitus interruptus → P8 → 4 */
Q23|P9|"96%"|S24|Q178 /* Coitus interruptus → P9 → 96% */
Q23|P10|"4-18" /* Coitus interruptus → P10 → 4-18 */
Q23|P11|Q204 /* Coitus interruptus → P11 → bei Bedarf */
Q23|P12|Q206 /* Coitus interruptus → P12 → ungewollte Schwangerschaft */
Q23|P13|"Binomialverteilung Verhütung mit Coitus Interruptus (GeoGebra).png" /* Coitus interruptus → P13 → Binomialverteilung Verhütung mit Coitus Interruptus (GeoGebra).png */
Q24|P3|Q207|S24|Q183 /* Temperaturmethode (Symptothermale Methode) → P3 → Weiblich */
Q24|P3|Q203|S24|Q183 /* Temperaturmethode (Symptothermale Methode) → P3 → Intersexuell */
Q24|P4|Q209 /* Temperaturmethode (Symptothermale Methode) → P4 → natürlich */
Q24|P5|Q201 /* Temperaturmethode (Symptothermale Methode) → P5 → Thermometer */
Q24|P6|"Nein" /* Temperaturmethode (Symptothermale Methode) → P6 → Nein */
Q24|P7|"somevalue" /* Temperaturmethode (Symptothermale Methode) → P7 → somevalue */
Q24|P8|"somevalue" /* Temperaturmethode (Symptothermale Methode) → P8 → somevalue */
Q24|P9|"97-99%" /* Temperaturmethode (Symptothermale Methode) → P9 → 97-99% */
Q24|P10|"0.8-3"|S24|Q181|S24|Q182 /* Temperaturmethode (Symptothermale Methode) → P10 → 0.8-3 */
Q24|P11|Q204 /* Temperaturmethode (Symptothermale Methode) → P11 → bei Bedarf */
Q24|P12|Q206 /* Temperaturmethode (Symptothermale Methode) → P12 → ungewollte Schwangerschaft */
Q24|P13|"FruchtbarePhase.png" /* Temperaturmethode (Symptothermale Methode) → P13 → FruchtbarePhase.png */
Q24|P14|"https://www.profamilia.de/themen/verhuetung/fruchtbarkeitswahrnehmung" /* Temperaturmethode (Symptothermale Methode) → P14 → https://www.profamilia.de/themen/verhuetung/fruchtbarkeitswahrnehmung */
Q25|P3|Q207|S24|Q184|S24|Q185|S24|Q186 /* Kalendermethode → P3 → Weiblich */
Q25|P3|Q203|S24|Q184|S24|Q185|S24|Q186 /* Kalendermethode → P3 → Intersexuell */
Q25|P4|Q209 /* Kalendermethode → P4 → natürlich */
Q25|P5|Q218 /* Kalendermethode → P5 → Zykluskalender */
Q25|P6|"Nein" /* Kalendermethode → P6 → Nein */
Q25|P7|"15-24" /* Kalendermethode → P7 → 15-24 */
Q25|P8|"somevalue" /* Kalendermethode → P8 → somevalue */
Q25|P9|"76-85%" /* Kalendermethode → P9 → 76-85% */
Q25|P10|"9" /* Kalendermethode → P10 → 9 */
Q25|P11|Q224 /* Kalendermethode → P11 → täglich */
Q25|P12|Q206 /* Kalendermethode → P12 → ungewollte Schwangerschaft */
Q25|P13|"Typical mentrual monthly cycle.png" /* Kalendermethode → P13 → Typical mentrual monthly cycle.png */
Q25|P14|"https://www.profamilia.de/themen/verhuetung/fruchtbarkeitswahrnehmung" /* Kalendermethode → P14 → https://www.profamilia.de/themen/verhuetung/fruchtbarkeitswahrnehmung */
Q26|P3|Q207|S24|Q187|S24|Q188|S24|Q189|S24|Q190 /* Pille Danach → P3 → Weiblich */
Q26|P4|Q213 /* Pille Danach → P4 → Notfallkontrazeptivum */
Q26|P5|Q226|S24|Q193|S24|Q194 /* Pille Danach → P5 → medizinische Substanz */
Q26|P6|"Nein" /* Pille Danach → P6 → Nein */
Q26|P7|"2-41" /* Pille Danach → P7 → 2-41 */
Q26|P8|"somevalue" /* Pille Danach → P8 → somevalue */
Q26|P9|"59-98%"|S24|Q191|S24|Q192 /* Pille Danach → P9 → 59-98% */
Q26|P10|"1-30" /* Pille Danach → P10 → 1-30 */
Q26|P11|Q204 /* Pille Danach → P11 → Bei Bedarf */
Q26|P12|Q206 /* Pille Danach → P12 → ungewollte Schwangerschaft */
Q26|P13|"Emergency contraceptive.jpg" /* Pille Danach → P13 → Emergency contraceptive.jpg */
Q26|P14|"https://www.profamilia.de/themen/verhuetung/pille-danach" /* Pille Danach → P14 → https://www.profamilia.de/themen/verhuetung/pille-danach */
Q27|P3|Q207|S24|Q46|S24|Q47|S24|Q51|S24|Q53|S24|Q54|S24|Q55 /* Sterilisation der Frau (Tubenligatur) → P3 → Weiblich */
Q27|P4|Q223 /* Sterilisation der Frau (Tubenligatur) → P4 → operativ */
Q27|P5|Q195|S24|Q48|S24|Q50|S24|Q52 /* Sterilisation der Frau (Tubenligatur) → P5 → medizinischer Eingriff */
Q27|P6|"Ja" /* Sterilisation der Frau (Tubenligatur) → P6 → Ja */
Q27|P7|"0.5" /* Sterilisation der Frau (Tubenligatur) → P7 → 0.5 */
Q27|P8|"0.5" /* Sterilisation der Frau (Tubenligatur) → P8 → 0.5 */
Q27|P9|">99%"|S24|Q49|S24|Q56|S24|Q57 /* Sterilisation der Frau (Tubenligatur) → P9 → >99% */
Q27|P10|"0.2-0.3" /* Sterilisation der Frau (Tubenligatur) → P10 → 0.2-0.3 */
Q27|P11|Q196 /* Sterilisation der Frau (Tubenligatur) → P11 → einmalig */
Q27|P12|Q206 /* Sterilisation der Frau (Tubenligatur) → P12 → ungewollte Schwangerschaft */
Q27|P13|"Sterilizace ženy.jpg" /* Sterilisation der Frau (Tubenligatur) → P13 → Sterilizace ženy.jpg */
Q27|P14|"https://www.profamilia.de/themen/verhuetung/sterilisation" /* Sterilisation der Frau (Tubenligatur) → P14 → https://www.profamilia.de/themen/verhuetung/sterilisation */
Q28|P3|Q208|S24|Q41 /* Sterilisation des Mannes (Vasektomie) → P3 → Männlich */
Q28|P4|Q223 /* Sterilisation des Mannes (Vasektomie) → P4 → operativ */
Q28|P5|Q195|S24|Q42|S24|Q43|S24|Q44|S24|Q45 /* Sterilisation des Mannes (Vasektomie) → P5 → medizinischer Eingriff */
Q28|P6|"Ja" /* Sterilisation des Mannes (Vasektomie) → P6 → Ja */
Q28|P7|"0.15" /* Sterilisation des Mannes (Vasektomie) → P7 → 0.15 */
Q28|P8|"0.1" /* Sterilisation des Mannes (Vasektomie) → P8 → 0.1 */
Q28|P9|">99%"|S24|Q36|S24|Q37|S24|Q38|S24|Q39|S24|Q40 /* Sterilisation des Mannes (Vasektomie) → P9 → >99% */
Q28|P10|"0.1" /* Sterilisation des Mannes (Vasektomie) → P10 → 0.1 */
Q28|P11|Q196 /* Sterilisation des Mannes (Vasektomie) → P11 → einmalig */
Q28|P12|Q206 /* Sterilisation des Mannes (Vasektomie) → P12 → ungewollte Schwangerschaft */
Q28|P13|"Open Vasectomy .jpeg" /* Sterilisation des Mannes (Vasektomie) → P13 → Open Vasectomy .jpeg */
Q28|P14|"https://www.profamilia.de/themen/verhuetung/sterilisation" /* Sterilisation des Mannes (Vasektomie) → P14 → https://www.profamilia.de/themen/verhuetung/sterilisation */
Q29|P3|Q203|S24|Q30|S24|Q31|S24|Q32|S24|Q33|S24|Q34|S24|Q35 /* Sterilisation von intergeschlechtlichen Personen (meist unfreiwillig) → P3 → Intersexuell */
Q29|P4|Q223 /* Sterilisation von intergeschlechtlichen Personen (meist unfreiwillig) → P4 → operativ */
Q29|P5|Q195 /* Sterilisation von intergeschlechtlichen Personen (meist unfreiwillig) → P5 → medizinischer Eingriff */
Q29|P6|"Ja" /* Sterilisation von intergeschlechtlichen Personen (meist unfreiwillig) → P6 → Ja */
Q29|P7|"somevalue" /* Sterilisation von intergeschlechtlichen Personen (meist unfreiwillig) → P7 → somevalue */
Q29|P8|"somevalue" /* Sterilisation von intergeschlechtlichen Personen (meist unfreiwillig) → P8 → somevalue */
Q29|P9|"somevalue" /* Sterilisation von intergeschlechtlichen Personen (meist unfreiwillig) → P9 → somevalue */
Q29|P10|"somevalue" /* Sterilisation von intergeschlechtlichen Personen (meist unfreiwillig) → P10 → somevalue */
Q29|P12|Q206 /* Sterilisation von intergeschlechtlichen Personen (meist unfreiwillig) → P12 → ungewollte Schwangerschaft */
Q29|P13|"Phall-O-Meter (Intersex Society of North America).jpg" /* Sterilisation von intergeschlechtlichen Personen (meist unfreiwillig) → P13 → Phall-O-Meter (Intersex Society of North America).jpg */
Q30|P15|"Loder CM, Minadeo L, Jimenez L, Luna Z, Ross L, Rosenbloom N, Stalburg CM, Harris LH"/* Bridging the Expertise of Advocates and Academics to Identify Reproductive Justice Learning Outcomes → P15 → Loder CM, Minadeo L, Jimenez L, Luna Z, Ross L, Rosenbloom N, Stalburg CM, Harris LH */
Q30|P16|"Teach Learn Med"/* Bridging the Expertise of Advocates and Academics to Identify Reproductive Justice Learning Outcomes → P16 → Teach Learn Med */
Q30|P17|"Jan-Mar;32(1):11-22"/* Bridging the Expertise of Advocates and Academics to Identify Reproductive Justice Learning Outcomes → P17 → Jan-Mar;32(1):11-22 */
Q30|P18|+2020-01-01T00:00:00Z/9/* Bridging the Expertise of Advocates and Academics to Identify Reproductive Justice Learning Outcomes → P18 → +2020-01-01T00:00:00Z/9 */
Q30|P19|"10.1080/10401334.2019.1631168"/* Bridging the Expertise of Advocates and Academics to Identify Reproductive Justice Learning Outcomes → P19 → 10.1080/10401334.2019.1631168 */
Q30|P20|"Reproductive justice; advocacy; curriculum development; health disparities"/* Bridging the Expertise of Advocates and Academics to Identify Reproductive Justice Learning Outcomes → P20 → Reproductive justice; advocacy; curriculum development; health disparities */
Q30|P1|"https://pubmed.ncbi.nlm.nih.gov/31293184/"/* Bridging the Expertise of Advocates and Academics to Identify Reproductive Justice Learning Outcomes → P1 → https://pubmed.ncbi.nlm.nih.gov/31293184/ */
Q30|P22|Q29/* Bridging the Expertise of Advocates and Academics to Identify Reproductive Justice Learning Outcomes → P22 → Sterilisation von intergeschlechtlichen Personen (meist unfreiwillig) */
Q30|P23|Q2/* Bridging the Expertise of Advocates and Academics to Identify Reproductive Justice Learning Outcomes → P23 → Geschlecht */
Q31|P15|"Cregan K"/* Sex definitions and gender practices. An update from Australia → P15 → Cregan K */
Q31|P16|"Camb Q Healthc Ethics"/* Sex definitions and gender practices. An update from Australia → P16 → Camb Q Healthc Ethics */
Q31|P17|"Jul;23(3):319-25"/* Sex definitions and gender practices. An update from Australia → P17 → Jul;23(3):319-25 */
Q31|P18|+2014-01-01T00:00:00Z/9/* Sex definitions and gender practices. An update from Australia → P18 → +2014-01-01T00:00:00Z/9 */
Q31|P19|"10.1017/S0963180113000923"/* Sex definitions and gender practices. An update from Australia → P19 → 10.1017/S0963180113000923 */
Q31|P1|"https://pubmed.ncbi.nlm.nih.gov/24867337/"/* Sex definitions and gender practices. An update from Australia → P1 → https://pubmed.ncbi.nlm.nih.gov/24867337/ */
Q31|P22|Q29/* Sex definitions and gender practices. An update from Australia → P22 → Sterilisation von intergeschlechtlichen Personen (meist unfreiwillig) */
Q31|P23|Q2/* Sex definitions and gender practices. An update from Australia → P23 → Geschlecht */
Q32|P15|"O'Connor M"/* THE TREATMENT OF INTERSEX AND THE PROBLEM OF DELAY: THE AUSTRALIAN SENATE INQUIRY INTO INTERSEX SURGERY AND CONFLICTING HUMAN RIGHTS FOR CHILDREN → P15 → O'Connor M */
Q32|P16|"J Law Med."/* THE TREATMENT OF INTERSEX AND THE PROBLEM OF DELAY: THE AUSTRALIAN SENATE INQUIRY INTO INTERSEX SURGERY AND CONFLICTING HUMAN RIGHTS FOR CHILDREN → P16 → J Law Med. */
Q32|P17|"Mar;23(3):531-43"/* THE TREATMENT OF INTERSEX AND THE PROBLEM OF DELAY: THE AUSTRALIAN SENATE INQUIRY INTO INTERSEX SURGERY AND CONFLICTING HUMAN RIGHTS FOR CHILDREN → P17 → Mar;23(3):531-43 */
Q32|P18|+2016-01-01T00:00:00Z/9/* THE TREATMENT OF INTERSEX AND THE PROBLEM OF DELAY: THE AUSTRALIAN SENATE INQUIRY INTO INTERSEX SURGERY AND CONFLICTING HUMAN RIGHTS FOR CHILDREN → P18 → +2016-01-01T00:00:00Z/9 */
Q32|P1|"https://pubmed.ncbi.nlm.nih.gov/27323632/"/* THE TREATMENT OF INTERSEX AND THE PROBLEM OF DELAY: THE AUSTRALIAN SENATE INQUIRY INTO INTERSEX SURGERY AND CONFLICTING HUMAN RIGHTS FOR CHILDREN → P1 → https://pubmed.ncbi.nlm.nih.gov/27323632/ */
Q32|P22|Q29/* THE TREATMENT OF INTERSEX AND THE PROBLEM OF DELAY: THE AUSTRALIAN SENATE INQUIRY INTO INTERSEX SURGERY AND CONFLICTING HUMAN RIGHTS FOR CHILDREN → P22 → Sterilisation von intergeschlechtlichen Personen (meist unfreiwillig) */
Q32|P23|Q2/* THE TREATMENT OF INTERSEX AND THE PROBLEM OF DELAY: THE AUSTRALIAN SENATE INQUIRY INTO INTERSEX SURGERY AND CONFLICTING HUMAN RIGHTS FOR CHILDREN → P23 → Geschlecht */
Q33|P15|"Carpenter M"/* The human rights of intersex people: addressing harmful practices and rhetoric of change → P15 → Carpenter M */
Q33|P16|"Reprod Health Matters"/* The human rights of intersex people: addressing harmful practices and rhetoric of change → P16 → Reprod Health Matters */
Q33|P17|"May;24(47):74-84"/* The human rights of intersex people: addressing harmful practices and rhetoric of change → P17 → May;24(47):74-84 */
Q33|P18|+2016-01-01T00:00:00Z/9/* The human rights of intersex people: addressing harmful practices and rhetoric of change → P18 → +2016-01-01T00:00:00Z/9 */
Q33|P19|"10.1016/j.rhm.2016.06.003"/* The human rights of intersex people: addressing harmful practices and rhetoric of change → P19 → 10.1016/j.rhm.2016.06.003 */
Q33|P20|"disorders of sex development; harmful practices; hermeneutical injustice; human rights; intersex"/* The human rights of intersex people: addressing harmful practices and rhetoric of change → P20 → disorders of sex development; harmful practices; hermeneutical injustice; human rights; intersex */
Q33|P1|"https://pubmed.ncbi.nlm.nih.gov/27578341/"/* The human rights of intersex people: addressing harmful practices and rhetoric of change → P1 → https://pubmed.ncbi.nlm.nih.gov/27578341/ */
Q33|P22|Q29/* The human rights of intersex people: addressing harmful practices and rhetoric of change → P22 → Sterilisation von intergeschlechtlichen Personen (meist unfreiwillig) */
Q33|P23|Q2/* The human rights of intersex people: addressing harmful practices and rhetoric of change → P23 → Geschlecht */
Q34|P15|"Anderson S"/* Disorders of Sexual Differentiation: Ethical Considerations Surrounding Early Cosmetic Genital Surgery → P15 → Anderson S */
Q34|P16|"Pediatr Nurs"/* Disorders of Sexual Differentiation: Ethical Considerations Surrounding Early Cosmetic Genital Surgery → P16 → Pediatr Nurs */
Q34|P17|"Jul-Aug;41(4):176-86"/* Disorders of Sexual Differentiation: Ethical Considerations Surrounding Early Cosmetic Genital Surgery → P17 → Jul-Aug;41(4):176-86 */
Q34|P18|+2015-01-01T00:00:00Z/9/* Disorders of Sexual Differentiation: Ethical Considerations Surrounding Early Cosmetic Genital Surgery → P18 → +2015-01-01T00:00:00Z/9 */
Q34|P1|"https://pubmed.ncbi.nlm.nih.gov/26470466/"/* Disorders of Sexual Differentiation: Ethical Considerations Surrounding Early Cosmetic Genital Surgery → P1 → https://pubmed.ncbi.nlm.nih.gov/26470466/ */
Q34|P22|Q29/* Disorders of Sexual Differentiation: Ethical Considerations Surrounding Early Cosmetic Genital Surgery → P22 → Sterilisation von intergeschlechtlichen Personen (meist unfreiwillig) */
Q34|P23|Q2/* Disorders of Sexual Differentiation: Ethical Considerations Surrounding Early Cosmetic Genital Surgery → P23 → Geschlecht */
Q35|P15|"Tam MW"/* Queering reproductive access: reproductive justice in assisted reproductive technologies → P15 → Tam MW */
Q35|P16|"Reprod Health"/* Queering reproductive access: reproductive justice in assisted reproductive technologies → P16 → Reprod Health */
Q35|P17|"Aug 2;18(1):164"/* Queering reproductive access: reproductive justice in assisted reproductive technologies → P17 → Aug 2;18(1):164 */
Q35|P18|+2021-01-01T00:00:00Z/9/* Queering reproductive access: reproductive justice in assisted reproductive technologies → P18 → +2021-01-01T00:00:00Z/9 */
Q35|P19|"10.1186/s12978-021-01214-8"/* Queering reproductive access: reproductive justice in assisted reproductive technologies → P19 → 10.1186/s12978-021-01214-8 */
Q35|P1|"https://pubmed.ncbi.nlm.nih.gov/34340704/"/* Queering reproductive access: reproductive justice in assisted reproductive technologies → P1 → https://pubmed.ncbi.nlm.nih.gov/34340704/ */
Q35|P22|Q29/* Queering reproductive access: reproductive justice in assisted reproductive technologies → P22 → Sterilisation von intergeschlechtlichen Personen (meist unfreiwillig) */
Q35|P23|Q2/* Queering reproductive access: reproductive justice in assisted reproductive technologies → P23 → Geschlecht */
Q36|P15|"Edwards IS, Farlow JL"/* Vasectomy → P15 → Edwards IS, Farlow JL */
Q36|P16|"Med J Aust"/* Vasectomy → P16 → Med J Aust */
Q36|P17|"Jan 12;1(1):39"/* Vasectomy → P17 → Jan 12;1(1):39 */
Q36|P18|+1980-01-01T00:00:00Z/9/* Vasectomy → P18 → +1980-01-01T00:00:00Z/9 */
Q36|P19|"10.5694/j.1326-5377.1980.tb134598.x"/* Vasectomy → P19 → 10.5694/j.1326-5377.1980.tb134598.x */
Q36|P1|"https://pubmed.ncbi.nlm.nih.gov/7360080/"/* Vasectomy → P1 → https://pubmed.ncbi.nlm.nih.gov/7360080/ */
Q36|P22|Q28/* Vasectomy → P22 → Sterilisation des Mannes (Vasektomie) */
Q36|P23|Q6/* Vasectomy → P23 → Effizienzmaße */
Q37|P15|"Freund MJ, Weidmann JE, Goldstein M, Marmar J, Santulli R, Oliveira N"/* Microrecanalization after vasectomy in man → P15 → Freund MJ, Weidmann JE, Goldstein M, Marmar J, Santulli R, Oliveira N */
Q37|P16|"J Androl"/* Microrecanalization after vasectomy in man → P16 → J Androl */
Q37|P17|"Mar-Apr;10(2):120-32"/* Microrecanalization after vasectomy in man → P17 → Mar-Apr;10(2):120-32 */
Q37|P18|+1989-01-01T00:00:00Z/9/* Microrecanalization after vasectomy in man → P18 → +1989-01-01T00:00:00Z/9 */
Q37|P19|"10.1002/j.1939-4640.1989.tb00073.x"/* Microrecanalization after vasectomy in man → P19 → 10.1002/j.1939-4640.1989.tb00073.x */
Q37|P1|"https://pubmed.ncbi.nlm.nih.gov/2715100/"/* Microrecanalization after vasectomy in man → P1 → https://pubmed.ncbi.nlm.nih.gov/2715100/ */
Q37|P22|Q28/* Microrecanalization after vasectomy in man → P22 → Sterilisation des Mannes (Vasektomie) */
Q37|P23|Q6/* Microrecanalization after vasectomy in man → P23 → Effizienzmaße */
Q38|P15|"Smith JC, Cranston D, O'Brien T, Guillebaud J, Hindmarsh J, Turner AG"/* Fatherhood without apparent spermatozoa after vasectomy → P15 → Smith JC, Cranston D, O'Brien T, Guillebaud J, Hindmarsh J, Turner AG */
Q38|P16|"Lancet"/* Fatherhood without apparent spermatozoa after vasectomy → P16 → Lancet */
Q38|P17|"Jul 2;344(8914):30"/* Fatherhood without apparent spermatozoa after vasectomy → P17 → Jul 2;344(8914):30 */
Q38|P18|+1994-01-01T00:00:00Z/9/* Fatherhood without apparent spermatozoa after vasectomy → P18 → +1994-01-01T00:00:00Z/9 */
Q38|P19|"10.1016/s0140-6736(94)91052-9"/* Fatherhood without apparent spermatozoa after vasectomy → P19 → 10.1016/s0140-6736(94)91052-9 */
Q38|P1|"https://pubmed.ncbi.nlm.nih.gov/7912302/"/* Fatherhood without apparent spermatozoa after vasectomy → P1 → https://pubmed.ncbi.nlm.nih.gov/7912302/ */
Q38|P22|Q28/* Fatherhood without apparent spermatozoa after vasectomy → P22 → Sterilisation des Mannes (Vasektomie) */
Q38|P23|Q6/* Fatherhood without apparent spermatozoa after vasectomy → P23 → Effizienzmaße */
Q39|P15|"Temmerman M, Cammu H, Devroey P, Amy JJ"/* Evaluation of one-hundred open-ended vasectomies → P15 → Temmerman M, Cammu H, Devroey P, Amy JJ */
Q39|P16|"Contraception"/* Evaluation of one-hundred open-ended vasectomies → P16 → Contraception */
Q39|P17|"Jun;33(6):529-32"/* Evaluation of one-hundred open-ended vasectomies → P17 → Jun;33(6):529-32 */
Q39|P18|+1986-01-01T00:00:00Z/9/* Evaluation of one-hundred open-ended vasectomies → P18 → +1986-01-01T00:00:00Z/9 */
Q39|P19|"10.1016/0010-7824(86)90040-5"/* Evaluation of one-hundred open-ended vasectomies → P19 → 10.1016/0010-7824(86)90040-5 */
Q39|P1|"https://pubmed.ncbi.nlm.nih.gov/3769480/"/* Evaluation of one-hundred open-ended vasectomies → P1 → https://pubmed.ncbi.nlm.nih.gov/3769480/ */
Q39|P22|Q28/* Evaluation of one-hundred open-ended vasectomies → P22 → Sterilisation des Mannes (Vasektomie) */
Q39|P23|Q6/* Evaluation of one-hundred open-ended vasectomies → P23 → Effizienzmaße */
Q40|P15|"Lucon M, Lucon AM, Pasqualoto FF, Srougi M"/* Paternity after vasectomy with two previous semen analyses without spermatozoa → P15 → Lucon M, Lucon AM, Pasqualoto FF, Srougi M */
Q40|P16|"Sao Paulo Med J"/* Paternity after vasectomy with two previous semen analyses without spermatozoa → P16 → Sao Paulo Med J */
Q40|P17|"Mar 1;125(2):122-3"/* Paternity after vasectomy with two previous semen analyses without spermatozoa → P17 → Mar 1;125(2):122-3 */
Q40|P18|+2007-01-01T00:00:00Z/9/* Paternity after vasectomy with two previous semen analyses without spermatozoa → P18 → +2007-01-01T00:00:00Z/9 */
Q40|P19|"10.1590/s1516-31802007000200011"/* Paternity after vasectomy with two previous semen analyses without spermatozoa → P19 → 10.1590/s1516-31802007000200011 */
Q40|P1|"https://pubmed.ncbi.nlm.nih.gov/17625712/"/* Paternity after vasectomy with two previous semen analyses without spermatozoa → P1 → https://pubmed.ncbi.nlm.nih.gov/17625712/ */
Q40|P22|Q28/* Paternity after vasectomy with two previous semen analyses without spermatozoa → P22 → Sterilisation des Mannes (Vasektomie) */
Q40|P23|Q6/* Paternity after vasectomy with two previous semen analyses without spermatozoa → P23 → Effizienzmaße */
Q41|P15|"Kreutzig-Langenfeld T, Lellig E, Hinz P, Zilg F"/* Vasectomy: Current information → P15 → Kreutzig-Langenfeld T, Lellig E, Hinz P, Zilg F */
Q41|P16|"Urologe A"/* Vasectomy: Current information → P16 → Urologe A */
Q41|P17|"Apr;60(4):523-532"/* Vasectomy: Current information → P17 → Apr;60(4):523-532 */
Q41|P18|+2021-01-01T00:00:00Z/9/* Vasectomy: Current information → P18 → +2021-01-01T00:00:00Z/9 */
Q41|P19|"10.1007/s00120-021-01494-9"/* Vasectomy: Current information → P19 → 10.1007/s00120-021-01494-9 */
Q41|P20|"Contraception; Contraception without side effects; Fertility; Hormone-free contraception; Men; No-scalpel vasectomy; Sterilization"/* Vasectomy: Current information → P20 → Contraception; Contraception without side effects; Fertility; Hormone-free contraception; Men; No-scalpel vasectomy; Sterilization */
Q41|P1|"https://pubmed.ncbi.nlm.nih.gov/33738559/"/* Vasectomy: Current information → P1 → https://pubmed.ncbi.nlm.nih.gov/33738559/ */
Q41|P22|Q28/* Vasectomy: Current information → P22 → Sterilisation des Mannes (Vasektomie) */
Q41|P23|Q2/* Vasectomy: Current information → P23 → Geschlecht */
Q42|P15|"Cook LA, Van Vliet HA, Lopez LM, Pun A, Gallo MF"/* Vasectomy occlusion techniques for male sterilization → P15 → Cook LA, Van Vliet HA, Lopez LM, Pun A, Gallo MF */
Q42|P16|"Cochrane Database Syst Rev"/* Vasectomy occlusion techniques for male sterilization → P16 → Cochrane Database Syst Rev */
Q42|P17|"Mar 30;2014(3):CD003991"/* Vasectomy occlusion techniques for male sterilization → P17 → Mar 30;2014(3):CD003991 */
Q42|P18|+2014-01-01T00:00:00Z/9/* Vasectomy occlusion techniques for male sterilization → P18 → +2014-01-01T00:00:00Z/9 */
Q42|P19|"10.1002/14651858.CD003991.pub4"/* Vasectomy occlusion techniques for male sterilization → P19 → 10.1002/14651858.CD003991.pub4 */
Q42|P1|"https://pubmed.ncbi.nlm.nih.gov/24683020/"/* Vasectomy occlusion techniques for male sterilization → P1 → https://pubmed.ncbi.nlm.nih.gov/24683020/ */
Q42|P22|Q28/* Vasectomy occlusion techniques for male sterilization → P22 → Sterilisation des Mannes (Vasektomie) */
Q42|P23|Q3/* Vasectomy occlusion techniques for male sterilization → P23 → Material des Verhütungsmittels */
Q43|P15|"Zeitler M, Rayala B"/* Outpatient Vasectomy: Safe, Reliable, and Cost-effective → P15 → Zeitler M, Rayala B */
Q43|P16|"Prim Care"/* Outpatient Vasectomy: Safe, Reliable, and Cost-effective → P16 → Prim Care */
Q43|P17|"Dec;48(4):613-625"/* Outpatient Vasectomy: Safe, Reliable, and Cost-effective → P17 → Dec;48(4):613-625 */
Q43|P18|+2021-01-01T00:00:00Z/9/* Outpatient Vasectomy: Safe, Reliable, and Cost-effective → P18 → +2021-01-01T00:00:00Z/9 */
Q43|P19|"10.1016/j.pop.2021.08.001"/* Outpatient Vasectomy: Safe, Reliable, and Cost-effective → P19 → 10.1016/j.pop.2021.08.001 */
Q43|P20|"Contraception; Outpatient; Safety; Vasectomy"/* Outpatient Vasectomy: Safe, Reliable, and Cost-effective → P20 → Contraception; Outpatient; Safety; Vasectomy */
Q43|P1|"https://pubmed.ncbi.nlm.nih.gov/34752273/"/* Outpatient Vasectomy: Safe, Reliable, and Cost-effective → P1 → https://pubmed.ncbi.nlm.nih.gov/34752273/ */
Q43|P22|Q28/* Outpatient Vasectomy: Safe, Reliable, and Cost-effective → P22 → Sterilisation des Mannes (Vasektomie) */
Q43|P23|Q3/* Outpatient Vasectomy: Safe, Reliable, and Cost-effective → P23 → Material des Verhütungsmittels */
Q44|P15|"Practice Committee of American Society for Reproductive Medicine"/* Vasectomy reversal → P15 → Practice Committee of American Society for Reproductive Medicine */
Q44|P16|"Fertil Steril"/* Vasectomy reversal → P16 → Fertil Steril */
Q44|P17|"Nov;90(5 Suppl):S78-82"/* Vasectomy reversal → P17 → Nov;90(5 Suppl):S78-82 */
Q44|P18|+2008-01-01T00:00:00Z/9/* Vasectomy reversal → P18 → +2008-01-01T00:00:00Z/9 */
Q44|P19|"10.1016/j.fertnstert.2008.08.097"/* Vasectomy reversal → P19 → 10.1016/j.fertnstert.2008.08.097 */
Q44|P1|"https://pubmed.ncbi.nlm.nih.gov/19007653/"/* Vasectomy reversal → P1 → https://pubmed.ncbi.nlm.nih.gov/19007653/ */
Q44|P22|Q28/* Vasectomy reversal → P22 → Sterilisation des Mannes (Vasektomie) */
Q44|P23|Q3/* Vasectomy reversal → P23 → Material des Verhütungsmittels */
Q45|P15|"Schwarzer JU, Steinfatt H"/* Current status of vasectomy reversal → P15 → Schwarzer JU, Steinfatt H */
Q45|P16|"Nat Rev Urol"/* Current status of vasectomy reversal → P16 → Nat Rev Urol */
Q45|P17|"Apr;10(4):195-205"/* Current status of vasectomy reversal → P17 → Apr;10(4):195-205 */
Q45|P18|+2013-01-01T00:00:00Z/9/* Current status of vasectomy reversal → P18 → +2013-01-01T00:00:00Z/9 */
Q45|P19|"10.1038/nrurol.2013.14"/* Current status of vasectomy reversal → P19 → 10.1038/nrurol.2013.14 */
Q45|P1|"https://pubmed.ncbi.nlm.nih.gov/23399733/"/* Current status of vasectomy reversal → P1 → https://pubmed.ncbi.nlm.nih.gov/23399733/ */
Q45|P22|Q28/* Current status of vasectomy reversal → P22 → Sterilisation des Mannes (Vasektomie) */
Q45|P23|Q3/* Current status of vasectomy reversal → P23 → Material des Verhütungsmittels */
Q46|P15|"von Mering R, Merki GS, Keller P"/* Is there a place for tubal ligation in modern contraception? → P15 → von Mering R, Merki GS, Keller P */
Q46|P16|"Gynakol Geburtshilfliche Rundsch"/* Is there a place for tubal ligation in modern contraception? → P16 → Gynakol Geburtshilfliche Rundsch */
Q46|P17|"Jan;43(1):25-30"/* Is there a place for tubal ligation in modern contraception? → P17 → Jan;43(1):25-30 */
Q46|P18|+2003-01-01T00:00:00Z/9/* Is there a place for tubal ligation in modern contraception? → P18 → +2003-01-01T00:00:00Z/9 */
Q46|P19|"10.1159/000067166"/* Is there a place for tubal ligation in modern contraception? → P19 → 10.1159/000067166 */
Q46|P1|"https://pubmed.ncbi.nlm.nih.gov/12499754/"/* Is there a place for tubal ligation in modern contraception? → P1 → https://pubmed.ncbi.nlm.nih.gov/12499754/ */
Q46|P22|Q27/* Is there a place for tubal ligation in modern contraception? → P22 → Sterilisation der Frau (Tubenligatur) */
Q46|P23|Q2/* Is there a place for tubal ligation in modern contraception? → P23 → Geschlecht */
Q47|P15|"Walter S, Upadhjay M, Beslic J, Pucher M, Herbel R, Stavroula S, Dayan D, Janni W, Ebner F"/* FSFI score and timing of tubal ligation in patients: preliminary results of an online survey → P15 → Walter S, Upadhjay M, Beslic J, Pucher M, Herbel R, Stavroula S, Dayan D, Janni W, Ebner F */
Q47|P16|"Arch Gynecol Obstet"/* FSFI score and timing of tubal ligation in patients: preliminary results of an online survey → P16 → Arch Gynecol Obstet */
Q47|P17|"Sep;306(3):795-800"/* FSFI score and timing of tubal ligation in patients: preliminary results of an online survey → P17 → Sep;306(3):795-800 */
Q47|P18|+2022-01-01T00:00:00Z/9/* FSFI score and timing of tubal ligation in patients: preliminary results of an online survey → P18 → +2022-01-01T00:00:00Z/9 */
Q47|P19|"10.1007/s00404-022-06547-8"/* FSFI score and timing of tubal ligation in patients: preliminary results of an online survey → P19 → 10.1007/s00404-022-06547-8 */
Q47|P20|"FSFI; Regretting; Sterilisation; Tubal ligation"/* FSFI score and timing of tubal ligation in patients: preliminary results of an online survey → P20 → FSFI; Regretting; Sterilisation; Tubal ligation */
Q47|P1|"https://pubmed.ncbi.nlm.nih.gov/35397718/"/* FSFI score and timing of tubal ligation in patients: preliminary results of an online survey → P1 → https://pubmed.ncbi.nlm.nih.gov/35397718/ */
Q47|P22|Q27/* FSFI score and timing of tubal ligation in patients: preliminary results of an online survey → P22 → Sterilisation der Frau (Tubenligatur) */
Q47|P23|Q2/* FSFI score and timing of tubal ligation in patients: preliminary results of an online survey → P23 → Geschlecht */
Q48|P15|"Mills K, Marchand G, Sainz K, Azadi A, Ware K, Vallejo J, Anderson S, King A, Osborn A, Ruther S, Brazil G, Cieminski K, Hopewell S, Rials L, Klipp A"/* Salpingectomy vs tubal ligation for sterilization: a systematic review and meta-analysis → P15 → Mills K, Marchand G, Sainz K, Azadi A, Ware K, Vallejo J, Anderson S, King A, Osborn A, Ruther S, Brazil G, Cieminski K, Hopewell S, Rials L, Klipp A */
Q48|P16|"Am J Obstet Gynecol"/* Salpingectomy vs tubal ligation for sterilization: a systematic review and meta-analysis → P16 → Am J Obstet Gynecol */
Q48|P17|"Mar;224(3):258-265.e4"/* Salpingectomy vs tubal ligation for sterilization: a systematic review and meta-analysis → P17 → Mar;224(3):258-265.e4 */
Q48|P18|+2021-01-01T00:00:00Z/9/* Salpingectomy vs tubal ligation for sterilization: a systematic review and meta-analysis → P18 → +2021-01-01T00:00:00Z/9 */
Q48|P19|"10.1016/j.ajog.2020.09.011"/* Salpingectomy vs tubal ligation for sterilization: a systematic review and meta-analysis → P19 → 10.1016/j.ajog.2020.09.011 */
Q48|P20|"risk-reducing salpingectomy; risk-reducing surgery; salpingectomy; sterilization; surgery to reduce the risk of ovarian cancer; tubal ligation"/* Salpingectomy vs tubal ligation for sterilization: a systematic review and meta-analysis → P20 → risk-reducing salpingectomy; risk-reducing surgery; salpingectomy; sterilization; surgery to reduce the risk of ovarian cancer; tubal ligation */
Q48|P1|"https://pubmed.ncbi.nlm.nih.gov/32941790/"/* Salpingectomy vs tubal ligation for sterilization: a systematic review and meta-analysis → P1 → https://pubmed.ncbi.nlm.nih.gov/32941790/ */
Q48|P22|Q27/* Salpingectomy vs tubal ligation for sterilization: a systematic review and meta-analysis → P22 → Sterilisation der Frau (Tubenligatur) */
Q48|P23|Q3/* Salpingectomy vs tubal ligation for sterilization: a systematic review and meta-analysis → P23 → Material des Verhütungsmittels */
Q49|P15|"Stephens DB"/* Vaginal tubal ligation → P15 → Stephens DB */
Q49|P16|"South Med J"/* Vaginal tubal ligation → P16 → South Med J */
Q49|P17|"Dec;73(12):1578-80"/* Vaginal tubal ligation → P17 → Dec;73(12):1578-80 */
Q49|P18|+1980-01-01T00:00:00Z/9/* Vaginal tubal ligation → P18 → +1980-01-01T00:00:00Z/9 */
Q49|P19|"10.1097/00007611-198012000-00012"/* Vaginal tubal ligation → P19 → 10.1097/00007611-198012000-00012 */
Q49|P1|"https://pubmed.ncbi.nlm.nih.gov/7444547/"/* Vaginal tubal ligation → P1 → https://pubmed.ncbi.nlm.nih.gov/7444547/ */
Q49|P22|Q27/* Vaginal tubal ligation → P22 → Sterilisation der Frau (Tubenligatur) */
Q49|P23|Q6/* Vaginal tubal ligation → P23 → Effizienzmaße */
Q50|P15|"Messinger LB, Alford CE, Csokmay JM, Henne MB, Mumford SL, Segars JH, Armstrong AY"/* Cost and efficacy comparison of in vitro fertilization and tubal anastomosis for women after tubal ligation → P15 → Messinger LB, Alford CE, Csokmay JM, Henne MB, Mumford SL, Segars JH, Armstrong AY */
Q50|P16|"Fertil Steril"/* Cost and efficacy comparison of in vitro fertilization and tubal anastomosis for women after tubal ligation → P16 → Fertil Steril */
Q50|P17|"Jul;104(1):32-8.e4"/* Cost and efficacy comparison of in vitro fertilization and tubal anastomosis for women after tubal ligation → P17 → Jul;104(1):32-8.e4 */
Q50|P18|+2015-01-01T00:00:00Z/9/* Cost and efficacy comparison of in vitro fertilization and tubal anastomosis for women after tubal ligation → P18 → +2015-01-01T00:00:00Z/9 */
Q50|P19|"10.1016/j.fertnstert.2015.04.019"/* Cost and efficacy comparison of in vitro fertilization and tubal anastomosis for women after tubal ligation → P19 → 10.1016/j.fertnstert.2015.04.019 */
Q50|P20|"In vitro fertilization (IVF); bilateral tubal anastomosis (BTA); cost effectiveness; decision tree; tubal reversal"/* Cost and efficacy comparison of in vitro fertilization and tubal anastomosis for women after tubal ligation → P20 → In vitro fertilization (IVF); bilateral tubal anastomosis (BTA); cost effectiveness; decision tree; tubal reversal */
Q50|P1|"https://pubmed.ncbi.nlm.nih.gov/26006734/"/* Cost and efficacy comparison of in vitro fertilization and tubal anastomosis for women after tubal ligation → P1 → https://pubmed.ncbi.nlm.nih.gov/26006734/ */
Q50|P22|Q27/* Cost and efficacy comparison of in vitro fertilization and tubal anastomosis for women after tubal ligation → P22 → Sterilisation der Frau (Tubenligatur) */
Q50|P23|Q3/* Cost and efficacy comparison of in vitro fertilization and tubal anastomosis for women after tubal ligation → P23 → Material des Verhütungsmittels */
Q51|P15|"Saldanha S"/* Tubal ligation on an unmarried girl: How and why? → P15 → Saldanha S */
Q51|P16|"Indian J Med Ethics"/* Tubal ligation on an unmarried girl: How and why? → P16 → Indian J Med Ethics */
Q51|P17|"Apr-Jun;1(2):116-7"/* Tubal ligation on an unmarried girl: How and why? → P17 → Apr-Jun;1(2):116-7 */
Q51|P18|+2016-01-01T00:00:00Z/9/* Tubal ligation on an unmarried girl: How and why? → P18 → +2016-01-01T00:00:00Z/9 */
Q51|P19|"10.20529/IJME.2016.031"/* Tubal ligation on an unmarried girl: How and why? → P19 → 10.20529/IJME.2016.031 */
Q51|P1|"https://pubmed.ncbi.nlm.nih.gov/27260823/"/* Tubal ligation on an unmarried girl: How and why? → P1 → https://pubmed.ncbi.nlm.nih.gov/27260823/ */
Q51|P22|Q27/* Tubal ligation on an unmarried girl: How and why? → P22 → Sterilisation der Frau (Tubenligatur) */
Q51|P23|Q2/* Tubal ligation on an unmarried girl: How and why? → P23 → Geschlecht */
Q52|P15|"Barss P"/* Tubal ligation with local anaesthesia → P15 → Barss P */
Q52|P16|"Trop Doct"/* Tubal ligation with local anaesthesia → P16 → Trop Doct */
Q52|P17|"Oct;15(4):175-9"/* Tubal ligation with local anaesthesia → P17 → Oct;15(4):175-9 */
Q52|P18|+1985-01-01T00:00:00Z/9/* Tubal ligation with local anaesthesia → P18 → +1985-01-01T00:00:00Z/9 */
Q52|P19|"10.1177/004947558501500410"/* Tubal ligation with local anaesthesia → P19 → 10.1177/004947558501500410 */
Q52|P1|"https://pubmed.ncbi.nlm.nih.gov/4049507/"/* Tubal ligation with local anaesthesia → P1 → https://pubmed.ncbi.nlm.nih.gov/4049507/ */
Q52|P22|Q27/* Tubal ligation with local anaesthesia → P22 → Sterilisation der Frau (Tubenligatur) */
Q52|P23|Q3/* Tubal ligation with local anaesthesia → P23 → Material des Verhütungsmittels */
Q53|P15|"Murtagh J"/* Patient education. Tubal ligation → P15 → Murtagh J */
Q53|P16|"Aust Fam Physician"/* Patient education. Tubal ligation → P16 → Aust Fam Physician */
Q53|P17|"Apr;22(4):611"/* Patient education. Tubal ligation → P17 → Apr;22(4):611 */
Q53|P18|+1993-01-01T00:00:00Z/9/* Patient education. Tubal ligation → P18 → +1993-01-01T00:00:00Z/9 */
Q53|P1|"https://pubmed.ncbi.nlm.nih.gov/8481125/"/* Patient education. Tubal ligation → P1 → https://pubmed.ncbi.nlm.nih.gov/8481125/ */
Q53|P22|Q27/* Patient education. Tubal ligation → P22 → Sterilisation der Frau (Tubenligatur) */
Q53|P23|Q2/* Patient education. Tubal ligation → P23 → Geschlecht */
Q54|P15|"Patil E, Jensen JT"/* Permanent Contraception for Women → P15 → Patil E, Jensen JT */
Q54|P16|"Semin Reprod Med"/* Permanent Contraception for Women → P16 → Semin Reprod Med */
Q54|P17|"May;34(3):139-44"/* Permanent Contraception for Women → P17 → May;34(3):139-44 */
Q54|P18|+2016-01-01T00:00:00Z/9/* Permanent Contraception for Women → P18 → +2016-01-01T00:00:00Z/9 */
Q54|P19|"10.1055/s-0036-1571434"/* Permanent Contraception for Women → P19 → 10.1055/s-0036-1571434 */
Q54|P1|"https://pubmed.ncbi.nlm.nih.gov/26960907/"/* Permanent Contraception for Women → P1 → https://pubmed.ncbi.nlm.nih.gov/26960907/ */
Q54|P22|Q27/* Permanent Contraception for Women → P22 → Sterilisation der Frau (Tubenligatur) */
Q54|P23|Q2/* Permanent Contraception for Women → P23 → Geschlecht */
Q55|P15|"Fang NZ, Advaney SP, Castaño PM, Davis A, Westhoff CL"/* Female permanent contraception trends and updates → P15 → Fang NZ, Advaney SP, Castaño PM, Davis A, Westhoff CL */
Q55|P16|"Am J Obstet Gynecol"/* Female permanent contraception trends and updates → P16 → Am J Obstet Gynecol */
Q55|P17|"Jun;226(6):773-780"/* Female permanent contraception trends and updates → P17 → Jun;226(6):773-780 */
Q55|P18|+2022-01-01T00:00:00Z/9/* Female permanent contraception trends and updates → P18 → +2022-01-01T00:00:00Z/9 */
Q55|P19|"10.1016/j.ajog.2021.12.261"/* Female permanent contraception trends and updates → P19 → 10.1016/j.ajog.2021.12.261 */
Q55|P20|"female sterilization; permanent contraception; postpartum sterilization; tubal ligation"/* Female permanent contraception trends and updates → P20 → female sterilization; permanent contraception; postpartum sterilization; tubal ligation */
Q55|P1|"https://pubmed.ncbi.nlm.nih.gov/34973178/"/* Female permanent contraception trends and updates → P1 → https://pubmed.ncbi.nlm.nih.gov/34973178/ */
Q55|P22|Q27/* Female permanent contraception trends and updates → P22 → Sterilisation der Frau (Tubenligatur) */
Q55|P23|Q2/* Female permanent contraception trends and updates → P23 → Geschlecht */
Q56|P15|"Gormley R, Vickers B, Cheng B, Norman WV"/* Comparing options for females seeking permanent contraception in high resource countries: a systematic review → P15 → Gormley R, Vickers B, Cheng B, Norman WV */
Q56|P16|"Reprod Health"/* Comparing options for females seeking permanent contraception in high resource countries: a systematic review → P16 → Reprod Health */
Q56|P17|"Jul 20;18(1):154"/* Comparing options for females seeking permanent contraception in high resource countries: a systematic review → P17 → Jul 20;18(1):154 */
Q56|P18|+2021-01-01T00:00:00Z/9/* Comparing options for females seeking permanent contraception in high resource countries: a systematic review → P18 → +2021-01-01T00:00:00Z/9 */
Q56|P19|"10.1186/s12978-021-01201-z"/* Comparing options for females seeking permanent contraception in high resource countries: a systematic review → P19 → 10.1186/s12978-021-01201-z */
Q56|P20|"Hysteroscopic tubal occlusion; Laparoscopic tubal ligation; Levonorgestrel intrauterine contraceptive; Permanent contraception; Salpingectomy; Systematic review"/* Comparing options for females seeking permanent contraception in high resource countries: a systematic review → P20 → Hysteroscopic tubal occlusion; Laparoscopic tubal ligation; Levonorgestrel intrauterine contraceptive; Permanent contraception; Salpingectomy; Systematic review */
Q56|P1|"https://pubmed.ncbi.nlm.nih.gov/34284794/"/* Comparing options for females seeking permanent contraception in high resource countries: a systematic review → P1 → https://pubmed.ncbi.nlm.nih.gov/34284794/ */
Q56|P22|Q27/* Comparing options for females seeking permanent contraception in high resource countries: a systematic review → P22 → Sterilisation der Frau (Tubenligatur) */
Q56|P23|Q6/* Comparing options for females seeking permanent contraception in high resource countries: a systematic review → P23 → Effizienzmaße */
Q57|P15|"Schwarz EB, Lewis CA, Dove MS, Murphy E, Zuckerman D, Nunez-Eddy C, Tancredi DJ, McDonald-Mosley R, Sonalkar S, Hathaway M, Gariepy AM"/* Comparative Effectiveness and Safety of Intrauterine Contraception and Tubal Ligation → P15 → Schwarz EB, Lewis CA, Dove MS, Murphy E, Zuckerman D, Nunez-Eddy C, Tancredi DJ, McDonald-Mosley R, Sonalkar S, Hathaway M, Gariepy AM */
Q57|P16|"J Gen Intern Med"/* Comparative Effectiveness and Safety of Intrauterine Contraception and Tubal Ligation → P16 → J Gen Intern Med */
Q57|P17|"Dec;37(16):4168-4175"/* Comparative Effectiveness and Safety of Intrauterine Contraception and Tubal Ligation → P17 → Dec;37(16):4168-4175 */
Q57|P18|+2022-01-01T00:00:00Z/9/* Comparative Effectiveness and Safety of Intrauterine Contraception and Tubal Ligation → P18 → +2022-01-01T00:00:00Z/9 */
Q57|P19|"10.1007/s11606-022-07433-4"/* Comparative Effectiveness and Safety of Intrauterine Contraception and Tubal Ligation → P19 → 10.1007/s11606-022-07433-4 */
Q57|P20|"Medicaid; comparative effectiveness; disparities; female sterilization; intrauterine contraception; low income; permanent contraception; reproductive justice; tubal ligation"/* Comparative Effectiveness and Safety of Intrauterine Contraception and Tubal Ligation → P20 → Medicaid; comparative effectiveness; disparities; female sterilization; intrauterine contraception; low income; permanent contraception; reproductive justice; tubal ligation */
Q57|P1|"https://pubmed.ncbi.nlm.nih.gov/35194746/"/* Comparative Effectiveness and Safety of Intrauterine Contraception and Tubal Ligation → P1 → https://pubmed.ncbi.nlm.nih.gov/35194746/ */
Q57|P22|Q27/* Comparative Effectiveness and Safety of Intrauterine Contraception and Tubal Ligation → P22 → Sterilisation der Frau (Tubenligatur) */
Q57|P23|Q6/* Comparative Effectiveness and Safety of Intrauterine Contraception and Tubal Ligation → P23 → Effizienzmaße */
Q58|P15|"Sangi-Haghpeykar H, Poindexter AN 3rd, Levine H"/* Sperm transport and survival post-application of a new spermicide contraceptive. Advantage 24 Study Group → P15 → Sangi-Haghpeykar H, Poindexter AN 3rd, Levine H */
Q58|P16|"Contraception"/* Sperm transport and survival post-application of a new spermicide contraceptive. Advantage 24 Study Group → P16 → Contraception */
Q58|P17|"Jun;53(6):353-6"/* Sperm transport and survival post-application of a new spermicide contraceptive. Advantage 24 Study Group → P17 → Jun;53(6):353-6 */
Q58|P18|+1996-01-01T00:00:00Z/9/* Sperm transport and survival post-application of a new spermicide contraceptive. Advantage 24 Study Group → P18 → +1996-01-01T00:00:00Z/9 */
Q58|P19|"10.1016/0010-7824(96)00084-4"/* Sperm transport and survival post-application of a new spermicide contraceptive. Advantage 24 Study Group → P19 → 10.1016/0010-7824(96)00084-4 */
Q58|P1|"https://pubmed.ncbi.nlm.nih.gov/8773422/"/* Sperm transport and survival post-application of a new spermicide contraceptive. Advantage 24 Study Group → P1 → https://pubmed.ncbi.nlm.nih.gov/8773422/ */
Q58|P22|Q8/* Sperm transport and survival post-application of a new spermicide contraceptive. Advantage 24 Study Group → P22 → Spermizid */
Q58|P23|Q6/* Sperm transport and survival post-application of a new spermicide contraceptive. Advantage 24 Study Group → P23 → Effizienzmaße */
Q59|P15|"Gabbay MB, Thomas J, Gibbs A, Hold P"/* A randomized crossover trial of the impact of additional spermicide on condom failure rates → P15 → Gabbay MB, Thomas J, Gibbs A, Hold P */
Q59|P16|"Sex Transm Dis"/* A randomized crossover trial of the impact of additional spermicide on condom failure rates → P16 → Sex Transm Dis */
Q59|P17|"Oct;35(10):862-8"/* A randomized crossover trial of the impact of additional spermicide on condom failure rates → P17 → Oct;35(10):862-8 */
Q59|P18|+2008-01-01T00:00:00Z/9/* A randomized crossover trial of the impact of additional spermicide on condom failure rates → P18 → +2008-01-01T00:00:00Z/9 */
Q59|P19|"10.1097/OLQ.0b013e31817fb802"/* A randomized crossover trial of the impact of additional spermicide on condom failure rates → P19 → 10.1097/OLQ.0b013e31817fb802 */
Q59|P1|"https://pubmed.ncbi.nlm.nih.gov/18685543/"/* A randomized crossover trial of the impact of additional spermicide on condom failure rates → P1 → https://pubmed.ncbi.nlm.nih.gov/18685543/ */
Q59|P22|Q8/* A randomized crossover trial of the impact of additional spermicide on condom failure rates → P22 → Spermizid */
Q59|P23|Q6/* A randomized crossover trial of the impact of additional spermicide on condom failure rates → P23 → Effizienzmaße */
Q60|P15|"Jain A, Kumar L, Kushwaha B, Sharma M, Pandey A, Verma V, Sharma V, Singh V, Rawat T, Sharma VL, Maikhuri JP, Gupta G"/* Combining a synthetic spermicide with a natural trichomonacide for safe, prophylactic contraception → P15 → Jain A, Kumar L, Kushwaha B, Sharma M, Pandey A, Verma V, Sharma V, Singh V, Rawat T, Sharma VL, Maikhuri JP, Gupta G */
Q60|P16|"Hum Reprod"/* Combining a synthetic spermicide with a natural trichomonacide for safe, prophylactic contraception → P16 → Hum Reprod */
Q60|P17|"Feb;29(2):242-52"/* Combining a synthetic spermicide with a natural trichomonacide for safe, prophylactic contraception → P17 → Feb;29(2):242-52 */
Q60|P18|+2014-01-01T00:00:00Z/9/* Combining a synthetic spermicide with a natural trichomonacide for safe, prophylactic contraception → P18 → +2014-01-01T00:00:00Z/9 */
Q60|P19|"10.1093/humrep/det423"/* Combining a synthetic spermicide with a natural trichomonacide for safe, prophylactic contraception → P19 → 10.1093/humrep/det423 */
Q60|P20|"DSE-37; Sapindus saponins; Trichomonas vaginalis; spermicide; vaginal contraception"/* Combining a synthetic spermicide with a natural trichomonacide for safe, prophylactic contraception → P20 → DSE-37; Sapindus saponins; Trichomonas vaginalis; spermicide; vaginal contraception */
Q60|P1|"https://pubmed.ncbi.nlm.nih.gov/24291662/"/* Combining a synthetic spermicide with a natural trichomonacide for safe, prophylactic contraception → P1 → https://pubmed.ncbi.nlm.nih.gov/24291662/ */
Q60|P22|Q8/* Combining a synthetic spermicide with a natural trichomonacide for safe, prophylactic contraception → P22 → Spermizid */
Q60|P23|Q3/* Combining a synthetic spermicide with a natural trichomonacide for safe, prophylactic contraception → P23 → Material des Verhütungsmittels */
Q61|P15|"Wang H, Chen XX, Wang LR, Mao YD, Zhou ZM, Sha JH"/* AF-2364 is a prospective spermicide candidate → P15 → Wang H, Chen XX, Wang LR, Mao YD, Zhou ZM, Sha JH */
Q61|P16|"Asian J Androl"/* AF-2364 is a prospective spermicide candidate → P16 → Asian J Androl */
Q61|P17|"May;12(3):322-35"/* AF-2364 is a prospective spermicide candidate → P17 → May;12(3):322-35 */
Q61|P18|+2010-01-01T00:00:00Z/9/* AF-2364 is a prospective spermicide candidate → P18 → +2010-01-01T00:00:00Z/9 */
Q61|P19|"10.1038/aja.2010.11"/* AF-2364 is a prospective spermicide candidate → P19 → 10.1038/aja.2010.11 */
Q61|P1|"https://pubmed.ncbi.nlm.nih.gov/20418891/"/* AF-2364 is a prospective spermicide candidate → P1 → https://pubmed.ncbi.nlm.nih.gov/20418891/ */
Q61|P22|Q8/* AF-2364 is a prospective spermicide candidate → P22 → Spermizid */
Q61|P23|Q3/* AF-2364 is a prospective spermicide candidate → P23 → Material des Verhütungsmittels */
Q62|P15|"Grimes DA, Lopez LM, Raymond EG, Halpern V, Nanda K, Schulz KF"/* Spermicide used alone for contraception → P15 → Grimes DA, Lopez LM, Raymond EG, Halpern V, Nanda K, Schulz KF */
Q62|P16|"Cochrane Database Syst Rev"/* Spermicide used alone for contraception → P16 → Cochrane Database Syst Rev */
Q62|P17|"Sep 30;(9):CD005218"/* Spermicide used alone for contraception → P17 → Sep 30;(9):CD005218 */
Q62|P18|+2013-01-01T00:00:00Z/9/* Spermicide used alone for contraception → P18 → +2013-01-01T00:00:00Z/9 */
Q62|P19|"10.1002/14651858.CD005218.pub3"/* Spermicide used alone for contraception → P19 → 10.1002/14651858.CD005218.pub3 */
Q62|P1|"https://pubmed.ncbi.nlm.nih.gov/24085632/"/* Spermicide used alone for contraception → P1 → https://pubmed.ncbi.nlm.nih.gov/24085632/ */
Q62|P22|Q8/* Spermicide used alone for contraception → P22 → Spermizid */
Q62|P23|Q2/* Spermicide used alone for contraception → P23 → Geschlecht */
Q63|P15|"Iyer V, Poddar SS"/* Update on nonoxynol-9 as vaginal spermicide → P15 → Iyer V, Poddar SS */
Q63|P16|"Eur J Contracept Reprod Health Care"/* Update on nonoxynol-9 as vaginal spermicide → P16 → Eur J Contracept Reprod Health Care */
Q63|P17|"Dec;13(4):339-50"/* Update on nonoxynol-9 as vaginal spermicide → P17 → Dec;13(4):339-50 */
Q63|P18|+2008-01-01T00:00:00Z/9/* Update on nonoxynol-9 as vaginal spermicide → P18 → +2008-01-01T00:00:00Z/9 */
Q63|P19|"10.1080/13625180802263515"/* Update on nonoxynol-9 as vaginal spermicide → P19 → 10.1080/13625180802263515 */
Q63|P1|"https://pubmed.ncbi.nlm.nih.gov/19117251/"/* Update on nonoxynol-9 as vaginal spermicide → P1 → https://pubmed.ncbi.nlm.nih.gov/19117251/ */
Q63|P22|Q8/* Update on nonoxynol-9 as vaginal spermicide → P22 → Spermizid */
Q63|P23|Q3/* Update on nonoxynol-9 as vaginal spermicide → P23 → Material des Verhütungsmittels */
Q64|P15|"Xia M, Yang M, Wang Y, Tian F, Hu J, Yang W, Tao S, Lu L, Ding X, Jiang S, Li W"/* dl-Mandelic acid exhibits high sperm-immobilizing activity and low vaginal irritation: A potential non-surfactant spermicide for contraception → P15 → Xia M, Yang M, Wang Y, Tian F, Hu J, Yang W, Tao S, Lu L, Ding X, Jiang S, Li W */
Q64|P16|"Biomed Pharmacother"/* dl-Mandelic acid exhibits high sperm-immobilizing activity and low vaginal irritation: A potential non-surfactant spermicide for contraception → P16 → Biomed Pharmacother */
Q64|P17|"Jun;126:110104"/* dl-Mandelic acid exhibits high sperm-immobilizing activity and low vaginal irritation: A potential non-surfactant spermicide for contraception → P17 → Jun;126:110104 */
Q64|P18|+2020-01-01T00:00:00Z/9/* dl-Mandelic acid exhibits high sperm-immobilizing activity and low vaginal irritation: A potential non-surfactant spermicide for contraception → P18 → +2020-01-01T00:00:00Z/9 */
Q64|P19|"10.1016/j.biopha.2020.110104"/* dl-Mandelic acid exhibits high sperm-immobilizing activity and low vaginal irritation: A potential non-surfactant spermicide for contraception → P19 → 10.1016/j.biopha.2020.110104 */
Q64|P20|"Immobilization; Mandelic acid; Spermicide; Vaginal irritation"/* dl-Mandelic acid exhibits high sperm-immobilizing activity and low vaginal irritation: A potential non-surfactant spermicide for contraception → P20 → Immobilization; Mandelic acid; Spermicide; Vaginal irritation */
Q64|P1|"https://pubmed.ncbi.nlm.nih.gov/32224371/"/* dl-Mandelic acid exhibits high sperm-immobilizing activity and low vaginal irritation: A potential non-surfactant spermicide for contraception → P1 → https://pubmed.ncbi.nlm.nih.gov/32224371/ */
Q64|P22|Q8/* dl-Mandelic acid exhibits high sperm-immobilizing activity and low vaginal irritation: A potential non-surfactant spermicide for contraception → P22 → Spermizid */
Q64|P23|Q3/* dl-Mandelic acid exhibits high sperm-immobilizing activity and low vaginal irritation: A potential non-surfactant spermicide for contraception → P23 → Material des Verhütungsmittels */
Q65|P15|"Strobino B, Kline J, Warburton D"/* Spermicide use and pregnancy outcome → P15 → Strobino B, Kline J, Warburton D */
Q65|P16|"Am J Public Health"/* Spermicide use and pregnancy outcome → P16 → Am J Public Health */
Q65|P17|"Mar;78(3):260-3"/* Spermicide use and pregnancy outcome → P17 → Mar;78(3):260-3 */
Q65|P18|+1988-01-01T00:00:00Z/9/* Spermicide use and pregnancy outcome → P18 → +1988-01-01T00:00:00Z/9 */
Q65|P19|"10.2105/ajph.78.3.260"/* Spermicide use and pregnancy outcome → P19 → 10.2105/ajph.78.3.260 */
Q65|P1|"https://pubmed.ncbi.nlm.nih.gov/3341493/"/* Spermicide use and pregnancy outcome → P1 → https://pubmed.ncbi.nlm.nih.gov/3341493/ */
Q65|P22|Q8/* Spermicide use and pregnancy outcome → P22 → Spermizid */
Q65|P23|Q6/* Spermicide use and pregnancy outcome → P23 → Effizienzmaße */
Q66|P15|"Craig S, Hepburn S"/* The effectiveness of barrier methods of contraception with and without spermicide. Contraception → P15 → Craig S, Hepburn S */
Q66|P16|"Contraception"/* The effectiveness of barrier methods of contraception with and without spermicide. Contraception → P16 → Contraception */
Q66|P17|"Oct;26(4):347-59"/* The effectiveness of barrier methods of contraception with and without spermicide. Contraception → P17 → Oct;26(4):347-59 */
Q66|P18|+1982-01-01T00:00:00Z/9/* The effectiveness of barrier methods of contraception with and without spermicide. Contraception → P18 → +1982-01-01T00:00:00Z/9 */
Q66|P19|"10.1016/0010-7824(82)90102-0"/* The effectiveness of barrier methods of contraception with and without spermicide. Contraception → P19 → 10.1016/0010-7824(82)90102-0 */
Q66|P1|"https://pubmed.ncbi.nlm.nih.gov/6759027/"/* The effectiveness of barrier methods of contraception with and without spermicide. Contraception → P1 → https://pubmed.ncbi.nlm.nih.gov/6759027/ */
Q66|P22|Q8/* The effectiveness of barrier methods of contraception with and without spermicide. Contraception → P22 → Spermizid */
Q66|P23|Q6/* The effectiveness of barrier methods of contraception with and without spermicide. Contraception → P23 → Effizienzmaße */
Q67|P15|"Bodner K, Bodner-Adler B, Grünberger W"/* Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users → P15 → Bodner K, Bodner-Adler B, Grünberger W */
Q67|P16|"Arch Gynecol Obstet"/* Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users → P16 → Arch Gynecol Obstet */
Q67|P17|"Mar;283(3):525-30"/* Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users → P17 → Mar;283(3):525-30 */
Q67|P18|+2011-01-01T00:00:00Z/9/* Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users → P18 → +2011-01-01T00:00:00Z/9 */
Q67|P19|"10.1007/s00404-010-1368-6"/* Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users → P19 → 10.1007/s00404-010-1368-6 */
Q67|P1|"https://pubmed.ncbi.nlm.nih.gov/20111970/"/* Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users → P1 → https://pubmed.ncbi.nlm.nih.gov/20111970/ */
Q67|P22|Q9/* Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users → P22 → Hormonpflaster */
Q67|P23|Q6/* Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users → P23 → Effizienzmaße */
Q68|P15|"Sonnenberg FA, Burkman RT, Speroff L, Westhoff C, Hagerty CG"/* Cost-effectiveness and contraceptive effectiveness of the transdermal contraceptive patch → P15 → Sonnenberg FA, Burkman RT, Speroff L, Westhoff C, Hagerty CG */
Q68|P16|"Am J Obstet Gynecol"/* Cost-effectiveness and contraceptive effectiveness of the transdermal contraceptive patch → P16 → Am J Obstet Gynecol */
Q68|P17|"Jan;192(1):1-9"/* Cost-effectiveness and contraceptive effectiveness of the transdermal contraceptive patch → P17 → Jan;192(1):1-9 */
Q68|P18|+2005-01-01T00:00:00Z/9/* Cost-effectiveness and contraceptive effectiveness of the transdermal contraceptive patch → P18 → +2005-01-01T00:00:00Z/9 */
Q68|P19|"10.1016/j.ajog.2004.09.004"/* Cost-effectiveness and contraceptive effectiveness of the transdermal contraceptive patch → P19 → 10.1016/j.ajog.2004.09.004 */
Q68|P1|"https://pubmed.ncbi.nlm.nih.gov/15671994/"/* Cost-effectiveness and contraceptive effectiveness of the transdermal contraceptive patch → P1 → https://pubmed.ncbi.nlm.nih.gov/15671994/ */
Q68|P22|Q9/* Cost-effectiveness and contraceptive effectiveness of the transdermal contraceptive patch → P22 → Hormonpflaster */
Q68|P23|Q6/* Cost-effectiveness and contraceptive effectiveness of the transdermal contraceptive patch → P23 → Effizienzmaße */
Q69|P15|"Rubinstein ML, Halpern-Felsher BL, Irwin CE Jr"/* An evaluation of the use of the transdermal contraceptive patch in adolescents → P15 → Rubinstein ML, Halpern-Felsher BL, Irwin CE Jr */
Q69|P16|"J Adolesc Health"/* An evaluation of the use of the transdermal contraceptive patch in adolescents → P16 → J Adolesc Health */
Q69|P17|"May;34(5):395-401"/* An evaluation of the use of the transdermal contraceptive patch in adolescents → P17 → May;34(5):395-401 */
Q69|P18|+2004-01-01T00:00:00Z/9/* An evaluation of the use of the transdermal contraceptive patch in adolescents → P18 → +2004-01-01T00:00:00Z/9 */
Q69|P19|"10.1016/j.jadohealth.2003.08.017"/* An evaluation of the use of the transdermal contraceptive patch in adolescents → P19 → 10.1016/j.jadohealth.2003.08.017 */
Q69|P1|"https://pubmed.ncbi.nlm.nih.gov/15093794/"/* An evaluation of the use of the transdermal contraceptive patch in adolescents → P1 → https://pubmed.ncbi.nlm.nih.gov/15093794/ */
Q69|P22|Q9/* An evaluation of the use of the transdermal contraceptive patch in adolescents → P22 → Hormonpflaster */
Q69|P23|Q6/* An evaluation of the use of the transdermal contraceptive patch in adolescents → P23 → Effizienzmaße */
Q70|P15|"Zacur HA, Hedon B, Mansour D, Shangold GA, Fisher AC, Creasy GW"/* Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions → P15 → Zacur HA, Hedon B, Mansour D, Shangold GA, Fisher AC, Creasy GW */
Q70|P16|"Fertil Steril"/* Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions → P16 → Fertil Steril */
Q70|P17|"Feb;77(2 Suppl 2):S32-5"/* Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions → P17 → Feb;77(2 Suppl 2):S32-5 */
Q70|P18|+2002-01-01T00:00:00Z/9/* Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions → P18 → +2002-01-01T00:00:00Z/9 */
Q70|P19|"10.1016/s0015-0282(01)03262-9"/* Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions → P19 → 10.1016/s0015-0282(01)03262-9 */
Q70|P1|"https://pubmed.ncbi.nlm.nih.gov/11849634/"/* Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions → P1 → https://pubmed.ncbi.nlm.nih.gov/11849634/ */
Q70|P22|Q9/* Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions → P22 → Hormonpflaster */
Q70|P23|Q3/* Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions → P23 → Material des Verhütungsmittels */
Q71|P15|"Kaunitz AM, Portman D, Westhoff CL, Mishell DR Jr, Archer DF, Foegh M"/* New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study → P15 → Kaunitz AM, Portman D, Westhoff CL, Mishell DR Jr, Archer DF, Foegh M */
Q71|P16|"Contraception"/* New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study → P16 → Contraception */
Q71|P17|"Mar;91(3):211-6"/* New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study → P17 → Mar;91(3):211-6 */
Q71|P18|+2015-01-01T00:00:00Z/9/* New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study → P18 → +2015-01-01T00:00:00Z/9 */
Q71|P19|"10.1016/j.contraception.2014.11.013"/* New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study → P19 → 10.1016/j.contraception.2014.11.013 */
Q71|P20|"Adhesiveness; Ethinyl estradiol; Itching; Levonorgestrel; Transdermal patch"/* New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study → P20 → Adhesiveness; Ethinyl estradiol; Itching; Levonorgestrel; Transdermal patch */
Q71|P1|"https://pubmed.ncbi.nlm.nih.gov/25586864/"/* New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study → P1 → https://pubmed.ncbi.nlm.nih.gov/25586864/ */
Q71|P22|Q9/* New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study → P22 → Hormonpflaster */
Q71|P23|Q3/* New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study → P23 → Material des Verhütungsmittels */
Q72|P15|"Sanga M, Vaughan S, Nangosyah J, Scholz V, Fonseca S"/* Randomized, double-blind, two-way crossover bioequivalence and adhesion study, in healthy women, of a transdermal contraceptive patch with a newly sourced adhesive component at the end of shelf life vs. the EVRA patch at the beginning of shelf life → P15 → Sanga M, Vaughan S, Nangosyah J, Scholz V, Fonseca S */
Q72|P16|"Int J Clin Pharmacol Ther"/* Randomized, double-blind, two-way crossover bioequivalence and adhesion study, in healthy women, of a transdermal contraceptive patch with a newly sourced adhesive component at the end of shelf life vs. the EVRA patch at the beginning of shelf life → P16 → Int J Clin Pharmacol Ther */
Q72|P17|"Jan;60(1):67-78"/* Randomized, double-blind, two-way crossover bioequivalence and adhesion study, in healthy women, of a transdermal contraceptive patch with a newly sourced adhesive component at the end of shelf life vs. the EVRA patch at the beginning of shelf life → P17 → Jan;60(1):67-78 */
Q72|P18|+2022-01-01T00:00:00Z/9/* Randomized, double-blind, two-way crossover bioequivalence and adhesion study, in healthy women, of a transdermal contraceptive patch with a newly sourced adhesive component at the end of shelf life vs. the EVRA patch at the beginning of shelf life → P18 → +2022-01-01T00:00:00Z/9 */
Q72|P19|"10.5414/CP204034"/* Randomized, double-blind, two-way crossover bioequivalence and adhesion study, in healthy women, of a transdermal contraceptive patch with a newly sourced adhesive component at the end of shelf life vs. the EVRA patch at the beginning of shelf life → P19 → 10.5414/CP204034 */
Q72|P1|"https://pubmed.ncbi.nlm.nih.gov/34779392/"/* Randomized, double-blind, two-way crossover bioequivalence and adhesion study, in healthy women, of a transdermal contraceptive patch with a newly sourced adhesive component at the end of shelf life vs. the EVRA patch at the beginning of shelf life → P1 → https://pubmed.ncbi.nlm.nih.gov/34779392/ */
Q72|P22|Q9/* Randomized, double-blind, two-way crossover bioequivalence and adhesion study, in healthy women, of a transdermal contraceptive patch with a newly sourced adhesive component at the end of shelf life vs. the EVRA patch at the beginning of shelf life → P22 → Hormonpflaster */
Q72|P23|Q3/* Randomized, double-blind, two-way crossover bioequivalence and adhesion study, in healthy women, of a transdermal contraceptive patch with a newly sourced adhesive component at the end of shelf life vs. the EVRA patch at the beginning of shelf life → P23 → Material des Verhütungsmittels */
Q73|P15|"Graziottin A"/* A review of transdermal hormonal contraception : focus on the ethinylestradiol/norelgestromin contraceptive patch → P15 → Graziottin A */
Q73|P16|"Treat Endocrinol"/* A review of transdermal hormonal contraception : focus on the ethinylestradiol/norelgestromin contraceptive patch → P16 → Treat Endocrinol */
Q73|P17|"5(6):359-65"/* A review of transdermal hormonal contraception : focus on the ethinylestradiol/norelgestromin contraceptive patch → P17 → 5(6):359-65 */
Q73|P18|+2006-01-01T00:00:00Z/9/* A review of transdermal hormonal contraception : focus on the ethinylestradiol/norelgestromin contraceptive patch → P18 → +2006-01-01T00:00:00Z/9 */
Q73|P19|"10.2165/00024677-200605060-00004"/* A review of transdermal hormonal contraception : focus on the ethinylestradiol/norelgestromin contraceptive patch → P19 → 10.2165/00024677-200605060-00004 */
Q73|P1|"https://pubmed.ncbi.nlm.nih.gov/17107221/"/* A review of transdermal hormonal contraception : focus on the ethinylestradiol/norelgestromin contraceptive patch → P1 → https://pubmed.ncbi.nlm.nih.gov/17107221/ */
Q73|P22|Q9/* A review of transdermal hormonal contraception : focus on the ethinylestradiol/norelgestromin contraceptive patch → P22 → Hormonpflaster */
Q73|P23|Q2/* A review of transdermal hormonal contraception : focus on the ethinylestradiol/norelgestromin contraceptive patch → P23 → Geschlecht */
Q74|P15|"O'Connell K, Burkman RT"/* The transdermal contraceptive patch: an updated review of the literature → P15 → O'Connell K, Burkman RT */
Q74|P16|"Clin Obstet Gynecol"/* The transdermal contraceptive patch: an updated review of the literature → P16 → Clin Obstet Gynecol */
Q74|P17|"Dec;50(4):918-26"/* The transdermal contraceptive patch: an updated review of the literature → P17 → Dec;50(4):918-26 */
Q74|P18|+2007-01-01T00:00:00Z/9/* The transdermal contraceptive patch: an updated review of the literature → P18 → +2007-01-01T00:00:00Z/9 */
Q74|P19|"10.1097/GRF.0b013e318159c410"/* The transdermal contraceptive patch: an updated review of the literature → P19 → 10.1097/GRF.0b013e318159c410 */
Q74|P1|"https://pubmed.ncbi.nlm.nih.gov/17982334/"/* The transdermal contraceptive patch: an updated review of the literature → P1 → https://pubmed.ncbi.nlm.nih.gov/17982334/ */
Q74|P22|Q9/* The transdermal contraceptive patch: an updated review of the literature → P22 → Hormonpflaster */
Q74|P23|Q2/* The transdermal contraceptive patch: an updated review of the literature → P23 → Geschlecht */
Q75|P15|"Graham S, Fraser IS"/* The progestogen-only mini-pill → P15 → Graham S, Fraser IS */
Q75|P16|"Contraception"/* The progestogen-only mini-pill → P16 → Contraception */
Q75|P17|"Oct;26(4):373-88"/* The progestogen-only mini-pill → P17 → Oct;26(4):373-88 */
Q75|P18|+1982-01-01T00:00:00Z/9/* The progestogen-only mini-pill → P18 → +1982-01-01T00:00:00Z/9 */
Q75|P19|"10.1016/0010-7824(82)90104-4"/* The progestogen-only mini-pill → P19 → 10.1016/0010-7824(82)90104-4 */
Q75|P1|"https://pubmed.ncbi.nlm.nih.gov/6759029/"/* The progestogen-only mini-pill → P1 → https://pubmed.ncbi.nlm.nih.gov/6759029/ */
Q75|P22|Q10/* The progestogen-only mini-pill → P22 → Gestagenpille (Minipille) */
Q75|P23|Q2/* The progestogen-only mini-pill → P23 → Geschlecht */
Q76|P15|"Robertson MC"/* A study of women on the progestogen only pill → P15 → Robertson MC */
Q76|P16|"Practitioner"/* A study of women on the progestogen only pill → P16 → Practitioner */
Q76|P17|"Apr;228(1390):435-9"/* A study of women on the progestogen only pill → P17 → Apr;228(1390):435-9 */
Q76|P18|+1984-01-01T00:00:00Z/9/* A study of women on the progestogen only pill → P18 → +1984-01-01T00:00:00Z/9 */
Q76|P1|"https://pubmed.ncbi.nlm.nih.gov/6728816/"/* A study of women on the progestogen only pill → P1 → https://pubmed.ncbi.nlm.nih.gov/6728816/ */
Q76|P22|Q10/* A study of women on the progestogen only pill → P22 → Gestagenpille (Minipille) */
Q76|P23|Q2/* A study of women on the progestogen only pill → P23 → Geschlecht */
Q229|P16|"Eur J Contracept Reprod Health Care"/* A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day → P16 → Eur J Contracept Reprod Health Care */
Q229|P17|"Dec;3(4):169-78"/* A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day → P17 → Dec;3(4):169-78 */
Q229|P18|+1998-01-01T00:00:00Z/9/* A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day → P18 → +1998-01-01T00:00:00Z/9 */
Q229|P19|"10.3109/13625189809167250"/* A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day → P19 → 10.3109/13625189809167250 */
Q229|P1|"https://pubmed.ncbi.nlm.nih.gov/10036599/"/* A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day → P1 → https://pubmed.ncbi.nlm.nih.gov/10036599/ */
Q229|P22|Q10/* A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day → P22 → Gestagenpille (Minipille) */
Q229|P23|Q6/* A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day → P23 → Effizienzmaße */
Q78|P15|"Broome M, Fotherby K"/* Clinical experience with the progestogen-only pill → P15 → Broome M, Fotherby K */
Q78|P16|"Contraception"/* Clinical experience with the progestogen-only pill → P16 → Contraception */
Q78|P17|"Nov;42(5):489-95"/* Clinical experience with the progestogen-only pill → P17 → Nov;42(5):489-95 */
Q78|P18|+1990-01-01T00:00:00Z/9/* Clinical experience with the progestogen-only pill → P18 → +1990-01-01T00:00:00Z/9 */
Q78|P19|"10.1016/0010-7824(90)90077-9"/* Clinical experience with the progestogen-only pill → P19 → 10.1016/0010-7824(90)90077-9 */
Q78|P1|"https://pubmed.ncbi.nlm.nih.gov/2125544/"/* Clinical experience with the progestogen-only pill → P1 → https://pubmed.ncbi.nlm.nih.gov/2125544/ */
Q78|P22|Q10/* Clinical experience with the progestogen-only pill → P22 → Gestagenpille (Minipille) */
Q78|P23|Q6/* Clinical experience with the progestogen-only pill → P23 → Effizienzmaße */
Q79|P15|"Howie PW"/* The progestogen-only pill → P15 → Howie PW */
Q79|P16|"Br J Obstet Gynaecol"/* The progestogen-only pill → P16 → Br J Obstet Gynaecol */
Q79|P17|"Oct;92(10):1001-2"/* The progestogen-only pill → P17 → Oct;92(10):1001-2 */
Q79|P18|+1985-01-01T00:00:00Z/9/* The progestogen-only pill → P18 → +1985-01-01T00:00:00Z/9 */
Q79|P19|"10.1111/j.1471-0528.1985.tb02993.x"/* The progestogen-only pill → P19 → 10.1111/j.1471-0528.1985.tb02993.x */
Q79|P1|"https://pubmed.ncbi.nlm.nih.gov/3840384/"/* The progestogen-only pill → P1 → https://pubmed.ncbi.nlm.nih.gov/3840384/ */
Q79|P22|Q10/* The progestogen-only pill → P22 → Gestagenpille (Minipille) */
Q79|P23|Q6/* The progestogen-only pill → P23 → Effizienzmaße */
Q80|P15|"Glasier A, Sober S, Gasloli R, Goyal A, Laurora I"/* A review of the effectiveness of a progestogen-only pill containing norgestrel 75 µg/day → P15 → Glasier A, Sober S, Gasloli R, Goyal A, Laurora I */
Q80|P16|"Contraception"/* A review of the effectiveness of a progestogen-only pill containing norgestrel 75 µg/day → P16 → Contraception */
Q80|P17|"Jan;105:1-6"/* A review of the effectiveness of a progestogen-only pill containing norgestrel 75 µg/day → P17 → Jan;105:1-6 */
Q80|P18|+2022-01-01T00:00:00Z/9/* A review of the effectiveness of a progestogen-only pill containing norgestrel 75 µg/day → P18 → +2022-01-01T00:00:00Z/9 */
Q80|P19|"10.1016/j.contraception.2021.08.016"/* A review of the effectiveness of a progestogen-only pill containing norgestrel 75 µg/day → P19 → 10.1016/j.contraception.2021.08.016 */
Q80|P1|"https://pubmed.ncbi.nlm.nih.gov/34499877/"/* A review of the effectiveness of a progestogen-only pill containing norgestrel 75 µg/day → P1 → https://pubmed.ncbi.nlm.nih.gov/34499877/ */
Q80|P22|Q10/* A review of the effectiveness of a progestogen-only pill containing norgestrel 75 µg/day → P22 → Gestagenpille (Minipille) */
Q80|P23|Q6/* A review of the effectiveness of a progestogen-only pill containing norgestrel 75 µg/day → P23 → Effizienzmaße */
Q81|P15|"Duijkers IJM, Heger-Mahn D, Drouin D, Colli E, Skouby S"/* Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake → P15 → Duijkers IJM, Heger-Mahn D, Drouin D, Colli E, Skouby S */
Q81|P16|"Contraception"/* Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake → P16 → Contraception */
Q81|P17|"Apr;93(4):303-309"/* Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake → P17 → Apr;93(4):303-309 */
Q81|P18|+2016-01-01T00:00:00Z/9/* Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake → P18 → +2016-01-01T00:00:00Z/9 */
Q81|P19|"10.1016/j.contraception.2015.12.007"/* Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake → P19 → 10.1016/j.contraception.2015.12.007 */
Q81|P1|"https://pubmed.ncbi.nlm.nih.gov/26708301/"/* Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake → P1 → https://pubmed.ncbi.nlm.nih.gov/26708301/ */
Q81|P22|Q10/* Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake → P22 → Gestagenpille (Minipille) */
Q81|P23|Q6/* Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake → P23 → Effizienzmaße */
Q82|P15|"Glasier A, Edelman A, Creinin MD, Han L, Matulich MC, Brache V, Westhoff CL, Hemon A"/* Mechanism of action of norgestrel 0.075 mg a progestogen-only pill. I. Effect on ovarian activity → P15 → Glasier A, Edelman A, Creinin MD, Han L, Matulich MC, Brache V, Westhoff CL, Hemon A */
Q82|P16|"Contraception"/* Mechanism of action of norgestrel 0.075 mg a progestogen-only pill. I. Effect on ovarian activity → P16 → Contraception */
Q82|P17|"Aug;112:37-42"/* Mechanism of action of norgestrel 0.075 mg a progestogen-only pill. I. Effect on ovarian activity → P17 → Aug;112:37-42 */
Q82|P18|+2022-01-01T00:00:00Z/9/* Mechanism of action of norgestrel 0.075 mg a progestogen-only pill. I. Effect on ovarian activity → P18 → +2022-01-01T00:00:00Z/9 */
Q82|P19|"10.1016/j.contraception.2022.03.022"/* Mechanism of action of norgestrel 0.075 mg a progestogen-only pill. I. Effect on ovarian activity → P19 → 10.1016/j.contraception.2022.03.022 */
Q82|P20|"Contraception; Hoogland score; Ovulation; Pharmacodynamics; Progestogen-only pills"/* Mechanism of action of norgestrel 0.075 mg a progestogen-only pill. I. Effect on ovarian activity → P20 → Contraception; Hoogland score; Ovulation; Pharmacodynamics; Progestogen-only pills */
Q82|P1|"https://pubmed.ncbi.nlm.nih.gov/35351445/"/* Mechanism of action of norgestrel 0.075 mg a progestogen-only pill. I. Effect on ovarian activity → P1 → https://pubmed.ncbi.nlm.nih.gov/35351445/ */
Q82|P22|Q10/* Mechanism of action of norgestrel 0.075 mg a progestogen-only pill. I. Effect on ovarian activity → P22 → Gestagenpille (Minipille) */
Q82|P23|Q6/* Mechanism of action of norgestrel 0.075 mg a progestogen-only pill. I. Effect on ovarian activity → P23 → Effizienzmaße */
Q83|P15|"Grindlay K, Obedin-Maliver J, Ragosta S, Hastings J, Lunn MR, Flentje A, Capriotti MR, Dastur Z, Lubensky ME, Moseson H"/* Interest in over-the-counter progestin-only pills among transgender, nonbinary, and gender-expansive individuals in the United States → P15 → Grindlay K, Obedin-Maliver J, Ragosta S, Hastings J, Lunn MR, Flentje A, Capriotti MR, Dastur Z, Lubensky ME, Moseson H */
Q83|P16|"Am J Obstet Gynecol"/* Interest in over-the-counter progestin-only pills among transgender, nonbinary, and gender-expansive individuals in the United States → P16 → Am J Obstet Gynecol */
Q83|P17|"Jun;230(6):657.e1-657.e17"/* Interest in over-the-counter progestin-only pills among transgender, nonbinary, and gender-expansive individuals in the United States → P17 → Jun;230(6):657.e1-657.e17 */
Q83|P18|+2024-01-01T00:00:00Z/9/* Interest in over-the-counter progestin-only pills among transgender, nonbinary, and gender-expansive individuals in the United States → P18 → +2024-01-01T00:00:00Z/9 */
Q83|P19|"10.1016/j.ajog.2024.02.006"/* Interest in over-the-counter progestin-only pills among transgender, nonbinary, and gender-expansive individuals in the United States → P19 → 10.1016/j.ajog.2024.02.006 */
Q83|P20|"LGBTQ+ health; contraception; equity; equity: gender expression or identity; equity: sexual orientation; family planning; health disparities; health policy and health economics; transgender patient care"/* Interest in over-the-counter progestin-only pills among transgender, nonbinary, and gender-expansive individuals in the United States → P20 → LGBTQ+ health; contraception; equity; equity: gender expression or identity; equity: sexual orientation; family planning; health disparities; health policy and health economics; transgender patient care */
Q83|P1|"https://pubmed.ncbi.nlm.nih.gov/38365096/"/* Interest in over-the-counter progestin-only pills among transgender, nonbinary, and gender-expansive individuals in the United States → P1 → https://pubmed.ncbi.nlm.nih.gov/38365096/ */
Q83|P22|Q10/* Interest in over-the-counter progestin-only pills among transgender, nonbinary, and gender-expansive individuals in the United States → P22 → Gestagenpille (Minipille) */
Q83|P23|Q2/* Interest in over-the-counter progestin-only pills among transgender, nonbinary, and gender-expansive individuals in the United States → P23 → Geschlecht */
Q84|P15|"Kerns J, Darney P"/* Vaginal ring contraception → P15 → Kerns J, Darney P */
Q84|P16|"Contraception"/* Vaginal ring contraception → P16 → Contraception */
Q84|P17|"Feb;83(2):107-15"/* Vaginal ring contraception → P17 → Feb;83(2):107-15 */
Q84|P18|+2011-01-01T00:00:00Z/9/* Vaginal ring contraception → P18 → +2011-01-01T00:00:00Z/9 */
Q84|P19|"10.1016/j.contraception.2010.07.008"/* Vaginal ring contraception → P19 → 10.1016/j.contraception.2010.07.008 */
Q84|P1|"https://pubmed.ncbi.nlm.nih.gov/21237335/"/* Vaginal ring contraception → P1 → https://pubmed.ncbi.nlm.nih.gov/21237335/ */
Q84|P22|Q11/* Vaginal ring contraception → P22 → Vaginalring */
Q84|P23|Q2/* Vaginal ring contraception → P23 → Geschlecht */
Q85|P15|"Ridgeway K, Montgomery ET, Smith K, Torjesen K, van der Straten A, Achilles SL, Griffin JB"/* Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world → P15 → Ridgeway K, Montgomery ET, Smith K, Torjesen K, van der Straten A, Achilles SL, Griffin JB */
Q85|P16|"Contraception"/* Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world → P16 → Contraception */
Q85|P17|"Feb;106:16-33"/* Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world → P17 → Feb;106:16-33 */
Q85|P18|+2022-01-01T00:00:00Z/9/* Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world → P18 → +2022-01-01T00:00:00Z/9 */
Q85|P19|"10.1016/j.contraception.2021.10.001"/* Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world → P19 → 10.1016/j.contraception.2021.10.001 */
Q85|P20|"Acceptability; Contraception; HIV prevention; Meta-analysis; Systematic review; Vaginal ring"/* Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world → P20 → Acceptability; Contraception; HIV prevention; Meta-analysis; Systematic review; Vaginal ring */
Q85|P1|"https://pubmed.ncbi.nlm.nih.gov/34644609/"/* Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world → P1 → https://pubmed.ncbi.nlm.nih.gov/34644609/ */
Q85|P22|Q11/* Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world → P22 → Vaginalring */
Q85|P23|Q2/* Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world → P23 → Geschlecht */
Q86|P15|"Edwardson J, Jamshidi R"/* The contraceptive vaginal ring → P15 → Edwardson J, Jamshidi R */
Q86|P16|"Semin Reprod Med"/* The contraceptive vaginal ring → P16 → Semin Reprod Med */
Q86|P17|"Mar;28(2):133-9"/* The contraceptive vaginal ring → P17 → Mar;28(2):133-9 */
Q86|P18|+2010-01-01T00:00:00Z/9/* The contraceptive vaginal ring → P18 → +2010-01-01T00:00:00Z/9 */
Q86|P19|"10.1055/s-0030-1248138"/* The contraceptive vaginal ring → P19 → 10.1055/s-0030-1248138 */
Q86|P1|"https://pubmed.ncbi.nlm.nih.gov/20352563/"/* The contraceptive vaginal ring → P1 → https://pubmed.ncbi.nlm.nih.gov/20352563/ */
Q86|P22|Q11/* The contraceptive vaginal ring → P22 → Vaginalring */
Q86|P23|Q2/* The contraceptive vaginal ring → P23 → Geschlecht */
Q87|P15|"Bitzer J"/* The vaginal ring (NuvaRing®) for contraception in adolescent women → P15 → Bitzer J */
Q87|P16|"Gynecol Endocrinol"/* The vaginal ring (NuvaRing®) for contraception in adolescent women → P16 → Gynecol Endocrinol */
Q87|P17|"Feb;28(2):125-9"/* The vaginal ring (NuvaRing®) for contraception in adolescent women → P17 → Feb;28(2):125-9 */
Q87|P18|+2012-01-01T00:00:00Z/9/* The vaginal ring (NuvaRing®) for contraception in adolescent women → P18 → +2012-01-01T00:00:00Z/9 */
Q87|P19|"10.3109/09513590.2011.579665"/* The vaginal ring (NuvaRing®) for contraception in adolescent women → P19 → 10.3109/09513590.2011.579665 */
Q87|P1|"https://pubmed.ncbi.nlm.nih.gov/21615237/"/* The vaginal ring (NuvaRing®) for contraception in adolescent women → P1 → https://pubmed.ncbi.nlm.nih.gov/21615237/ */
Q87|P22|Q11/* The vaginal ring (NuvaRing®) for contraception in adolescent women → P22 → Vaginalring */
Q87|P23|Q2/* The vaginal ring (NuvaRing®) for contraception in adolescent women → P23 → Geschlecht */
Q88|P15|"Elkik F, Basdevant A, Jackanicz TM, Guy-Grand B, Mercier-Bodard C, Conard J, Bardin CW, Corvol P"/* Contraception in hypertensive women using a vaginal ring delivering estradiol and levonorgestrel → P15 → Elkik F, Basdevant A, Jackanicz TM, Guy-Grand B, Mercier-Bodard C, Conard J, Bardin CW, Corvol P */
Q88|P16|"J Clin Endocrinol Metab"/* Contraception in hypertensive women using a vaginal ring delivering estradiol and levonorgestrel → P16 → J Clin Endocrinol Metab */
Q88|P17|"Jul;63(1):29-35"/* Contraception in hypertensive women using a vaginal ring delivering estradiol and levonorgestrel → P17 → Jul;63(1):29-35 */
Q88|P18|+1986-01-01T00:00:00Z/9/* Contraception in hypertensive women using a vaginal ring delivering estradiol and levonorgestrel → P18 → +1986-01-01T00:00:00Z/9 */
Q88|P19|"10.1210/jcem-63-1-29"/* Contraception in hypertensive women using a vaginal ring delivering estradiol and levonorgestrel → P19 → 10.1210/jcem-63-1-29 */
Q88|P1|"https://pubmed.ncbi.nlm.nih.gov/3086360/"/* Contraception in hypertensive women using a vaginal ring delivering estradiol and levonorgestrel → P1 → https://pubmed.ncbi.nlm.nih.gov/3086360/ */
Q88|P22|Q11/* Contraception in hypertensive women using a vaginal ring delivering estradiol and levonorgestrel → P22 → Vaginalring */
Q88|P23|Q3/* Contraception in hypertensive women using a vaginal ring delivering estradiol and levonorgestrel → P23 → Material des Verhütungsmittels */
Q89|P15|"Olsson SE, Odlind V"/* Contraception with a vaginal ring releasing 3-keto desogestrel and ethinylestradiol → P15 → Olsson SE, Odlind V */
Q89|P16|"Contraception"/* Contraception with a vaginal ring releasing 3-keto desogestrel and ethinylestradiol → P16 → Contraception */
Q89|P17|"Nov;42(5):563-72"/* Contraception with a vaginal ring releasing 3-keto desogestrel and ethinylestradiol → P17 → Nov;42(5):563-72 */
Q89|P18|+1990-01-01T00:00:00Z/9/* Contraception with a vaginal ring releasing 3-keto desogestrel and ethinylestradiol → P18 → +1990-01-01T00:00:00Z/9 */
Q89|P19|"10.1016/0010-7824(90)90083-8"/* Contraception with a vaginal ring releasing 3-keto desogestrel and ethinylestradiol → P19 → 10.1016/0010-7824(90)90083-8 */
Q89|P1|"https://pubmed.ncbi.nlm.nih.gov/2272184/"/* Contraception with a vaginal ring releasing 3-keto desogestrel and ethinylestradiol → P1 → https://pubmed.ncbi.nlm.nih.gov/2272184/ */
Q89|P22|Q11/* Contraception with a vaginal ring releasing 3-keto desogestrel and ethinylestradiol → P22 → Vaginalring */
Q89|P23|Q3/* Contraception with a vaginal ring releasing 3-keto desogestrel and ethinylestradiol → P23 → Material des Verhütungsmittels */
Q90|P15|"Mishell DR Jr, Talas M, Parlow AF, Moyer DL"/* Contraception by means of a silastic vaginal ring impregnated with medroxyprogesterone acetate → P15 → Mishell DR Jr, Talas M, Parlow AF, Moyer DL */
Q90|P16|"Am J Obstet Gynecol"/* Contraception by means of a silastic vaginal ring impregnated with medroxyprogesterone acetate → P16 → Am J Obstet Gynecol */
Q90|P17|"May 1;107(1):100-7"/* Contraception by means of a silastic vaginal ring impregnated with medroxyprogesterone acetate → P17 → May 1;107(1):100-7 */
Q90|P18|+1970-01-01T00:00:00Z/9/* Contraception by means of a silastic vaginal ring impregnated with medroxyprogesterone acetate → P18 → +1970-01-01T00:00:00Z/9 */
Q90|P19|"10.1016/s0002-9378(16)33897-2"/* Contraception by means of a silastic vaginal ring impregnated with medroxyprogesterone acetate → P19 → 10.1016/s0002-9378(16)33897-2 */
Q90|P1|"https://pubmed.ncbi.nlm.nih.gov/5443056/"/* Contraception by means of a silastic vaginal ring impregnated with medroxyprogesterone acetate → P1 → https://pubmed.ncbi.nlm.nih.gov/5443056/ */
Q90|P22|Q11/* Contraception by means of a silastic vaginal ring impregnated with medroxyprogesterone acetate → P22 → Vaginalring */
Q90|P23|Q3/* Contraception by means of a silastic vaginal ring impregnated with medroxyprogesterone acetate → P23 → Material des Verhütungsmittels */
Q91|P15|"López-Picado A, Lapuente O, Lete I"/* Efficacy and side-effects profile of the ethinylestradiol and etonogestrel contraceptive vaginal ring: a systematic review and meta-analysis → P15 → López-Picado A, Lapuente O, Lete I */
Q91|P16|"Eur J Contracept Reprod Health Care"/* Efficacy and side-effects profile of the ethinylestradiol and etonogestrel contraceptive vaginal ring: a systematic review and meta-analysis → P16 → Eur J Contracept Reprod Health Care */
Q91|P17|"Apr;22(2):131-146"/* Efficacy and side-effects profile of the ethinylestradiol and etonogestrel contraceptive vaginal ring: a systematic review and meta-analysis → P17 → Apr;22(2):131-146 */
Q91|P18|+2017-01-01T00:00:00Z/9/* Efficacy and side-effects profile of the ethinylestradiol and etonogestrel contraceptive vaginal ring: a systematic review and meta-analysis → P18 → +2017-01-01T00:00:00Z/9 */
Q91|P19|"10.1080/13625187.2017.1287351"/* Efficacy and side-effects profile of the ethinylestradiol and etonogestrel contraceptive vaginal ring: a systematic review and meta-analysis → P19 → 10.1080/13625187.2017.1287351 */
Q91|P20|"Contraceptive vaginal ring; meta-analysis; oral contraceptives; systematic review"/* Efficacy and side-effects profile of the ethinylestradiol and etonogestrel contraceptive vaginal ring: a systematic review and meta-analysis → P20 → Contraceptive vaginal ring; meta-analysis; oral contraceptives; systematic review */
Q91|P1|"https://pubmed.ncbi.nlm.nih.gov/28256919/"/* Efficacy and side-effects profile of the ethinylestradiol and etonogestrel contraceptive vaginal ring: a systematic review and meta-analysis → P1 → https://pubmed.ncbi.nlm.nih.gov/28256919/ */
Q91|P22|Q11/* Efficacy and side-effects profile of the ethinylestradiol and etonogestrel contraceptive vaginal ring: a systematic review and meta-analysis → P22 → Vaginalring */
Q91|P23|Q6/* Efficacy and side-effects profile of the ethinylestradiol and etonogestrel contraceptive vaginal ring: a systematic review and meta-analysis → P23 → Effizienzmaße */
Q92|P15|"Nguyen BT, Jensen JT"/* Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring → P15 → Nguyen BT, Jensen JT */
Q92|P16|"Expert Opin Drug Saf"/* Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring → P16 → Expert Opin Drug Saf */
Q92|P17|"Oct;13(10):1423-30"/* Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring → P17 → Oct;13(10):1423-30 */
Q92|P18|+2014-01-01T00:00:00Z/9/* Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring → P18 → +2014-01-01T00:00:00Z/9 */
Q92|P19|"10.1517/14740338.2014.948842"/* Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring → P19 → 10.1517/14740338.2014.948842 */
Q92|P20|"combined contraceptive vaginal ring; contraception; contraceptive failure; deep vein thrombosis; safety; venous thromboembolism"/* Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring → P20 → combined contraceptive vaginal ring; contraception; contraceptive failure; deep vein thrombosis; safety; venous thromboembolism */
Q92|P1|"https://pubmed.ncbi.nlm.nih.gov/25106828/"/* Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring → P1 → https://pubmed.ncbi.nlm.nih.gov/25106828/ */
Q92|P22|Q11/* Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring → P22 → Vaginalring */
Q92|P23|Q6/* Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring → P23 → Effizienzmaße */
Q93|P15|"Roumen F"/* Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing → P15 → Roumen F */
Q93|P16|"Eur J Contracept Reprod Health Care"/* Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing → P16 → Eur J Contracept Reprod Health Care */
Q93|P17|"Dec;7 Suppl 2:19-24; discussion 37-9"/* Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing → P17 → Dec;7 Suppl 2:19-24; discussion 37-9 */
Q93|P18|+2002-01-01T00:00:00Z/9/* Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing → P18 → +2002-01-01T00:00:00Z/9 */
Q93|P1|"https://pubmed.ncbi.nlm.nih.gov/12659398/"/* Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing → P1 → https://pubmed.ncbi.nlm.nih.gov/12659398/ */
Q93|P22|Q11/* Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing → P22 → Vaginalring */
Q93|P23|Q6/* Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing → P23 → Effizienzmaße */
Q94|P15|"Roumen FJ, Apter D, Mulders TM, Dieben TO"/* Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol → P15 → Roumen FJ, Apter D, Mulders TM, Dieben TO */
Q94|P16|"Hum Reprod"/* Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol → P16 → Hum Reprod */
Q94|P17|"Mar;16(3):469-75"/* Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol → P17 → Mar;16(3):469-75 */
Q94|P18|+2001-01-01T00:00:00Z/9/* Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol → P18 → +2001-01-01T00:00:00Z/9 */
Q94|P19|"10.1093/humrep/16.3.469"/* Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol → P19 → 10.1093/humrep/16.3.469 */
Q94|P1|"https://pubmed.ncbi.nlm.nih.gov/11228213/"/* Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol → P1 → https://pubmed.ncbi.nlm.nih.gov/11228213/ */
Q94|P22|Q11/* Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol → P22 → Vaginalring */
Q94|P23|Q6/* Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol → P23 → Effizienzmaße */
Q95|P15|"Weisberg E, Fraser IS, Lacarra M, Mishell DR Jr, Alvarez F, Brache V, Nash HA"/* Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring → P15 → Weisberg E, Fraser IS, Lacarra M, Mishell DR Jr, Alvarez F, Brache V, Nash HA */
Q95|P16|"Contraception"/* Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring → P16 → Contraception */
Q95|P17|"May;59(5):311-8"/* Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring → P17 → May;59(5):311-8 */
Q95|P18|+1999-01-01T00:00:00Z/9/* Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring → P18 → +1999-01-01T00:00:00Z/9 */
Q95|P19|"10.1016/s0010-7824(99)00035-9"/* Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring → P19 → 10.1016/s0010-7824(99)00035-9 */
Q95|P1|"https://pubmed.ncbi.nlm.nih.gov/10494485/"/* Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring → P1 → https://pubmed.ncbi.nlm.nih.gov/10494485/ */
Q95|P22|Q11/* Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring → P22 → Vaginalring */
Q95|P23|Q6/* Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring → P23 → Effizienzmaße */
Q96|P15|"Bakry S, Merhi ZO, Scalise TJ, Mahmoud MS, Fadiel A, Naftolin F"/* Depot-medroxyprogesterone acetate: an update → P15 → Bakry S, Merhi ZO, Scalise TJ, Mahmoud MS, Fadiel A, Naftolin F */
Q96|P16|"Arch Gynecol Obstet"/* Depot-medroxyprogesterone acetate: an update → P16 → Arch Gynecol Obstet */
Q96|P17|"Jul;278(1):1-12"/* Depot-medroxyprogesterone acetate: an update → P17 → Jul;278(1):1-12 */
Q96|P18|+2008-01-01T00:00:00Z/9/* Depot-medroxyprogesterone acetate: an update → P18 → +2008-01-01T00:00:00Z/9 */
Q96|P19|"10.1007/s00404-007-0497-z"/* Depot-medroxyprogesterone acetate: an update → P19 → 10.1007/s00404-007-0497-z */
Q96|P1|"https://pubmed.ncbi.nlm.nih.gov/18470526/"/* Depot-medroxyprogesterone acetate: an update → P1 → https://pubmed.ncbi.nlm.nih.gov/18470526/ */
Q96|P22|Q12/* Depot-medroxyprogesterone acetate: an update → P22 → Dreimonatsspritze */
Q96|P23|Q2/* Depot-medroxyprogesterone acetate: an update → P23 → Geschlecht */
Q97|P15|"Frederiksen MC"/* Depot medroxyprogesterone acetate contraception in women with medical problems → P15 → Frederiksen MC */
Q97|P16|"J Reprod Med"/* Depot medroxyprogesterone acetate contraception in women with medical problems → P16 → J Reprod Med */
Q97|P17|"May;41(5 Suppl):414-8"/* Depot medroxyprogesterone acetate contraception in women with medical problems → P17 → May;41(5 Suppl):414-8 */
Q97|P18|+1996-01-01T00:00:00Z/9/* Depot medroxyprogesterone acetate contraception in women with medical problems → P18 → +1996-01-01T00:00:00Z/9 */
Q97|P1|"https://pubmed.ncbi.nlm.nih.gov/8725704/"/* Depot medroxyprogesterone acetate contraception in women with medical problems → P1 → https://pubmed.ncbi.nlm.nih.gov/8725704/ */
Q97|P22|Q12/* Depot medroxyprogesterone acetate contraception in women with medical problems → P22 → Dreimonatsspritze */
Q97|P23|Q2/* Depot medroxyprogesterone acetate contraception in women with medical problems → P23 → Geschlecht */
Q98|P15|"Dragoman MV, Gaffield ME"/* The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review → P15 → Dragoman MV, Gaffield ME */
Q98|P16|"Contraception"/* The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review → P16 → Contraception */
Q98|P17|"Sep;94(3):202-15"/* The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review → P17 → Sep;94(3):202-15 */
Q98|P18|+2016-01-01T00:00:00Z/9/* The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review → P18 → +2016-01-01T00:00:00Z/9 */
Q98|P19|"10.1016/j.contraception.2016.02.003"/* The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review → P19 → 10.1016/j.contraception.2016.02.003 */
Q98|P20|"DMPA; Depot medroxyprogesterone; Progestogen-only injectables; Safety; Subcutaneous"/* The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review → P20 → DMPA; Depot medroxyprogesterone; Progestogen-only injectables; Safety; Subcutaneous */
Q98|P1|"https://pubmed.ncbi.nlm.nih.gov/26874275/"/* The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review → P1 → https://pubmed.ncbi.nlm.nih.gov/26874275/ */
Q98|P22|Q12/* The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review → P22 → Dreimonatsspritze */
Q98|P23|Q2/* The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review → P23 → Geschlecht */
Q99|P15|"Mishell DR Jr"/* Pharmacokinetics of depot medroxyprogesterone acetate contraception → P15 → Mishell DR Jr */
Q99|P16|"J Reprod Med"/* Pharmacokinetics of depot medroxyprogesterone acetate contraception → P16 → J Reprod Med */
Q99|P17|"May;41(5 Suppl):381-90"/* Pharmacokinetics of depot medroxyprogesterone acetate contraception → P17 → May;41(5 Suppl):381-90 */
Q99|P18|+1996-01-01T00:00:00Z/9/* Pharmacokinetics of depot medroxyprogesterone acetate contraception → P18 → +1996-01-01T00:00:00Z/9 */
Q99|P1|"https://pubmed.ncbi.nlm.nih.gov/8725700/"/* Pharmacokinetics of depot medroxyprogesterone acetate contraception → P1 → https://pubmed.ncbi.nlm.nih.gov/8725700/ */
Q99|P22|Q12/* Pharmacokinetics of depot medroxyprogesterone acetate contraception → P22 → Dreimonatsspritze */
Q99|P23|Q3/* Pharmacokinetics of depot medroxyprogesterone acetate contraception → P23 → Material des Verhütungsmittels */
Q100|P15|"Westhoff C"/* Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety → P15 → Westhoff C */
Q100|P16|"Contraception"/* Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety → P16 → Contraception */
Q100|P17|"Aug;68(2):75-87"/* Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety → P17 → Aug;68(2):75-87 */
Q100|P18|+2003-01-01T00:00:00Z/9/* Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety → P18 → +2003-01-01T00:00:00Z/9 */
Q100|P19|"10.1016/s0010-7824(03)00136-7"/* Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety → P19 → 10.1016/s0010-7824(03)00136-7 */
Q100|P1|"https://pubmed.ncbi.nlm.nih.gov/12954518/"/* Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety → P1 → https://pubmed.ncbi.nlm.nih.gov/12954518/ */
Q100|P22|Q12/* Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety → P22 → Dreimonatsspritze */
Q100|P23|Q6/* Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety → P23 → Effizienzmaße */
Q101|P15|"Kaunitz AM"/* Long-acting injectable contraception with depot medroxyprogesterone acetate → P15 → Kaunitz AM */
Q101|P16|"Am J Obstet Gynecol"/* Long-acting injectable contraception with depot medroxyprogesterone acetate → P16 → Am J Obstet Gynecol */
Q101|P17|"May;170(5 Pt 2):1543-9"/* Long-acting injectable contraception with depot medroxyprogesterone acetate → P17 → May;170(5 Pt 2):1543-9 */
Q101|P18|+1994-01-01T00:00:00Z/9/* Long-acting injectable contraception with depot medroxyprogesterone acetate → P18 → +1994-01-01T00:00:00Z/9 */
Q101|P1|"://pubmed.ncbi.nlm.nih.gov/8178904/"/* Long-acting injectable contraception with depot medroxyprogesterone acetate → P1 → ://pubmed.ncbi.nlm.nih.gov/8178904/ */
Q101|P22|Q12/* Long-acting injectable contraception with depot medroxyprogesterone acetate → P22 → Dreimonatsspritze */
Q101|P23|Q6/* Long-acting injectable contraception with depot medroxyprogesterone acetate → P23 → Effizienzmaße */
Q228|P15|"Said S, Omar K, Koetsawang S, Kiriwat O, Srisatayapan Y, Kazi A, Ajmal F, Wynter HH, Pretnar-Darovec A, Benitez IB, et al"/* A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg → P15 → Said S, Omar K, Koetsawang S, Kiriwat O, Srisatayapan Y, Kazi A, Ajmal F, Wynter HH, Pretnar-Darovec A, Benitez IB, et al */
Q228|P16|"Contraception"/* A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg → P16 → Contraception */
Q228|P17|"Sep;34(3):223-35"/* A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg → P17 → Sep;34(3):223-35 */
Q228|P18|+1986-01-01T00:00:00Z/9/* A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg → P18 → +1986-01-01T00:00:00Z/9 */
Q228|P19|"10.1016/0010-7824(86)90004-1"/* A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg → P19 → 10.1016/0010-7824(86)90004-1 */
Q228|P1|"https://pubmed.ncbi.nlm.nih.gov/2947777/"/* A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg → P1 → https://pubmed.ncbi.nlm.nih.gov/2947777/ */
Q228|P22|Q12/* A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg → P22 → Dreimonatsspritze */
Q228|P23|Q6/* A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg → P23 → Effizienzmaße */
Q103|P15|"Dinehart E, Lathi RB, Aghajanova L"/* Levonorgestrel IUD: is there a long-lasting effect on return to fertility? → P15 → Dinehart E, Lathi RB, Aghajanova L */
Q103|P16|"J Assist Reprod Genet"/* Levonorgestrel IUD: is there a long-lasting effect on return to fertility? → P16 → J Assist Reprod Genet */
Q103|P17|"Jan;37(1):45-52"/* Levonorgestrel IUD: is there a long-lasting effect on return to fertility? → P17 → Jan;37(1):45-52 */
Q103|P18|+2020-01-01T00:00:00Z/9/* Levonorgestrel IUD: is there a long-lasting effect on return to fertility? → P18 → +2020-01-01T00:00:00Z/9 */
Q103|P19|"10.1007/s10815-019-01624-5"/* Levonorgestrel IUD: is there a long-lasting effect on return to fertility? → P19 → 10.1007/s10815-019-01624-5 */
Q103|P20|"Copper IUD; Endometrial gene expression; Infertility; Intrauterine device; LNG-IUD; Levonorgestrel"/* Levonorgestrel IUD: is there a long-lasting effect on return to fertility? → P20 → Copper IUD; Endometrial gene expression; Infertility; Intrauterine device; LNG-IUD; Levonorgestrel */
Q103|P1|"https://pubmed.ncbi.nlm.nih.gov/31709489/"/* Levonorgestrel IUD: is there a long-lasting effect on return to fertility? → P1 → https://pubmed.ncbi.nlm.nih.gov/31709489/ */
Q103|P22|Q13/* Levonorgestrel IUD: is there a long-lasting effect on return to fertility? → P22 → Hormonspirale */
Q103|P23|Q3/* Levonorgestrel IUD: is there a long-lasting effect on return to fertility? → P23 → Material des Verhütungsmittels */
Q104|P15|"Bjørkås M, Skjeldestad FE"/* Hormonal IUD is the major hormonal contraceptive method used among women aged 40-49 years: Data from the 2015-16 Tromsø Study, Norway → P15 → Bjørkås M, Skjeldestad FE */
Q104|P16|"Eur J Obstet Gynecol Reprod Biol"/* Hormonal IUD is the major hormonal contraceptive method used among women aged 40-49 years: Data from the 2015-16 Tromsø Study, Norway → P16 → Eur J Obstet Gynecol Reprod Biol */
Q104|P17|"Jan;280:93-97"/* Hormonal IUD is the major hormonal contraceptive method used among women aged 40-49 years: Data from the 2015-16 Tromsø Study, Norway → P17 → Jan;280:93-97 */
Q104|P18|+2023-01-01T00:00:00Z/9/* Hormonal IUD is the major hormonal contraceptive method used among women aged 40-49 years: Data from the 2015-16 Tromsø Study, Norway → P18 → +2023-01-01T00:00:00Z/9 */
Q104|P19|"10.1016/j.ejogrb.2022.11.019"/* Hormonal IUD is the major hormonal contraceptive method used among women aged 40-49 years: Data from the 2015-16 Tromsø Study, Norway → P19 → 10.1016/j.ejogrb.2022.11.019 */
Q104|P20|"Combined oral contraceptives; Hormonal contraceptives; Hormonal injection; Hormonal intrauterine device; Hormonal patch; Implants; Premenopausal women; Progestogen-only pills"/* Hormonal IUD is the major hormonal contraceptive method used among women aged 40-49 years: Data from the 2015-16 Tromsø Study, Norway → P20 → Combined oral contraceptives; Hormonal contraceptives; Hormonal injection; Hormonal intrauterine device; Hormonal patch; Implants; Premenopausal women; Progestogen-only pills */
Q104|P1|"https://pubmed.ncbi.nlm.nih.gov/36442379/"/* Hormonal IUD is the major hormonal contraceptive method used among women aged 40-49 years: Data from the 2015-16 Tromsø Study, Norway → P1 → https://pubmed.ncbi.nlm.nih.gov/36442379/ */
Q104|P22|Q13/* Hormonal IUD is the major hormonal contraceptive method used among women aged 40-49 years: Data from the 2015-16 Tromsø Study, Norway → P22 → Hormonspirale */
Q104|P23|Q2/* Hormonal IUD is the major hormonal contraceptive method used among women aged 40-49 years: Data from the 2015-16 Tromsø Study, Norway → P23 → Geschlecht */
Q105|P15|"Barbosa I, Olsson SE, Odlind V, Goncalves T, Coutinho E"/* Ovarian function after seven years' use of a levonorgestrel IUD → P15 → Barbosa I, Olsson SE, Odlind V, Goncalves T, Coutinho E */
Q105|P16|"Adv Contracept"/* Ovarian function after seven years' use of a levonorgestrel IUD → P16 → Adv Contracept */
Q105|P17|"Jun;11(2):85-95"/* Ovarian function after seven years' use of a levonorgestrel IUD → P17 → Jun;11(2):85-95 */
Q105|P18|+1995-01-01T00:00:00Z/9/* Ovarian function after seven years' use of a levonorgestrel IUD → P18 → +1995-01-01T00:00:00Z/9 */
Q105|P19|"10.1007/BF01987274"/* Ovarian function after seven years' use of a levonorgestrel IUD → P19 → 10.1007/BF01987274 */
Q105|P1|"https://pubmed.ncbi.nlm.nih.gov/7491859/"/* Ovarian function after seven years' use of a levonorgestrel IUD → P1 → https://pubmed.ncbi.nlm.nih.gov/7491859/ */
Q105|P22|Q13/* Ovarian function after seven years' use of a levonorgestrel IUD → P22 → Hormonspirale */
Q105|P23|Q6/* Ovarian function after seven years' use of a levonorgestrel IUD → P23 → Effizienzmaße */
Q106|P15|"Nitke S, Rabinerson D, Dekel A, Sheiner E, Kaplan B, Hackmon R"/* Lost levonorgestrel IUD: diagnosis and therapy → P15 → Nitke S, Rabinerson D, Dekel A, Sheiner E, Kaplan B, Hackmon R */
Q106|P16|"Contraception"/* Lost levonorgestrel IUD: diagnosis and therapy → P16 → Contraception */
Q106|P17|"Apr;69(4):289-93"/* Lost levonorgestrel IUD: diagnosis and therapy → P17 → Apr;69(4):289-93 */
Q106|P18|+2004-01-01T00:00:00Z/9/* Lost levonorgestrel IUD: diagnosis and therapy → P18 → +2004-01-01T00:00:00Z/9 */
Q106|P19|"10.1016/j.contraception.2003.11.017"/* Lost levonorgestrel IUD: diagnosis and therapy → P19 → 10.1016/j.contraception.2003.11.017 */
Q106|P1|"https://pubmed.ncbi.nlm.nih.gov/15033403/"/* Lost levonorgestrel IUD: diagnosis and therapy → P1 → https://pubmed.ncbi.nlm.nih.gov/15033403/ */
Q106|P22|Q13/* Lost levonorgestrel IUD: diagnosis and therapy → P22 → Hormonspirale */
Q106|P23|Q6/* Lost levonorgestrel IUD: diagnosis and therapy → P23 → Effizienzmaße */
Q107|P15|"Blumenthal PD, Lerma K, Bhamrah R, Singh S; Dedicated PPIUD Inserter Working Group"/* Comparative safety and efficacy of a dedicated postpartum IUD inserter versus forceps for immediate postpartum IUD insertion: a randomized trial → P15 → Blumenthal PD, Lerma K, Bhamrah R, Singh S; Dedicated PPIUD Inserter Working Group */
Q107|P16|"Contraception"/* Comparative safety and efficacy of a dedicated postpartum IUD inserter versus forceps for immediate postpartum IUD insertion: a randomized trial → P16 → Contraception */
Q107|P17|"Sep;98(3):215-219"/* Comparative safety and efficacy of a dedicated postpartum IUD inserter versus forceps for immediate postpartum IUD insertion: a randomized trial → P17 → Sep;98(3):215-219 */
Q107|P18|+2018-01-01T00:00:00Z/9/* Comparative safety and efficacy of a dedicated postpartum IUD inserter versus forceps for immediate postpartum IUD insertion: a randomized trial → P18 → +2018-01-01T00:00:00Z/9 */
Q107|P19|"10.1016/j.contraception.2018.04.019"/* Comparative safety and efficacy of a dedicated postpartum IUD inserter versus forceps for immediate postpartum IUD insertion: a randomized trial → P19 → 10.1016/j.contraception.2018.04.019 */
Q107|P20|"IUD; LARC; PPIUD; Postpartum contraception"/* Comparative safety and efficacy of a dedicated postpartum IUD inserter versus forceps for immediate postpartum IUD insertion: a randomized trial → P20 → IUD; LARC; PPIUD; Postpartum contraception */
Q107|P1|"https://pubmed.ncbi.nlm.nih.gov/29750926/"/* Comparative safety and efficacy of a dedicated postpartum IUD inserter versus forceps for immediate postpartum IUD insertion: a randomized trial → P1 → https://pubmed.ncbi.nlm.nih.gov/29750926/ */
Q107|P22|Q13/* Comparative safety and efficacy of a dedicated postpartum IUD inserter versus forceps for immediate postpartum IUD insertion: a randomized trial → P22 → Hormonspirale */
Q107|P23|Q3/* Comparative safety and efficacy of a dedicated postpartum IUD inserter versus forceps for immediate postpartum IUD insertion: a randomized trial → P23 → Material des Verhütungsmittels */
Q108|P15|"Thonneau P, Almont T, de La Rochebrochard E, Maria B"/* Risk factors for IUD failure: results of a large multicentre case-control study → P15 → Thonneau P, Almont T, de La Rochebrochard E, Maria B */
Q108|P16|"Hum Reprod"/* Risk factors for IUD failure: results of a large multicentre case-control study → P16 → Hum Reprod */
Q108|P17|"Oct;21(10):2612-6"/* Risk factors for IUD failure: results of a large multicentre case-control study → P17 → Oct;21(10):2612-6 */
Q108|P18|+2006-01-01T00:00:00Z/9/* Risk factors for IUD failure: results of a large multicentre case-control study → P18 → +2006-01-01T00:00:00Z/9 */
Q108|P19|"10.1093/humrep/del208"/* Risk factors for IUD failure: results of a large multicentre case-control study → P19 → 10.1093/humrep/del208 */
Q108|P1|"https://pubmed.ncbi.nlm.nih.gov/16775156/"/* Risk factors for IUD failure: results of a large multicentre case-control study → P1 → https://pubmed.ncbi.nlm.nih.gov/16775156/ */
Q108|P22|Q13/* Risk factors for IUD failure: results of a large multicentre case-control study → P22 → Hormonspirale */
Q108|P23|Q6/* Risk factors for IUD failure: results of a large multicentre case-control study → P23 → Effizienzmaße */
Q109|P15|"Chi IC"/* An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs → P15 → Chi IC */
Q109|P16|"Contraception"/* An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs → P16 → Contraception */
Q109|P17|"Dec;44(6):573-88"/* An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs → P17 → Dec;44(6):573-88 */
Q109|P18|+1991-01-01T00:00:00Z/9/* An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs → P18 → +1991-01-01T00:00:00Z/9 */
Q109|P19|"10.1016/0010-7824(91)90078-t"/* An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs → P19 → 10.1016/0010-7824(91)90078-t */
Q109|P1|"https://pubmed.ncbi.nlm.nih.gov/1773615/"/* An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs → P1 → https://pubmed.ncbi.nlm.nih.gov/1773615/ */
Q109|P22|Q13/* An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs → P22 → Hormonspirale */
Q109|P23|Q3/* An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs → P23 → Material des Verhütungsmittels */
Q110|P15|"Barbosa I, Bakos O, Olsson SE, Odlind V, Johansson ED"/* Ovarian function during use of a levonorgestrel-releasing IUD → P15 → Barbosa I, Bakos O, Olsson SE, Odlind V, Johansson ED */
Q110|P16|"Contraception"/* Ovarian function during use of a levonorgestrel-releasing IUD → P16 → Contraception */
Q110|P17|"Jul;42(1):51-66"/* Ovarian function during use of a levonorgestrel-releasing IUD → P17 → Jul;42(1):51-66 */
Q110|P18|+1990-01-01T00:00:00Z/9/* Ovarian function during use of a levonorgestrel-releasing IUD → P18 → +1990-01-01T00:00:00Z/9 */
Q110|P19|"10.1016/0010-7824(90)90092-a"/* Ovarian function during use of a levonorgestrel-releasing IUD → P19 → 10.1016/0010-7824(90)90092-a */
Q110|P1|"https://pubmed.ncbi.nlm.nih.gov/2117516/"/* Ovarian function during use of a levonorgestrel-releasing IUD → P1 → https://pubmed.ncbi.nlm.nih.gov/2117516/ */
Q110|P22|Q13/* Ovarian function during use of a levonorgestrel-releasing IUD → P22 → Hormonspirale */
Q110|P23|Q6/* Ovarian function during use of a levonorgestrel-releasing IUD → P23 → Effizienzmaße */
Q111|P15|"Farr G, Amatya R"/* Contraceptive efficacy of the Copper T380A and the Multiload Cu250 IUD in three developing countries → P15 → Farr G, Amatya R */
Q111|P16|"Adv Contracept"/* Contraceptive efficacy of the Copper T380A and the Multiload Cu250 IUD in three developing countries → P16 → Adv Contracept */
Q111|P17|"Jun;10(2):137-49"/* Contraceptive efficacy of the Copper T380A and the Multiload Cu250 IUD in three developing countries → P17 → Jun;10(2):137-49 */
Q111|P18|+1994-01-01T00:00:00Z/9/* Contraceptive efficacy of the Copper T380A and the Multiload Cu250 IUD in three developing countries → P18 → +1994-01-01T00:00:00Z/9 */
Q111|P19|"10.1007/BF01978107"/* Contraceptive efficacy of the Copper T380A and the Multiload Cu250 IUD in three developing countries → P19 → 10.1007/BF01978107 */
Q111|P1|"https://pubmed.ncbi.nlm.nih.gov/7942261/"/* Contraceptive efficacy of the Copper T380A and the Multiload Cu250 IUD in three developing countries → P1 → https://pubmed.ncbi.nlm.nih.gov/7942261/ */
Q111|P22|Q17/* Contraceptive efficacy of the Copper T380A and the Multiload Cu250 IUD in three developing countries → P22 → Kupferspirale */
Q111|P23|Q6/* Contraceptive efficacy of the Copper T380A and the Multiload Cu250 IUD in three developing countries → P23 → Effizienzmaße */
Q112|P15|"Chi IC"/* The TCu-380A (AG), MLCu375, and Nova-T IUDs and the IUD daily releasing 20 micrograms levonorgestrel--four pillars of IUD contraception for the nineties and beyond? → P15 → Chi IC */
Q112|P16|"Contraception"/* The TCu-380A (AG), MLCu375, and Nova-T IUDs and the IUD daily releasing 20 micrograms levonorgestrel--four pillars of IUD contraception for the nineties and beyond? → P16 → Contraception */
Q112|P17|"Apr;47(4):325-47"/* The TCu-380A (AG), MLCu375, and Nova-T IUDs and the IUD daily releasing 20 micrograms levonorgestrel--four pillars of IUD contraception for the nineties and beyond? → P17 → Apr;47(4):325-47 */
Q112|P18|+1993-01-01T00:00:00Z/9/* The TCu-380A (AG), MLCu375, and Nova-T IUDs and the IUD daily releasing 20 micrograms levonorgestrel--four pillars of IUD contraception for the nineties and beyond? → P18 → +1993-01-01T00:00:00Z/9 */
Q112|P19|"10.1016/0010-7824(93)90031-2"/* The TCu-380A (AG), MLCu375, and Nova-T IUDs and the IUD daily releasing 20 micrograms levonorgestrel--four pillars of IUD contraception for the nineties and beyond? → P19 → 10.1016/0010-7824(93)90031-2 */
Q112|P1|"https://pubmed.ncbi.nlm.nih.gov/8508663/"/* The TCu-380A (AG), MLCu375, and Nova-T IUDs and the IUD daily releasing 20 micrograms levonorgestrel--four pillars of IUD contraception for the nineties and beyond? → P1 → https://pubmed.ncbi.nlm.nih.gov/8508663/ */
Q112|P22|Q17/* The TCu-380A (AG), MLCu375, and Nova-T IUDs and the IUD daily releasing 20 micrograms levonorgestrel--four pillars of IUD contraception for the nineties and beyond? → P22 → Kupferspirale */
Q112|P23|Q3/* The TCu-380A (AG), MLCu375, and Nova-T IUDs and the IUD daily releasing 20 micrograms levonorgestrel--four pillars of IUD contraception for the nineties and beyond? → P23 → Material des Verhütungsmittels */
Q113|P15|"Chi IC"/* The multiload IUD--a U.S. researcher's evaluation of a European device → P15 → Chi IC */
Q113|P16|"Contraception"/* The multiload IUD--a U.S. researcher's evaluation of a European device → P16 → Contraception */
Q113|P17|"Nov;46(5):407-25"/* The multiload IUD--a U.S. researcher's evaluation of a European device → P17 → Nov;46(5):407-25 */
Q113|P18|+1992-01-01T00:00:00Z/9/* The multiload IUD--a U.S. researcher's evaluation of a European device → P18 → +1992-01-01T00:00:00Z/9 */
Q113|P19|"10.1016/0010-7824(92)90145-j"/* The multiload IUD--a U.S. researcher's evaluation of a European device → P19 → 10.1016/0010-7824(92)90145-j */
Q113|P1|"https://pubmed.ncbi.nlm.nih.gov/1458888/"/* The multiload IUD--a U.S. researcher's evaluation of a European device → P1 → https://pubmed.ncbi.nlm.nih.gov/1458888/ */
Q113|P22|Q17/* The multiload IUD--a U.S. researcher's evaluation of a European device → P22 → Kupferspirale */
Q113|P23|Q3/* The multiload IUD--a U.S. researcher's evaluation of a European device → P23 → Material des Verhütungsmittels */
Q114|P15|"Bonacho I, Pita S, Gómez-Besteiro MI"/* Eight years with the same IUD → P15 → Bonacho I, Pita S, Gómez-Besteiro MI */
Q114|P16|"Contraception"/* Eight years with the same IUD → P16 → Contraception */
Q114|P17|"Apr;59(4):233-6"/* Eight years with the same IUD → P17 → Apr;59(4):233-6 */
Q114|P18|+1999-01-01T00:00:00Z/9/* Eight years with the same IUD → P18 → +1999-01-01T00:00:00Z/9 */
Q114|P19|"10.1016/s0010-7824(99)00022-0"/* Eight years with the same IUD → P19 → 10.1016/s0010-7824(99)00022-0 */
Q114|P1|"https://pubmed.ncbi.nlm.nih.gov/10457867/"/* Eight years with the same IUD → P1 → https://pubmed.ncbi.nlm.nih.gov/10457867/ */
Q114|P22|Q17/* Eight years with the same IUD → P22 → Kupferspirale */
Q114|P23|Q6/* Eight years with the same IUD → P23 → Effizienzmaße */
Q115|P15|"Larsson B, Frankman O, Hamberger L"/* Concentrations of copper in human secretions and weight of the copper wire during the 4 to 7 years after insertion of a Cu-IUD (intrauterine device) → P15 → Larsson B, Frankman O, Hamberger L */
Q115|P16|"Fertil Steril"/* Concentrations of copper in human secretions and weight of the copper wire during the 4 to 7 years after insertion of a Cu-IUD (intrauterine device) → P16 → Fertil Steril */
Q115|P17|"Dec;36(6):734-6"/* Concentrations of copper in human secretions and weight of the copper wire during the 4 to 7 years after insertion of a Cu-IUD (intrauterine device) → P17 → Dec;36(6):734-6 */
Q115|P18|+1981-01-01T00:00:00Z/9/* Concentrations of copper in human secretions and weight of the copper wire during the 4 to 7 years after insertion of a Cu-IUD (intrauterine device) → P18 → +1981-01-01T00:00:00Z/9 */
Q115|P19|"10.1016/s0015-0282(16)45917-0"/* Concentrations of copper in human secretions and weight of the copper wire during the 4 to 7 years after insertion of a Cu-IUD (intrauterine device) → P19 → 10.1016/s0015-0282(16)45917-0 */
Q115|P1|"https://pubmed.ncbi.nlm.nih.gov/7308517/"/* Concentrations of copper in human secretions and weight of the copper wire during the 4 to 7 years after insertion of a Cu-IUD (intrauterine device) → P1 → https://pubmed.ncbi.nlm.nih.gov/7308517/ */
Q115|P22|Q17/* Concentrations of copper in human secretions and weight of the copper wire during the 4 to 7 years after insertion of a Cu-IUD (intrauterine device) → P22 → Kupferspirale */
Q115|P23|Q6/* Concentrations of copper in human secretions and weight of the copper wire during the 4 to 7 years after insertion of a Cu-IUD (intrauterine device) → P23 → Effizienzmaße */
Q116|P15|"Batár I"/* One-year results with the Fincoid IUD--a Hungarian experience with the short model → P15 → Batár I */
Q116|P16|"Adv Contracept"/* One-year results with the Fincoid IUD--a Hungarian experience with the short model → P16 → Adv Contracept */
Q116|P17|"Jun;4(2):137-42"/* One-year results with the Fincoid IUD--a Hungarian experience with the short model → P17 → Jun;4(2):137-42 */
Q116|P18|+1988-01-01T00:00:00Z/9/* One-year results with the Fincoid IUD--a Hungarian experience with the short model → P18 → +1988-01-01T00:00:00Z/9 */
Q116|P19|"10.1007/BF01849515"/* One-year results with the Fincoid IUD--a Hungarian experience with the short model → P19 → 10.1007/BF01849515 */
Q116|P1|"https://pubmed.ncbi.nlm.nih.gov/3213671/"/* One-year results with the Fincoid IUD--a Hungarian experience with the short model → P1 → https://pubmed.ncbi.nlm.nih.gov/3213671/ */
Q116|P22|Q17/* One-year results with the Fincoid IUD--a Hungarian experience with the short model → P22 → Kupferspirale */
Q116|P23|Q6/* One-year results with the Fincoid IUD--a Hungarian experience with the short model → P23 → Effizienzmaße */
Q117|P15|"Thiery M, Van Kets H, van der Pas H, Delbarge W, Parewijck W"/* The Dimélys IUD → P15 → Thiery M, Van Kets H, van der Pas H, Delbarge W, Parewijck W */
Q117|P16|"Adv Contracept"/* The Dimélys IUD → P16 → Adv Contracept */
Q117|P17|"Mar;3(1):43-7"/* The Dimélys IUD → P17 → Mar;3(1):43-7 */
Q117|P18|+1987-01-01T00:00:00Z/9/* The Dimélys IUD → P18 → +1987-01-01T00:00:00Z/9 */
Q117|P19|"10.1007/BF01849252"/* The Dimélys IUD → P19 → 10.1007/BF01849252 */
Q117|P1|"https://pubmed.ncbi.nlm.nih.gov/3307331/"/* The Dimélys IUD → P1 → https://pubmed.ncbi.nlm.nih.gov/3307331/ */
Q117|P22|Q17/* The Dimélys IUD → P22 → Kupferspirale */
Q117|P23|Q2/* The Dimélys IUD → P23 → Geschlecht */
Q118|P15|"Foran T, Butcher BE, Kovacs G, Bateson D, O'Connor V"/* Safety of insertion of the copper IUD and LNG-IUS in nulliparous women: a systematic review → P15 → Foran T, Butcher BE, Kovacs G, Bateson D, O'Connor V */
Q118|P16|"Eur J Contracept Reprod Health Care"/* Safety of insertion of the copper IUD and LNG-IUS in nulliparous women: a systematic review → P16 → Eur J Contracept Reprod Health Care */
Q118|P17|"Oct;23(5):379-386"/* Safety of insertion of the copper IUD and LNG-IUS in nulliparous women: a systematic review → P17 → Oct;23(5):379-386 */
Q118|P18|+2018-01-01T00:00:00Z/9/* Safety of insertion of the copper IUD and LNG-IUS in nulliparous women: a systematic review → P18 → +2018-01-01T00:00:00Z/9 */
Q118|P19|"10.1080/13625187.2018.1526898"/* Safety of insertion of the copper IUD and LNG-IUS in nulliparous women: a systematic review → P19 → 10.1080/13625187.2018.1526898 */
Q118|P20|"Fertility; infection; intrauterine contraceptive devices; intrauterine device complications; intrauterine device expulsion; pain; parity"/* Safety of insertion of the copper IUD and LNG-IUS in nulliparous women: a systematic review → P20 → Fertility; infection; intrauterine contraceptive devices; intrauterine device complications; intrauterine device expulsion; pain; parity */
Q118|P1|"https://pubmed.ncbi.nlm.nih.gov/30382754/"/* Safety of insertion of the copper IUD and LNG-IUS in nulliparous women: a systematic review → P1 → https://pubmed.ncbi.nlm.nih.gov/30382754/ */
Q118|P22|Q17/* Safety of insertion of the copper IUD and LNG-IUS in nulliparous women: a systematic review → P22 → Kupferspirale */
Q118|P23|Q3/* Safety of insertion of the copper IUD and LNG-IUS in nulliparous women: a systematic review → P23 → Material des Verhütungsmittels */
Q119|P15|"Croxatto HB"/* Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant → P15 → Croxatto HB */
Q119|P16|"Eur J Contracept Reprod Health Care"/* Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant → P16 → Eur J Contracept Reprod Health Care */
Q119|P17|"Sep;5 Suppl 2:21-8"/* Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant → P17 → Sep;5 Suppl 2:21-8 */
Q119|P18|+2000-01-01T00:00:00Z/9/* Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant → P18 → +2000-01-01T00:00:00Z/9 */
Q119|P1|"https://pubmed.ncbi.nlm.nih.gov/11246604/"/* Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant → P1 → https://pubmed.ncbi.nlm.nih.gov/11246604/ */
Q119|P22|Q15/* Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant → P22 → Hormonimplantat (Hormonstäbchen) */
Q119|P23|Q2/* Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant → P23 → Geschlecht */
Q120|P15|"Darney P, Patel A, Rosen K, Shapiro LS, Kaunitz AM"/* Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials → P15 → Darney P, Patel A, Rosen K, Shapiro LS, Kaunitz AM */
Q120|P16|"Fertil Steril"/* Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials → P16 → Fertil Steril */
Q120|P17|"May;91(5):1646-53"/* Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials → P17 → May;91(5):1646-53 */
Q120|P18|+2009-01-01T00:00:00Z/9/* Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials → P18 → +2009-01-01T00:00:00Z/9 */
Q120|P19|"10.1016/j.fertnstert.2008.02.140"/* Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials → P19 → 10.1016/j.fertnstert.2008.02.140 */
Q120|P1|"https://pubmed.ncbi.nlm.nih.gov/18423453/"/* Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials → P1 → https://pubmed.ncbi.nlm.nih.gov/18423453/ */
Q120|P22|Q15/* Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials → P22 → Hormonimplantat (Hormonstäbchen) */
Q120|P23|Q6/* Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials → P23 → Effizienzmaße */
Q121|P15|"Shulman LP, Gabriel H"/* Management and localization strategies for the nonpalpable Implanon rod → P15 → Shulman LP, Gabriel H */
Q121|P16|"Contraception"/* Management and localization strategies for the nonpalpable Implanon rod → P16 → Contraception */
Q121|P17|"Apr;73(4):325-30"/* Management and localization strategies for the nonpalpable Implanon rod → P17 → Apr;73(4):325-30 */
Q121|P18|+2006-01-01T00:00:00Z/9/* Management and localization strategies for the nonpalpable Implanon rod → P18 → +2006-01-01T00:00:00Z/9 */
Q121|P19|"10.1016/j.contraception.2005.10.009"/* Management and localization strategies for the nonpalpable Implanon rod → P19 → 10.1016/j.contraception.2005.10.009 */
Q121|P1|"https://pubmed.ncbi.nlm.nih.gov/16531160/"/* Management and localization strategies for the nonpalpable Implanon rod → P1 → https://pubmed.ncbi.nlm.nih.gov/16531160/ */
Q121|P22|Q15/* Management and localization strategies for the nonpalpable Implanon rod → P22 → Hormonimplantat (Hormonstäbchen) */
Q121|P23|Q3/* Management and localization strategies for the nonpalpable Implanon rod → P23 → Material des Verhütungsmittels */
Q122|P15|"Kiriwat O, Patanayindee A, Koetsawang S, Korver T, Bennink HJ"/* A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand → P15 → Kiriwat O, Patanayindee A, Koetsawang S, Korver T, Bennink HJ */
Q122|P16|"Eur J Contracept Reprod Health Care"/* A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand → P16 → Eur J Contracept Reprod Health Care */
Q122|P17|"Jun;3(2):85-91"/* A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand → P17 → Jun;3(2):85-91 */
Q122|P18|+1998-01-01T00:00:00Z/9/* A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand → P18 → +1998-01-01T00:00:00Z/9 */
Q122|P19|"10.3109/13625189809051409"/* A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand → P19 → 10.3109/13625189809051409 */
Q122|P1|"https://pubmed.ncbi.nlm.nih.gov/9710712/"/* A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand → P1 → https://pubmed.ncbi.nlm.nih.gov/9710712/ */
Q122|P22|Q15/* A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand → P22 → Hormonimplantat (Hormonstäbchen) */
Q122|P23|Q6/* A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand → P23 → Effizienzmaße */
Q123|P15|"Zheng SR, Zheng HM, Qian SZ, Sang GW, Kaper RF"/* A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China → P15 → Zheng SR, Zheng HM, Qian SZ, Sang GW, Kaper RF */
Q123|P16|"Eur J Contracept Reprod Health Care"/* A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China → P16 → Eur J Contracept Reprod Health Care */
Q123|P17|"Jun;4(2):85-93"/* A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China → P17 → Jun;4(2):85-93 */
Q123|P18|+1999-01-01T00:00:00Z/9/* A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China → P18 → +1999-01-01T00:00:00Z/9 */
Q123|P19|"10.3109/13625189909064009"/* A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China → P19 → 10.3109/13625189909064009 */
Q123|P1|"https://pubmed.ncbi.nlm.nih.gov/10427483/"/* A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China → P1 → https://pubmed.ncbi.nlm.nih.gov/10427483/ */
Q123|P22|Q15/* A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China → P22 → Hormonimplantat (Hormonstäbchen) */
Q123|P23|Q6/* A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China → P23 → Effizienzmaße */
Q124|P15|"Zheng SR, Zheng HM, Qian SZ, Sang GW, Kaper RF"/* A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant → P15 → Zheng SR, Zheng HM, Qian SZ, Sang GW, Kaper RF */
Q124|P16|"Contraception"/* A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant → P16 → Contraception */
Q124|P17|"Jul;60(1):1-8"/* A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant → P17 → Jul;60(1):1-8 */
Q124|P18|+1999-01-01T00:00:00Z/9/* A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant → P18 → +1999-01-01T00:00:00Z/9 */
Q124|P19|"10.1016/s0010-7824(99)00053-0"/* A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant → P19 → 10.1016/s0010-7824(99)00053-0 */
Q124|P1|"https://pubmed.ncbi.nlm.nih.gov/10549446/"/* A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant → P1 → https://pubmed.ncbi.nlm.nih.gov/10549446/ */
Q124|P22|Q15/* A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant → P22 → Hormonimplantat (Hormonstäbchen) */
Q124|P23|Q3/* A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant → P23 → Material des Verhütungsmittels */
Q125|P15|"Ortayli N, Culwell K, Jackson E, Ali M; WHO Study Group on Contraceptive Implants for Women"/* A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data → P15 → Ortayli N, Culwell K, Jackson E, Ali M; WHO Study Group on Contraceptive Implants for Women */
Q125|P16|"Contraception"/* A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data → P16 → Contraception */
Q125|P17|"Jan;87(1):113-20"/* A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data → P17 → Jan;87(1):113-20 */
Q125|P18|+2013-01-01T00:00:00Z/9/* A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data → P18 → +2013-01-01T00:00:00Z/9 */
Q125|P19|"10.1016/j.contraception.2012.08.044"/* A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data → P19 → 10.1016/j.contraception.2012.08.044 */
Q125|P1|"https://pubmed.ncbi.nlm.nih.gov/23063337/"/* A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data → P1 → https://pubmed.ncbi.nlm.nih.gov/23063337/ */
Q125|P22|Q15/* A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data → P22 → Hormonimplantat (Hormonstäbchen) */
Q125|P23|Q3/* A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data → P23 → Material des Verhütungsmittels */
Q126|P15|"Funk S, Miller MM, Mishell DR Jr, Archer DF, Poindexter A, Schmidt J, Zampaglione E; Implanon US Study Group"/* Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel → P15 → Funk S, Miller MM, Mishell DR Jr, Archer DF, Poindexter A, Schmidt J, Zampaglione E; Implanon US Study Group */
Q126|P16|"Contraception"/* Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel → P16 → Contraception */
Q126|P17|"May;71(5):319-26"/* Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel → P17 → May;71(5):319-26 */
Q126|P18|+2005-01-01T00:00:00Z/9/* Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel → P18 → +2005-01-01T00:00:00Z/9 */
Q126|P19|"10.1016/j.contraception.2004.11.007"/* Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel → P19 → 10.1016/j.contraception.2004.11.007 */
Q126|P1|"https://pubmed.ncbi.nlm.nih.gov/15854630/"/* Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel → P1 → https://pubmed.ncbi.nlm.nih.gov/15854630/ */
Q126|P22|Q15/* Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel → P22 → Hormonimplantat (Hormonstäbchen) */
Q126|P23|Q6/* Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel → P23 → Effizienzmaße */
Q127|P15|"Bennink HJ"/* The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant → P15 → Bennink HJ */
Q127|P16|"Eur J Contracept Reprod Health Care"/* The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant → P16 → Eur J Contracept Reprod Health Care */
Q127|P17|"Sep;5 Suppl 2:12-20"/* The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant → P17 → Sep;5 Suppl 2:12-20 */
Q127|P18|+2000-01-01T00:00:00Z/9/* The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant → P18 → +2000-01-01T00:00:00Z/9 */
Q127|P1|"https://pubmed.ncbi.nlm.nih.gov/11246602/"/* The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant → P1 → https://pubmed.ncbi.nlm.nih.gov/11246602/ */
Q127|P22|Q15/* The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant → P22 → Hormonimplantat (Hormonstäbchen) */
Q127|P23|Q3/* The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant → P23 → Material des Verhütungsmittels */
Q128|P15|"Hoy SM, Scott LJ"/* Estradiol valerate/dienogest: in oral contraception → P15 → Hoy SM, Scott LJ */
Q128|P16|"Drugs"/* Estradiol valerate/dienogest: in oral contraception → P16 → Drugs */
Q128|P17|"Aug 20;69(12):1635-46"/* Estradiol valerate/dienogest: in oral contraception → P17 → Aug 20;69(12):1635-46 */
Q128|P18|+2009-01-01T00:00:00Z/9/* Estradiol valerate/dienogest: in oral contraception → P18 → +2009-01-01T00:00:00Z/9 */
Q128|P19|"10.2165/11202820-000000000-00000"/* Estradiol valerate/dienogest: in oral contraception → P19 → 10.2165/11202820-000000000-00000 */
Q128|P1|"https://pubmed.ncbi.nlm.nih.gov/19678714/"/* Estradiol valerate/dienogest: in oral contraception → P1 → https://pubmed.ncbi.nlm.nih.gov/19678714/ */
Q128|P22|Q14/* Estradiol valerate/dienogest: in oral contraception → P22 → Kombinierte orale Kontrazeptiva (Pille) */
Q128|P23|Q6/* Estradiol valerate/dienogest: in oral contraception → P23 → Effizienzmaße */
Q129|P15|"Kovacs L"/* Oral contraception over the age of 40 → P15 → Kovacs L */
Q129|P16|"Ann N Y Acad Sci"/* Oral contraception over the age of 40 → P16 → Ann N Y Acad Sci */
Q129|P17|"Nov;997:194-8"/* Oral contraception over the age of 40 → P17 → Nov;997:194-8 */
Q129|P18|+2003-01-01T00:00:00Z/9/* Oral contraception over the age of 40 → P18 → +2003-01-01T00:00:00Z/9 */
Q129|P19|"10.1196/annals.1290.022"/* Oral contraception over the age of 40 → P19 → 10.1196/annals.1290.022 */
Q129|P1|"https://pubmed.ncbi.nlm.nih.gov/14644826/"/* Oral contraception over the age of 40 → P1 → https://pubmed.ncbi.nlm.nih.gov/14644826/ */
Q129|P22|Q14/* Oral contraception over the age of 40 → P22 → Kombinierte orale Kontrazeptiva (Pille) */
Q129|P23|Q2/* Oral contraception over the age of 40 → P23 → Geschlecht */
Q130|P15|"London RS"/* The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel → P15 → London RS */
Q130|P16|"Obstet Gynecol Surv"/* The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel → P16 → Obstet Gynecol Surv */
Q130|P17|"Nov;47(11):777-82"/* The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel → P17 → Nov;47(11):777-82 */
Q130|P18|+1992-01-01T00:00:00Z/9/* The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel → P18 → +1992-01-01T00:00:00Z/9 */
Q130|P19|"10.1097/00006254-199211000-00014"/* The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel → P19 → 10.1097/00006254-199211000-00014 */
Q130|P1|"https://pubmed.ncbi.nlm.nih.gov/1436906/"/* The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel → P1 → https://pubmed.ncbi.nlm.nih.gov/1436906/ */
Q130|P22|Q14/* The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel → P22 → Kombinierte orale Kontrazeptiva (Pille) */
Q130|P23|Q3/* The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel → P23 → Material des Verhütungsmittels */
Q131|P15|Q131/* A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel → P15 → A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel */
Q131|P16|"Contraception"/* A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel → P16 → Contraception */
Q131|P17|"Mar;89(3):215-21"/* A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel → P17 → Mar;89(3):215-21 */
Q131|P18|+2014-01-01T00:00:00Z/9/* A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel → P18 → +2014-01-01T00:00:00Z/9 */
Q131|P19|"10.1016/j.contraception.2013.11.013"/* A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel → P19 → 10.1016/j.contraception.2013.11.013 */
Q131|P20|"Levonorgestrel; Pericoital oral contraception; Single-arm study"/* A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel → P20 → Levonorgestrel; Pericoital oral contraception; Single-arm study */
Q131|P1|"https://pubmed.ncbi.nlm.nih.gov/24388695/"/* A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel → P1 → https://pubmed.ncbi.nlm.nih.gov/24388695/ */
Q131|P22|Q14/* A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel → P22 → Kombinierte orale Kontrazeptiva (Pille) */
Q131|P23|Q6/* A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel → P23 → Effizienzmaße */
Q132|P15|"Jensen JT, Kaunitz AM, Achilles SL, Zatik J, Weyers S, Piltonen T, Suturina L, Apolikhina I, Bouchard C, Chen MJ, Apter D, Jost M, Foidart JM, Creinin MD"/* Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials → P15 → Jensen JT, Kaunitz AM, Achilles SL, Zatik J, Weyers S, Piltonen T, Suturina L, Apolikhina I, Bouchard C, Chen MJ, Apter D, Jost M, Foidart JM, Creinin MD */
Q132|P16|"Contraception"/* Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials → P16 → Contraception */
Q132|P17|"Dec;116:37-43"/* Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials → P17 → Dec;116:37-43 */
Q132|P18|+2022-01-01T00:00:00Z/9/* Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials → P18 → +2022-01-01T00:00:00Z/9 */
Q132|P19|"10.1016/j.contraception.2022.07.009"/* Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials → P19 → 10.1016/j.contraception.2022.07.009 */
Q132|P20|"Combined oral contraception; Contraceptive efficacy; Drospirenone; E4; Estetrol; Native estrogen; Pearl Index"/* Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials → P20 → Combined oral contraception; Contraceptive efficacy; Drospirenone; E4; Estetrol; Native estrogen; Pearl Index */
Q132|P1|"https://pubmed.ncbi.nlm.nih.gov/35921870/"/* Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials → P1 → https://pubmed.ncbi.nlm.nih.gov/35921870/ */
Q132|P22|Q14/* Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials → P22 → Kombinierte orale Kontrazeptiva (Pille) */
Q132|P23|Q6/* Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials → P23 → Effizienzmaße */
Q133|P15|"Evans G, Sutton EL"/* Oral contraception → P15 → Evans G, Sutton EL */
Q133|P16|"Med Clin North Am"/* Oral contraception → P16 → Med Clin North Am */
Q133|P17|"May;99(3):479-503"/* Oral contraception → P17 → May;99(3):479-503 */
Q133|P18|+2015-01-01T00:00:00Z/9/* Oral contraception → P18 → +2015-01-01T00:00:00Z/9 */
Q133|P19|"10.1016/j.mcna.2015.01.004"/* Oral contraception → P19 → 10.1016/j.mcna.2015.01.004 */
Q133|P20|"Ethinyl estradiol; Levonorgestrel; Medical eligibility criteria; Oral contraception; Venous thromboembolism"/* Oral contraception → P20 → Ethinyl estradiol; Levonorgestrel; Medical eligibility criteria; Oral contraception; Venous thromboembolism */
Q133|P1|"https://pubmed.ncbi.nlm.nih.gov/25841596/"/* Oral contraception → P1 → https://pubmed.ncbi.nlm.nih.gov/25841596/ */
Q133|P22|Q14/* Oral contraception → P22 → Kombinierte orale Kontrazeptiva (Pille) */
Q133|P23|Q2/* Oral contraception → P23 → Geschlecht */
Q134|P15|"Pérez-Campos EF"/* Ethinylestradiol/dienogest in oral contraception → P15 → Pérez-Campos EF */
Q134|P16|"Drugs"/* Ethinylestradiol/dienogest in oral contraception → P16 → Drugs */
Q134|P17|"Apr 16;70(6):681-9"/* Ethinylestradiol/dienogest in oral contraception → P17 → Apr 16;70(6):681-9 */
Q134|P18|+2010-01-01T00:00:00Z/9/* Ethinylestradiol/dienogest in oral contraception → P18 → +2010-01-01T00:00:00Z/9 */
Q134|P19|"10.2165/11536320-000000000-00000"/* Ethinylestradiol/dienogest in oral contraception → P19 → 10.2165/11536320-000000000-00000 */
Q134|P1|"https://pubmed.ncbi.nlm.nih.gov/20394455/"/* Ethinylestradiol/dienogest in oral contraception → P1 → https://pubmed.ncbi.nlm.nih.gov/20394455/ */
Q134|P22|Q14/* Ethinylestradiol/dienogest in oral contraception → P22 → Kombinierte orale Kontrazeptiva (Pille) */
Q134|P23|Q3/* Ethinylestradiol/dienogest in oral contraception → P23 → Material des Verhütungsmittels */
Q135|P15|"Lawrie TA, Helmerhorst FM, Maitra NK, Kulier R, Bloemenkamp K, Gülmezoglu AM"/* Types of progestogens in combined oral contraception: effectiveness and side-effects → P15 → Lawrie TA, Helmerhorst FM, Maitra NK, Kulier R, Bloemenkamp K, Gülmezoglu AM */
Q135|P16|"Cochrane Database Syst Rev"/* Types of progestogens in combined oral contraception: effectiveness and side-effects → P16 → Cochrane Database Syst Rev */
Q135|P17|"May 11;(5):CD004861"/* Types of progestogens in combined oral contraception: effectiveness and side-effects → P17 → May 11;(5):CD004861 */
Q135|P18|+2011-01-01T00:00:00Z/9/* Types of progestogens in combined oral contraception: effectiveness and side-effects → P18 → +2011-01-01T00:00:00Z/9 */
Q135|P19|"10.1002/14651858.CD004861.pub2"/* Types of progestogens in combined oral contraception: effectiveness and side-effects → P19 → 10.1002/14651858.CD004861.pub2 */
Q135|P1|"https://pubmed.ncbi.nlm.nih.gov/21563141/"/* Types of progestogens in combined oral contraception: effectiveness and side-effects → P1 → https://pubmed.ncbi.nlm.nih.gov/21563141/ */
Q135|P22|Q14/* Types of progestogens in combined oral contraception: effectiveness and side-effects → P22 → Kombinierte orale Kontrazeptiva (Pille) */
Q135|P23|Q3/* Types of progestogens in combined oral contraception: effectiveness and side-effects → P23 → Material des Verhütungsmittels */
Q136|P15|"Nappi RE, Kaunitz AM, Bitzer J"/* Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians → P15 → Nappi RE, Kaunitz AM, Bitzer J */
Q136|P16|"Eur J Contracept Reprod Health Care"/* Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians → P16 → Eur J Contracept Reprod Health Care */
Q136|P17|"21(2):106-15"/* Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians → P17 → 21(2):106-15 */
Q136|P18|+2016-01-01T00:00:00Z/9/* Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians → P18 → +2016-01-01T00:00:00Z/9 */
Q136|P19|"10.3109/13625187.2015.1107894"/* Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians → P19 → 10.3109/13625187.2015.1107894 */
Q136|P20|"Bleeding; Clinician attitudes; Combined hormonal contraception; Menstrual suppression; Oral contraceptives; Patient satisfaction"/* Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians → P20 → Bleeding; Clinician attitudes; Combined hormonal contraception; Menstrual suppression; Oral contraceptives; Patient satisfaction */
Q136|P1|"https://pubmed.ncbi.nlm.nih.gov/26572318/"/* Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians → P1 → https://pubmed.ncbi.nlm.nih.gov/26572318/ */
Q136|P22|Q14/* Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians → P22 → Kombinierte orale Kontrazeptiva (Pille) */
Q136|P23|Q2/* Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians → P23 → Geschlecht */
Q137|P15|"Palacios S, Regidor PA, Colli E, Skouby SO, Apter D, Roemer T, Egarter C, Nappi RE, Skřivánek A, Jakimiuk AJ, Weyers S, Ács N, Elia D, Gemzell Danielsson K, Bitzer J"/* Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature → P15 → Palacios S, Regidor PA, Colli E, Skouby SO, Apter D, Roemer T, Egarter C, Nappi RE, Skřivánek A, Jakimiuk AJ, Weyers S, Ács N, Elia D, Gemzell Danielsson K, Bitzer J */
Q137|P16|"Eur J Contracept Reprod Health Care"/* Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature → P16 → Eur J Contracept Reprod Health Care */
Q137|P17|"Jun;25(3):221-227"/* Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature → P17 → Jun;25(3):221-227 */
Q137|P18|+2020-01-01T00:00:00Z/9/* Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature → P18 → +2020-01-01T00:00:00Z/9 */
Q137|P19|"10.1080/13625187.2020.1743828"/* Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature → P19 → 10.1080/13625187.2020.1743828 */
Q137|P20|"Drospirenone; oestrogen-free contraception; progestins; spirolactone derivative"/* Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature → P20 → Drospirenone; oestrogen-free contraception; progestins; spirolactone derivative */
Q137|P1|"https://pubmed.ncbi.nlm.nih.gov/32312141/"/* Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature → P1 → https://pubmed.ncbi.nlm.nih.gov/32312141/ */
Q137|P22|Q14/* Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature → P22 → Kombinierte orale Kontrazeptiva (Pille) */
Q137|P23|Q3/* Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature → P23 → Material des Verhütungsmittels */
Q138|P15|"Steinberg WM"/* Oral contraception: risks and benefits → P15 → Steinberg WM */
Q138|P16|"Adv Contracept"/* Oral contraception: risks and benefits → P16 → Adv Contracept */
Q138|P17|"Dec;5(4):219-28"/* Oral contraception: risks and benefits → P17 → Dec;5(4):219-28 */
Q138|P18|+1989-01-01T00:00:00Z/9/* Oral contraception: risks and benefits → P18 → +1989-01-01T00:00:00Z/9 */
Q138|P19|"10.1007/BF01890893"/* Oral contraception: risks and benefits → P19 → 10.1007/BF01890893 */
Q138|P1|"https://pubmed.ncbi.nlm.nih.gov/2700420/"/* Oral contraception: risks and benefits → P1 → https://pubmed.ncbi.nlm.nih.gov/2700420/ */
Q138|P22|Q14/* Oral contraception: risks and benefits → P22 → Kombinierte orale Kontrazeptiva (Pille) */
Q138|P23|Q2/* Oral contraception: risks and benefits → P23 → Geschlecht */
Q139|P15|"Brown EJ, Deshmukh P, Antell K"/* Contraception Update: Oral Contraception → P15 → Brown EJ, Deshmukh P, Antell K */
Q139|P16|"FP Essent"/* Contraception Update: Oral Contraception → P16 → FP Essent */
Q139|P17|"Nov;462:11-19"/* Contraception Update: Oral Contraception → P17 → Nov;462:11-19 */
Q139|P18|+2017-01-01T00:00:00Z/9/* Contraception Update: Oral Contraception → P18 → +2017-01-01T00:00:00Z/9 */
Q139|P1|"https://pubmed.ncbi.nlm.nih.gov/29172411/"/* Contraception Update: Oral Contraception → P1 → https://pubmed.ncbi.nlm.nih.gov/29172411/ */
Q139|P22|Q14/* Contraception Update: Oral Contraception → P22 → Kombinierte orale Kontrazeptiva (Pille) */
Q139|P23|Q2/* Contraception Update: Oral Contraception → P23 → Geschlecht */
Q140|P15|"Lee A, Syed YY"/* Estetrol/Drospirenone: A Review in Oral Contraception → P15 → Lee A, Syed YY */
Q140|P16|"Drugs"/* Estetrol/Drospirenone: A Review in Oral Contraception → P16 → Drugs */
Q140|P17|"Jul;82(10):1117-1125"/* Estetrol/Drospirenone: A Review in Oral Contraception → P17 → Jul;82(10):1117-1125 */
Q140|P18|+2022-01-01T00:00:00Z/9/* Estetrol/Drospirenone: A Review in Oral Contraception → P18 → +2022-01-01T00:00:00Z/9 */
Q140|P19|"10.1007/s40265-022-01738-8"/* Estetrol/Drospirenone: A Review in Oral Contraception → P19 → 10.1007/s40265-022-01738-8 */
Q140|P1|"https://pubmed.ncbi.nlm.nih.gov/35781795/"/* Estetrol/Drospirenone: A Review in Oral Contraception → P1 → https://pubmed.ncbi.nlm.nih.gov/35781795/ */
Q140|P22|Q14/* Estetrol/Drospirenone: A Review in Oral Contraception → P22 → Kombinierte orale Kontrazeptiva (Pille) */
Q140|P23|Q3/* Estetrol/Drospirenone: A Review in Oral Contraception → P23 → Material des Verhütungsmittels */
Q141|P15|"Farr G, Gabelnick H, Sturgen K, Dorflinger L"/* Contraceptive efficacy and acceptability of the female condom → P15 → Farr G, Gabelnick H, Sturgen K, Dorflinger L */
Q141|P16|"Am J Public Health"/* Contraceptive efficacy and acceptability of the female condom → P16 → Am J Public Health */
Q141|P17|"Dec;84(12):1960-4"/* Contraceptive efficacy and acceptability of the female condom → P17 → Dec;84(12):1960-4 */
Q141|P18|+1994-01-01T00:00:00Z/9/* Contraceptive efficacy and acceptability of the female condom → P18 → +1994-01-01T00:00:00Z/9 */
Q141|P19|"10.2105/ajph.84.12.1960"/* Contraceptive efficacy and acceptability of the female condom → P19 → 10.2105/ajph.84.12.1960 */
Q141|P1|"https://pubmed.ncbi.nlm.nih.gov/7998637/"/* Contraceptive efficacy and acceptability of the female condom → P1 → https://pubmed.ncbi.nlm.nih.gov/7998637/ */
Q141|P22|Q18/* Contraceptive efficacy and acceptability of the female condom → P22 → Kondom für Frauen (Femidom) */
Q141|P23|Q6/* Contraceptive efficacy and acceptability of the female condom → P23 → Effizienzmaße */
Q142|P15|"Wiyeh AB, Mome RKB, Mahasha PW, Kongnyuy EJ, Wiysonge CS"/* Effectiveness of the female condom in preventing HIV and sexually transmitted infections: a systematic review and meta-analysis → P15 → Wiyeh AB, Mome RKB, Mahasha PW, Kongnyuy EJ, Wiysonge CS */
Q142|P16|"BMC Public Health"/* Effectiveness of the female condom in preventing HIV and sexually transmitted infections: a systematic review and meta-analysis → P16 → BMC Public Health */
Q142|P17|"Mar 12;20(1):319"/* Effectiveness of the female condom in preventing HIV and sexually transmitted infections: a systematic review and meta-analysis → P17 → Mar 12;20(1):319 */
Q142|P18|+2020-01-01T00:00:00Z/9/* Effectiveness of the female condom in preventing HIV and sexually transmitted infections: a systematic review and meta-analysis → P18 → +2020-01-01T00:00:00Z/9 */
Q142|P19|"10.1186/s12889-020-8384-7"/* Effectiveness of the female condom in preventing HIV and sexually transmitted infections: a systematic review and meta-analysis → P19 → 10.1186/s12889-020-8384-7 */
Q142|P20|"Female condom; HIV; Sexually transmitted infections; Systematic review"/* Effectiveness of the female condom in preventing HIV and sexually transmitted infections: a systematic review and meta-analysis → P20 → Female condom; HIV; Sexually transmitted infections; Systematic review */
Q142|P1|"https://pubmed.ncbi.nlm.nih.gov/32164652/"/* Effectiveness of the female condom in preventing HIV and sexually transmitted infections: a systematic review and meta-analysis → P1 → https://pubmed.ncbi.nlm.nih.gov/32164652/ */
Q142|P22|Q18/* Effectiveness of the female condom in preventing HIV and sexually transmitted infections: a systematic review and meta-analysis → P22 → Kondom für Frauen (Femidom) */
Q142|P23|Q6/* Effectiveness of the female condom in preventing HIV and sexually transmitted infections: a systematic review and meta-analysis → P23 → Effizienzmaße */
Q143|P15|"Sapire KE"/* The female condom (Femidom)--a study of user acceptability → P15 → Sapire KE */
Q143|P16|"S Afr Med J"/* The female condom (Femidom)--a study of user acceptability → P16 → S Afr Med J */
Q143|P17|"Oct;85(10 Suppl):1081-4"/* The female condom (Femidom)--a study of user acceptability → P17 → Oct;85(10 Suppl):1081-4 */
Q143|P18|+1995-01-01T00:00:00Z/9/* The female condom (Femidom)--a study of user acceptability → P18 → +1995-01-01T00:00:00Z/9 */
Q143|P1|"https://pubmed.ncbi.nlm.nih.gov/8914556/"/* The female condom (Femidom)--a study of user acceptability → P1 → https://pubmed.ncbi.nlm.nih.gov/8914556/ */
Q143|P22|Q18/* The female condom (Femidom)--a study of user acceptability → P22 → Kondom für Frauen (Femidom) */
Q143|P23|Q2/* The female condom (Femidom)--a study of user acceptability → P23 → Geschlecht */
Q144|P15|"Trussell J, Sturgen K, Strickler J, Dominik R"/* Comparative contraceptive efficacy of the female condom and other barrier methods → P15 → Trussell J, Sturgen K, Strickler J, Dominik R */
Q144|P16|"Fam Plann Perspect"/* Comparative contraceptive efficacy of the female condom and other barrier methods → P16 → Fam Plann Perspect */
Q144|P17|"Mar-Apr;26(2):66-72"/* Comparative contraceptive efficacy of the female condom and other barrier methods → P17 → Mar-Apr;26(2):66-72 */
Q144|P18|+1994-01-01T00:00:00Z/9/* Comparative contraceptive efficacy of the female condom and other barrier methods → P18 → +1994-01-01T00:00:00Z/9 */
Q144|P1|"https://pubmed.ncbi.nlm.nih.gov/8033980/"/* Comparative contraceptive efficacy of the female condom and other barrier methods → P1 → https://pubmed.ncbi.nlm.nih.gov/8033980/ */
Q144|P22|Q18/* Comparative contraceptive efficacy of the female condom and other barrier methods → P22 → Kondom für Frauen (Femidom) */
Q144|P23|Q6/* Comparative contraceptive efficacy of the female condom and other barrier methods → P23 → Effizienzmaße */
Q145|P15|"Cook L, Nanda K, Grimes D"/* The diaphragm with and without spermicide for contraception: a Cochrane review → P15 → Cook L, Nanda K, Grimes D */
Q145|P16|"Hum Reprod"/* The diaphragm with and without spermicide for contraception: a Cochrane review → P16 → Hum Reprod */
Q145|P17|"Apr;17(4):867-9"/* The diaphragm with and without spermicide for contraception: a Cochrane review → P17 → Apr;17(4):867-9 */
Q145|P18|+2002-01-01T00:00:00Z/9/* The diaphragm with and without spermicide for contraception: a Cochrane review → P18 → +2002-01-01T00:00:00Z/9 */
Q145|P19|"10.1093/humrep/17.4.867"/* The diaphragm with and without spermicide for contraception: a Cochrane review → P19 → 10.1093/humrep/17.4.867 */
Q145|P1|"https://pubmed.ncbi.nlm.nih.gov/11925374/"/* The diaphragm with and without spermicide for contraception: a Cochrane review → P1 → https://pubmed.ncbi.nlm.nih.gov/11925374/ */
Q145|P22|Q19/* The diaphragm with and without spermicide for contraception: a Cochrane review → P22 → Diaphragma (Pessar) */
Q145|P23|Q6/* The diaphragm with and without spermicide for contraception: a Cochrane review → P23 → Effizienzmaße */
Q146|P15|"Ferreira AE, Araújo MJ, Regina CH, Diniz SG, Faúndes A"/* Effectiveness of the diaphragm, used continuously, without spermicide → P15 → Ferreira AE, Araújo MJ, Regina CH, Diniz SG, Faúndes A */
Q146|P16|"Contraception"/* Effectiveness of the diaphragm, used continuously, without spermicide → P16 → Contraception */
Q146|P17|"Jul;48(1):29-35"/* Effectiveness of the diaphragm, used continuously, without spermicide → P17 → Jul;48(1):29-35 */
Q146|P18|+1993-01-01T00:00:00Z/9/* Effectiveness of the diaphragm, used continuously, without spermicide → P18 → +1993-01-01T00:00:00Z/9 */
Q146|P19|"10.1016/0010-7824(93)90063-d"/* Effectiveness of the diaphragm, used continuously, without spermicide → P19 → 10.1016/0010-7824(93)90063-d */
Q146|P1|"https://pubmed.ncbi.nlm.nih.gov/8403903/"/* Effectiveness of the diaphragm, used continuously, without spermicide → P1 → https://pubmed.ncbi.nlm.nih.gov/8403903/ */
Q146|P22|Q19/* Effectiveness of the diaphragm, used continuously, without spermicide → P22 → Diaphragma (Pessar) */
Q146|P23|Q6/* Effectiveness of the diaphragm, used continuously, without spermicide → P23 → Effizienzmaße */
Q147|P15|"Bounds W, Guillebaud J, Dominik R, Dalberth BT"/* The diaphragm with and without spermicide. A randomized, comparative efficacy trial → P15 → Bounds W, Guillebaud J, Dominik R, Dalberth BT */
Q147|P16|"J Reprod Med"/* The diaphragm with and without spermicide. A randomized, comparative efficacy trial → P16 → J Reprod Med */
Q147|P17|"Nov;40(11):764-74"/* The diaphragm with and without spermicide. A randomized, comparative efficacy trial → P17 → Nov;40(11):764-74 */
Q147|P18|+1995-01-01T00:00:00Z/9/* The diaphragm with and without spermicide. A randomized, comparative efficacy trial → P18 → +1995-01-01T00:00:00Z/9 */
Q147|P1|"https://pubmed.ncbi.nlm.nih.gov/8592310/"/* The diaphragm with and without spermicide. A randomized, comparative efficacy trial → P1 → https://pubmed.ncbi.nlm.nih.gov/8592310/ */
Q147|P22|Q19/* The diaphragm with and without spermicide. A randomized, comparative efficacy trial → P22 → Diaphragma (Pessar) */
Q147|P23|Q6/* The diaphragm with and without spermicide. A randomized, comparative efficacy trial → P23 → Effizienzmaße */
Q148|P15|"Schwartz JL, Ballagh SA, Creinin MD, Rountree RW, Kilbourne-Brook M, Mauck CK, Callahan MM"/* SILCS diaphragm: postcoital testing of a new single-size contraceptive device → P15 → Schwartz JL, Ballagh SA, Creinin MD, Rountree RW, Kilbourne-Brook M, Mauck CK, Callahan MM */
Q148|P16|"Contraception"/* SILCS diaphragm: postcoital testing of a new single-size contraceptive device → P16 → Contraception */
Q148|P17|"Sep;78(3):237-44"/* SILCS diaphragm: postcoital testing of a new single-size contraceptive device → P17 → Sep;78(3):237-44 */
Q148|P18|+2008-01-01T00:00:00Z/9/* SILCS diaphragm: postcoital testing of a new single-size contraceptive device → P18 → +2008-01-01T00:00:00Z/9 */
Q148|P19|"10.1016/j.contraception.2008.04.118"/* SILCS diaphragm: postcoital testing of a new single-size contraceptive device → P19 → 10.1016/j.contraception.2008.04.118 */
Q148|P1|"https://pubmed.ncbi.nlm.nih.gov/18692615/"/* SILCS diaphragm: postcoital testing of a new single-size contraceptive device → P1 → https://pubmed.ncbi.nlm.nih.gov/18692615/ */
Q148|P22|Q19/* SILCS diaphragm: postcoital testing of a new single-size contraceptive device → P22 → Diaphragma (Pessar) */
Q148|P23|Q3/* SILCS diaphragm: postcoital testing of a new single-size contraceptive device → P23 → Material des Verhütungsmittels */
Q149|P15|"Schwartz JL, Weiner DH, Lai JJ, Frezieres RG, Creinin MD, Archer DF, Bradley L, Barnhart KT, Poindexter A, Kilbourne-Brook M, Callahan MM, Mauck CK"/* Contraceptive efficacy, safety, fit, and acceptability of a single-size diaphragm developed with end-user input → P15 → Schwartz JL, Weiner DH, Lai JJ, Frezieres RG, Creinin MD, Archer DF, Bradley L, Barnhart KT, Poindexter A, Kilbourne-Brook M, Callahan MM, Mauck CK */
Q149|P16|"Obstet Gynecol"/* Contraceptive efficacy, safety, fit, and acceptability of a single-size diaphragm developed with end-user input → P16 → Obstet Gynecol */
Q149|P17|"Apr;125(4):895-903"/* Contraceptive efficacy, safety, fit, and acceptability of a single-size diaphragm developed with end-user input → P17 → Apr;125(4):895-903 */
Q149|P18|+2015-01-01T00:00:00Z/9/* Contraceptive efficacy, safety, fit, and acceptability of a single-size diaphragm developed with end-user input → P18 → +2015-01-01T00:00:00Z/9 */
Q149|P19|"10.1097/AOG.0000000000000721"/* Contraceptive efficacy, safety, fit, and acceptability of a single-size diaphragm developed with end-user input → P19 → 10.1097/AOG.0000000000000721 */
Q149|P1|"https://pubmed.ncbi.nlm.nih.gov/25751199/"/* Contraceptive efficacy, safety, fit, and acceptability of a single-size diaphragm developed with end-user input → P1 → https://pubmed.ncbi.nlm.nih.gov/25751199/ */
Q149|P22|Q19/* Contraceptive efficacy, safety, fit, and acceptability of a single-size diaphragm developed with end-user input → P22 → Diaphragma (Pessar) */
Q149|P23|Q6/* Contraceptive efficacy, safety, fit, and acceptability of a single-size diaphragm developed with end-user input → P23 → Effizienzmaße */
Q150|P15|"Blanchard K, Bostrom A, Montgomery E, van der Straten A, Lince N, de Bruyn G, Grossman D, Chipato T, Ramjee G, Padian N"/* Contraception use and effectiveness among women in a trial of the diaphragm for HIV prevention → P15 → Blanchard K, Bostrom A, Montgomery E, van der Straten A, Lince N, de Bruyn G, Grossman D, Chipato T, Ramjee G, Padian N */
Q150|P16|"Contraception"/* Contraception use and effectiveness among women in a trial of the diaphragm for HIV prevention → P16 → Contraception */
Q150|P17|"Jun;83(6):556-63"/* Contraception use and effectiveness among women in a trial of the diaphragm for HIV prevention → P17 → Jun;83(6):556-63 */
Q150|P18|+2011-01-01T00:00:00Z/9/* Contraception use and effectiveness among women in a trial of the diaphragm for HIV prevention → P18 → +2011-01-01T00:00:00Z/9 */
Q150|P19|"10.1016/j.contraception.2010.10.018"/* Contraception use and effectiveness among women in a trial of the diaphragm for HIV prevention → P19 → 10.1016/j.contraception.2010.10.018 */
Q150|P1|"https://pubmed.ncbi.nlm.nih.gov/21570554/"/* Contraception use and effectiveness among women in a trial of the diaphragm for HIV prevention → P1 → https://pubmed.ncbi.nlm.nih.gov/21570554/ */
Q150|P22|Q18/* Contraception use and effectiveness among women in a trial of the diaphragm for HIV prevention → P22 → Kondom für Frauen (Femidom) */
Q150|P23|Q6/* Contraception use and effectiveness among women in a trial of the diaphragm for HIV prevention → P23 → Effizienzmaße */
Q151|P15|"McNamee K"/* The female condom → P15 → McNamee K */
Q151|P16|"Aust Fam Physician"/* The female condom → P16 → Aust Fam Physician */
Q151|P17|"Jun;29(6):555-7"/* The female condom → P17 → Jun;29(6):555-7 */
Q151|P18|+2000-01-01T00:00:00Z/9/* The female condom → P18 → +2000-01-01T00:00:00Z/9 */
Q151|P1|"https://pubmed.ncbi.nlm.nih.gov/10863812/"/* The female condom → P1 → https://pubmed.ncbi.nlm.nih.gov/10863812/ */
Q151|P22|Q18/* The female condom → P22 → Kondom für Frauen (Femidom) */
Q151|P23|Q2/* The female condom → P23 → Geschlecht */
Q152|P15|"Ruiseñor-Escudero H, Lyons C, Ketende S, Pitche V, Anato S, Tchalla J, Dometo S, Baral S"/* Consistent Condom Use Among Men Who Have Sex With Men in Lomé and Kara, Togo → P15 → Ruiseñor-Escudero H, Lyons C, Ketende S, Pitche V, Anato S, Tchalla J, Dometo S, Baral S */
Q152|P16|"AIDS Res Hum Retroviruses"/* Consistent Condom Use Among Men Who Have Sex With Men in Lomé and Kara, Togo → P16 → AIDS Res Hum Retroviruses */
Q152|P17|"Jun;35(6):519-528"/* Consistent Condom Use Among Men Who Have Sex With Men in Lomé and Kara, Togo → P17 → Jun;35(6):519-528 */
Q152|P18|+2019-01-01T00:00:00Z/9/* Consistent Condom Use Among Men Who Have Sex With Men in Lomé and Kara, Togo → P18 → +2019-01-01T00:00:00Z/9 */
Q152|P19|"10.1089/AID.2018.0212"/* Consistent Condom Use Among Men Who Have Sex With Men in Lomé and Kara, Togo → P19 → 10.1089/AID.2018.0212 */
Q152|P20|"HIV; MSM; Togo; behavior; condoms; men who have sex with men"/* Consistent Condom Use Among Men Who Have Sex With Men in Lomé and Kara, Togo → P20 → HIV; MSM; Togo; behavior; condoms; men who have sex with men */
Q152|P1|"https://pubmed.ncbi.nlm.nih.gov/30714385/"/* Consistent Condom Use Among Men Who Have Sex With Men in Lomé and Kara, Togo → P1 → https://pubmed.ncbi.nlm.nih.gov/30714385/ */
Q152|P22|Q20/* Consistent Condom Use Among Men Who Have Sex With Men in Lomé and Kara, Togo → P22 → Kondom für Männer */
Q152|P23|Q2/* Consistent Condom Use Among Men Who Have Sex With Men in Lomé and Kara, Togo → P23 → Geschlecht */
Q153|P15|"Corderoy EC"/* Condom effectiveness → P15 → Corderoy EC */
Q153|P16|"Fam Plann Perspect"/* Condom effectiveness → P16 → Fam Plann Perspect */
Q153|P17|"Oct;11(5):271"/* Condom effectiveness → P17 → Oct;11(5):271 */
Q153|P18|+1979-01-01T00:00:00Z/9/* Condom effectiveness → P18 → +1979-01-01T00:00:00Z/9 */
Q153|P1|"https://pubmed.ncbi.nlm.nih.gov/520506/"/* Condom effectiveness → P1 → https://pubmed.ncbi.nlm.nih.gov/520506/ */
Q153|P22|Q20/* Condom effectiveness → P22 → Kondom für Männer */
Q153|P23|Q6/* Condom effectiveness → P23 → Effizienzmaße */
Q154|P15|"Crosby R, Bounse S"/* Condom effectiveness: where are we now? → P15 → Crosby R, Bounse S */
Q154|P16|"Sex Health"/* Condom effectiveness: where are we now? → P16 → Sex Health */
Q154|P17|"Mar;9(1):10-7"/* Condom effectiveness: where are we now? → P17 → Mar;9(1):10-7 */
Q154|P18|+2012-01-01T00:00:00Z/9/* Condom effectiveness: where are we now? → P18 → +2012-01-01T00:00:00Z/9 */
Q154|P19|"10.1071/SH11036"/* Condom effectiveness: where are we now? → P19 → 10.1071/SH11036 */
Q154|P1|"https://pubmed.ncbi.nlm.nih.gov/22348628/"/* Condom effectiveness: where are we now? → P1 → https://pubmed.ncbi.nlm.nih.gov/22348628/ */
Q154|P22|Q20/* Condom effectiveness: where are we now? → P22 → Kondom für Männer */
Q154|P23|Q6/* Condom effectiveness: where are we now? → P23 → Effizienzmaße */
Q155|P15|"Sanders SA, Yarber WL, Kaufman EL, Crosby RA, Graham CA, Milhausen RR"/* Condom use errors and problems: a global view → P15 → Sanders SA, Yarber WL, Kaufman EL, Crosby RA, Graham CA, Milhausen RR */
Q155|P16|"Sex Health"/* Condom use errors and problems: a global view → P16 → Sex Health */
Q155|P17|"Mar;9(1):81-95"/* Condom use errors and problems: a global view → P17 → Mar;9(1):81-95 */
Q155|P18|+2012-01-01T00:00:00Z/9/* Condom use errors and problems: a global view → P18 → +2012-01-01T00:00:00Z/9 */
Q155|P19|"10.1071/SH11095"/* Condom use errors and problems: a global view → P19 → 10.1071/SH11095 */
Q155|P1|"https://pubmed.ncbi.nlm.nih.gov/22348636/"/* Condom use errors and problems: a global view → P1 → https://pubmed.ncbi.nlm.nih.gov/22348636/ */
Q155|P22|Q20/* Condom use errors and problems: a global view → P22 → Kondom für Männer */
Q155|P23|Q6/* Condom use errors and problems: a global view → P23 → Effizienzmaße */
Q156|P15|"Williams RL, Fortenberry JD"/* Update on adolescent condom use → P15 → Williams RL, Fortenberry JD */
Q156|P16|"Curr Opin Obstet Gynecol"/* Update on adolescent condom use → P16 → Curr Opin Obstet Gynecol */
Q156|P17|"Oct;23(5):350-4"/* Update on adolescent condom use → P17 → Oct;23(5):350-4 */
Q156|P18|+2011-01-01T00:00:00Z/9/* Update on adolescent condom use → P18 → +2011-01-01T00:00:00Z/9 */
Q156|P19|"10.1097/GCO.0b013e32834a93bf"/* Update on adolescent condom use → P19 → 10.1097/GCO.0b013e32834a93bf */
Q156|P1|"https://pubmed.ncbi.nlm.nih.gov/21825988/"/* Update on adolescent condom use → P1 → https://pubmed.ncbi.nlm.nih.gov/21825988/ */
Q156|P22|Q20/* Update on adolescent condom use → P22 → Kondom für Männer */
Q156|P23|Q2/* Update on adolescent condom use → P23 → Geschlecht */
Q157|P15|"Weller S, Davis K"/* Condom effectiveness in reducing heterosexual HIV transmission → P15 → Weller S, Davis K */
Q157|P16|"Cochrane Database Syst Rev"/* Condom effectiveness in reducing heterosexual HIV transmission → P16 → Cochrane Database Syst Rev */
Q157|P17|"2002(3):CD003255"/* Condom effectiveness in reducing heterosexual HIV transmission → P17 → 2002(3):CD003255 */
Q157|P18|+2001-01-01T00:00:00Z/9/* Condom effectiveness in reducing heterosexual HIV transmission → P18 → +2001-01-01T00:00:00Z/9 */
Q157|P19|"10.1002/14651858.CD003255"/* Condom effectiveness in reducing heterosexual HIV transmission → P19 → 10.1002/14651858.CD003255 */
Q157|P1|"https://pubmed.ncbi.nlm.nih.gov/11687062/"/* Condom effectiveness in reducing heterosexual HIV transmission → P1 → https://pubmed.ncbi.nlm.nih.gov/11687062/ */
Q157|P22|Q20/* Condom effectiveness in reducing heterosexual HIV transmission → P22 → Kondom für Männer */
Q157|P23|Q6/* Condom effectiveness in reducing heterosexual HIV transmission → P23 → Effizienzmaße */
Q158|P15|"Steiner M, Piedrahita C, Glover L, Joanis C"/* Can condom users likely to experience condom failure be identified? → P15 → Steiner M, Piedrahita C, Glover L, Joanis C */
Q158|P16|"Fam Plann Perspect"/* Can condom users likely to experience condom failure be identified? → P16 → Fam Plann Perspect */
Q158|P17|"Sep-Oct;25(5):220-3"/* Can condom users likely to experience condom failure be identified? → P17 → Sep-Oct;25(5):220-3 */
Q158|P18|+1993-01-01T00:00:00Z/9/* Can condom users likely to experience condom failure be identified? → P18 → +1993-01-01T00:00:00Z/9 */
Q158|P1|"https://pubmed.ncbi.nlm.nih.gov/8262171/"/* Can condom users likely to experience condom failure be identified? → P1 → https://pubmed.ncbi.nlm.nih.gov/8262171/ */
Q158|P22|Q20/* Can condom users likely to experience condom failure be identified? → P22 → Kondom für Männer */
Q158|P23|Q6/* Can condom users likely to experience condom failure be identified? → P23 → Effizienzmaße */
Q159|P15|"Stone E, Heagerty P, Vittinghoff E, Douglas JM Jr, Koblin BA, Mayer KH, Celum CL, Gross M, Woody GE, Marmor M, Seage GR 3rd, Buchbinder SP"/* Correlates of condom failure in a sexually active cohort of men who have sex with men → P15 → Stone E, Heagerty P, Vittinghoff E, Douglas JM Jr, Koblin BA, Mayer KH, Celum CL, Gross M, Woody GE, Marmor M, Seage GR 3rd, Buchbinder SP */
Q159|P16|"J Acquir Immune Defic Syndr Hum Retrovirol"/* Correlates of condom failure in a sexually active cohort of men who have sex with men → P16 → J Acquir Immune Defic Syndr Hum Retrovirol */
Q159|P17|"Apr 15;20(5):495-501"/* Correlates of condom failure in a sexually active cohort of men who have sex with men → P17 → Apr 15;20(5):495-501 */
Q159|P18|+1999-01-01T00:00:00Z/9/* Correlates of condom failure in a sexually active cohort of men who have sex with men → P18 → +1999-01-01T00:00:00Z/9 */
Q159|P19|"10.1097/00042560-199904150-00013"/* Correlates of condom failure in a sexually active cohort of men who have sex with men → P19 → 10.1097/00042560-199904150-00013 */
Q159|P1|"https://pubmed.ncbi.nlm.nih.gov/10225233/"/* Correlates of condom failure in a sexually active cohort of men who have sex with men → P1 → https://pubmed.ncbi.nlm.nih.gov/10225233/ */
Q159|P22|Q20/* Correlates of condom failure in a sexually active cohort of men who have sex with men → P22 → Kondom für Männer */
Q159|P23|Q2/* Correlates of condom failure in a sexually active cohort of men who have sex with men → P23 → Geschlecht */
Q160|P15|"Callahan M, Mauck C, Taylor D, Frezieres R, Walsh T, Martens M"/* Comparative evaluation of three Tactylon(TM) condoms and a latex condom during vaginal intercourse: breakage and slippage → P15 → Callahan M, Mauck C, Taylor D, Frezieres R, Walsh T, Martens M */
Q160|P16|"Contraception"/* Comparative evaluation of three Tactylon(TM) condoms and a latex condom during vaginal intercourse: breakage and slippage → P16 → Contraception */
Q160|P17|"Mar;61(3):205-15"/* Comparative evaluation of three Tactylon(TM) condoms and a latex condom during vaginal intercourse: breakage and slippage → P17 → Mar;61(3):205-15 */
Q160|P18|+2000-01-01T00:00:00Z/9/* Comparative evaluation of three Tactylon(TM) condoms and a latex condom during vaginal intercourse: breakage and slippage → P18 → +2000-01-01T00:00:00Z/9 */
Q160|P19|"10.1016/s0010-7824(00)00096-2"/* Comparative evaluation of three Tactylon(TM) condoms and a latex condom during vaginal intercourse: breakage and slippage → P19 → 10.1016/s0010-7824(00)00096-2 */
Q160|P1|"https://pubmed.ncbi.nlm.nih.gov/10827335/"/* Comparative evaluation of three Tactylon(TM) condoms and a latex condom during vaginal intercourse: breakage and slippage → P1 → https://pubmed.ncbi.nlm.nih.gov/10827335/ */
Q160|P22|Q20/* Comparative evaluation of three Tactylon(TM) condoms and a latex condom during vaginal intercourse: breakage and slippage → P22 → Kondom für Männer */
Q160|P23|Q3/* Comparative evaluation of three Tactylon(TM) condoms and a latex condom during vaginal intercourse: breakage and slippage → P23 → Material des Verhütungsmittels */
Q161|P15|"Frezieres RG, Walsh TL"/* Acceptability evaluation of a natural rubber latex, a polyurethane, and a new non-latex condom → P15 → Frezieres RG, Walsh TL */
Q161|P16|"Contraception"/* Acceptability evaluation of a natural rubber latex, a polyurethane, and a new non-latex condom → P16 → Contraception */
Q161|P17|"Jun;61(6):369-77"/* Acceptability evaluation of a natural rubber latex, a polyurethane, and a new non-latex condom → P17 → Jun;61(6):369-77 */
Q161|P18|+2000-01-01T00:00:00Z/9/* Acceptability evaluation of a natural rubber latex, a polyurethane, and a new non-latex condom → P18 → +2000-01-01T00:00:00Z/9 */
Q161|P19|"10.1016/s0010-7824(00)00119-0"/* Acceptability evaluation of a natural rubber latex, a polyurethane, and a new non-latex condom → P19 → 10.1016/s0010-7824(00)00119-0 */
Q161|P1|"https://pubmed.ncbi.nlm.nih.gov/10958880/"/* Acceptability evaluation of a natural rubber latex, a polyurethane, and a new non-latex condom → P1 → https://pubmed.ncbi.nlm.nih.gov/10958880/ */
Q161|P22|Q20/* Acceptability evaluation of a natural rubber latex, a polyurethane, and a new non-latex condom → P22 → Kondom für Männer */
Q161|P23|Q3/* Acceptability evaluation of a natural rubber latex, a polyurethane, and a new non-latex condom → P23 → Material des Verhütungsmittels */
Q162|P15|"Steiner MJ, Dominik R, Rountree RW, Nanda K, Dorflinger LJ"/* Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial → P15 → Steiner MJ, Dominik R, Rountree RW, Nanda K, Dorflinger LJ */
Q162|P16|"Obstet Gynecol"/* Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial → P16 → Obstet Gynecol */
Q162|P17|"Mar;101(3):539-47"/* Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial → P17 → Mar;101(3):539-47 */
Q162|P18|+2003-01-01T00:00:00Z/9/* Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial → P18 → +2003-01-01T00:00:00Z/9 */
Q162|P19|"10.1016/s0029-7844(02)02732-1"/* Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial → P19 → 10.1016/s0029-7844(02)02732-1 */
Q162|P1|"https://pubmed.ncbi.nlm.nih.gov/12636960/"/* Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial → P1 → https://pubmed.ncbi.nlm.nih.gov/12636960/ */
Q162|P22|Q20/* Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial → P22 → Kondom für Männer */
Q162|P23|Q3/* Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial → P23 → Material des Verhütungsmittels */
Q163|P15|"Gallo MF, Grimes DA, Schulz KF"/* Cervical cap versus diaphragm for contraception → P15 → Gallo MF, Grimes DA, Schulz KF */
Q163|P16|"Cochrane Database Syst Rev"/* Cervical cap versus diaphragm for contraception → P16 → Cochrane Database Syst Rev */
Q163|P17|"(4):CD003551"/* Cervical cap versus diaphragm for contraception → P17 → (4):CD003551 */
Q163|P18|+2002-01-01T00:00:00Z/9/* Cervical cap versus diaphragm for contraception → P18 → +2002-01-01T00:00:00Z/9 */
Q163|P19|"10.1002/14651858.CD003551"/* Cervical cap versus diaphragm for contraception → P19 → 10.1002/14651858.CD003551 */
Q163|P1|"https://pubmed.ncbi.nlm.nih.gov/12519602/"/* Cervical cap versus diaphragm for contraception → P1 → https://pubmed.ncbi.nlm.nih.gov/12519602/ */
Q163|P22|Q21/* Cervical cap versus diaphragm for contraception → P22 → Portiokappe */
Q163|P23|Q6/* Cervical cap versus diaphragm for contraception → P23 → Effizienzmaße */
Q164|P15|"Secor RM"/* The cervical cap → P15 → Secor RM */
Q164|P16|"NAACOGS Clin Issu Perinat Womens Health Nurs"/* The cervical cap → P16 → NAACOGS Clin Issu Perinat Womens Health Nurs */
Q164|P17|"3(2):236-45"/* The cervical cap → P17 → 3(2):236-45 */
Q164|P18|+1992-01-01T00:00:00Z/9/* The cervical cap → P18 → +1992-01-01T00:00:00Z/9 */
Q164|P1|"https://pubmed.ncbi.nlm.nih.gov/1596432/"/* The cervical cap → P1 → https://pubmed.ncbi.nlm.nih.gov/1596432/ */
Q164|P22|Q21/* The cervical cap → P22 → Portiokappe */
Q164|P23|Q2/* The cervical cap → P23 → Geschlecht */
Q165|P15|"Boehm D"/* The cervical cap: effectiveness as a contraceptive → P15 → Boehm D */
Q165|P16|"J Nurse Midwifery"/* The cervical cap: effectiveness as a contraceptive → P16 → J Nurse Midwifery */
Q165|P17|"Jan-Feb;28(1):3-6"/* The cervical cap: effectiveness as a contraceptive → P17 → Jan-Feb;28(1):3-6 */
Q165|P18|+1983-01-01T00:00:00Z/9/* The cervical cap: effectiveness as a contraceptive → P18 → +1983-01-01T00:00:00Z/9 */
Q165|P19|"10.1016/0091-2182(83)90238-0"/* The cervical cap: effectiveness as a contraceptive → P19 → 10.1016/0091-2182(83)90238-0 */
Q165|P1|"https://pubmed.ncbi.nlm.nih.gov/6551434/"/* The cervical cap: effectiveness as a contraceptive → P1 → https://pubmed.ncbi.nlm.nih.gov/6551434/ */
Q165|P22|Q21/* The cervical cap: effectiveness as a contraceptive → P22 → Portiokappe */
Q165|P23|Q6/* The cervical cap: effectiveness as a contraceptive → P23 → Effizienzmaße */
Q166|P15|"Powell MG, Mears BJ, Deber RB, Ferguson D"/* Contraception with the cervical cap: effectiveness, safety, continuity of use, and user satisfaction → P15 → Powell MG, Mears BJ, Deber RB, Ferguson D */
Q166|P16|"Contraception"/* Contraception with the cervical cap: effectiveness, safety, continuity of use, and user satisfaction → P16 → Contraception */
Q166|P17|"Mar;33(3):215-32"/* Contraception with the cervical cap: effectiveness, safety, continuity of use, and user satisfaction → P17 → Mar;33(3):215-32 */
Q166|P18|+1986-01-01T00:00:00Z/9/* Contraception with the cervical cap: effectiveness, safety, continuity of use, and user satisfaction → P18 → +1986-01-01T00:00:00Z/9 */
Q166|P19|"10.1016/0010-7824(86)90015-6"/* Contraception with the cervical cap: effectiveness, safety, continuity of use, and user satisfaction → P19 → 10.1016/0010-7824(86)90015-6 */
Q166|P1|"https://pubmed.ncbi.nlm.nih.gov/3720304/"/* Contraception with the cervical cap: effectiveness, safety, continuity of use, and user satisfaction → P1 → https://pubmed.ncbi.nlm.nih.gov/3720304/ */
Q166|P22|Q21/* Contraception with the cervical cap: effectiveness, safety, continuity of use, and user satisfaction → P22 → Portiokappe */
Q166|P23|Q6/* Contraception with the cervical cap: effectiveness, safety, continuity of use, and user satisfaction → P23 → Effizienzmaße */
Q167|P15|"Gilbirds WM 2nd, Jonas HS"/* The cervical cap. An alternate barrier contraceptive method → P15 → Gilbirds WM 2nd, Jonas HS */
Q167|P16|"Mo Med"/* The cervical cap. An alternate barrier contraceptive method → P16 → Mo Med */
Q167|P17|"Apr;79(4):216-8"/* The cervical cap. An alternate barrier contraceptive method → P17 → Apr;79(4):216-8 */
Q167|P18|+1982-01-01T00:00:00Z/9/* The cervical cap. An alternate barrier contraceptive method → P18 → +1982-01-01T00:00:00Z/9 */
Q167|P1|"https://pubmed.ncbi.nlm.nih.gov/7099129/"/* The cervical cap. An alternate barrier contraceptive method → P1 → https://pubmed.ncbi.nlm.nih.gov/7099129/ */
Q167|P22|Q21/* The cervical cap. An alternate barrier contraceptive method → P22 → Portiokappe */
Q167|P23|Q6/* The cervical cap. An alternate barrier contraceptive method → P23 → Effizienzmaße */
Q168|P15|"Richwald GA, Greenland S, Gerber MM, Potik R, Kersey L, Comas MA"/* Effectiveness of the cavity-rim cervical cap: results of a large clinical study → P15 → Richwald GA, Greenland S, Gerber MM, Potik R, Kersey L, Comas MA */
Q168|P16|"Obstet Gynecol"/* Effectiveness of the cavity-rim cervical cap: results of a large clinical study → P16 → Obstet Gynecol */
Q168|P17|"Aug;74(2):143-8"/* Effectiveness of the cavity-rim cervical cap: results of a large clinical study → P17 → Aug;74(2):143-8 */
Q168|P18|+1989-01-01T00:00:00Z/9/* Effectiveness of the cavity-rim cervical cap: results of a large clinical study → P18 → +1989-01-01T00:00:00Z/9 */
Q168|P1|"https://pubmed.ncbi.nlm.nih.gov/2664609/"/* Effectiveness of the cavity-rim cervical cap: results of a large clinical study → P1 → https://pubmed.ncbi.nlm.nih.gov/2664609/ */
Q168|P22|Q21/* Effectiveness of the cavity-rim cervical cap: results of a large clinical study → P22 → Portiokappe */
Q168|P23|Q6/* Effectiveness of the cavity-rim cervical cap: results of a large clinical study → P23 → Effizienzmaße */
Q169|P15|"Kuyoh MA, Toroitich-Ruto C, Grimes DA, Schulz KF, Gallo MF, Lopez LM"/* Sponge versus diaphragm for contraception → P15 → Kuyoh MA, Toroitich-Ruto C, Grimes DA, Schulz KF, Gallo MF, Lopez LM */
Q169|P16|"Cochrane Database Syst Rev"/* Sponge versus diaphragm for contraception → P16 → Cochrane Database Syst Rev */
Q169|P17|"Jul 22;(5):CD003172"/* Sponge versus diaphragm for contraception → P17 → Jul 22;(5):CD003172 */
Q169|P18|+2002-01-01T00:00:00Z/9/* Sponge versus diaphragm for contraception → P18 → +2002-01-01T00:00:00Z/9 */
Q169|P19|"10.1002/14651858.CD003172"/* Sponge versus diaphragm for contraception → P19 → 10.1002/14651858.CD003172 */
Q169|P1|"https://pubmed.ncbi.nlm.nih.gov/23866318/"/* Sponge versus diaphragm for contraception → P1 → https://pubmed.ncbi.nlm.nih.gov/23866318/ */
Q169|P22|Q22/* Sponge versus diaphragm for contraception → P22 → Verhütungsschwamm */
Q169|P23|Q6/* Sponge versus diaphragm for contraception → P23 → Effizienzmaße */
Q170|P15|"Lemberg E"/* The vaginal contraceptive sponge: a new non-prescription barrier contraceptive → P15 → Lemberg E */
Q170|P16|"Nurse Pract"/* The vaginal contraceptive sponge: a new non-prescription barrier contraceptive → P16 → Nurse Pract */
Q170|P17|"Oct;9(10):24-5, 29-32, 37"/* The vaginal contraceptive sponge: a new non-prescription barrier contraceptive → P17 → Oct;9(10):24-5, 29-32, 37 */
Q170|P18|+1984-01-01T00:00:00Z/9/* The vaginal contraceptive sponge: a new non-prescription barrier contraceptive → P18 → +1984-01-01T00:00:00Z/9 */
Q170|P1|"https://pubmed.ncbi.nlm.nih.gov/6387547/"/* The vaginal contraceptive sponge: a new non-prescription barrier contraceptive → P1 → https://pubmed.ncbi.nlm.nih.gov/6387547/ */
Q170|P22|Q22/* The vaginal contraceptive sponge: a new non-prescription barrier contraceptive → P22 → Verhütungsschwamm */
Q170|P23|Q2/* The vaginal contraceptive sponge: a new non-prescription barrier contraceptive → P23 → Geschlecht */
Q171|P15|"Chvapil M, Droegemueller W, Heine MW, MacGregor JC, Dotters D"/* Collagen sponge as vaginal contraceptive barrier: critical summary of seven years of research → P15 → Chvapil M, Droegemueller W, Heine MW, MacGregor JC, Dotters D */
Q171|P16|"Am J Obstet Gynecol"/* Collagen sponge as vaginal contraceptive barrier: critical summary of seven years of research → P16 → Am J Obstet Gynecol */
Q171|P17|"Feb 1;151(3):325-9"/* Collagen sponge as vaginal contraceptive barrier: critical summary of seven years of research → P17 → Feb 1;151(3):325-9 */
Q171|P18|+1985-01-01T00:00:00Z/9/* Collagen sponge as vaginal contraceptive barrier: critical summary of seven years of research → P18 → +1985-01-01T00:00:00Z/9 */
Q171|P19|"10.1016/0002-9378(85)90296-0"/* Collagen sponge as vaginal contraceptive barrier: critical summary of seven years of research → P19 → 10.1016/0002-9378(85)90296-0 */
Q171|P1|"https://pubmed.ncbi.nlm.nih.gov/2982268/"/* Collagen sponge as vaginal contraceptive barrier: critical summary of seven years of research → P1 → https://pubmed.ncbi.nlm.nih.gov/2982268/ */
Q171|P22|Q22/* Collagen sponge as vaginal contraceptive barrier: critical summary of seven years of research → P22 → Verhütungsschwamm */
Q171|P23|Q3/* Collagen sponge as vaginal contraceptive barrier: critical summary of seven years of research → P23 → Material des Verhütungsmittels */
Q172|P15|"McIntyre SL, Higgins JE"/* Parity and use-effectiveness with the contraceptive sponge → P15 → McIntyre SL, Higgins JE */
Q172|P16|"Am J Obstet Gynecol"/* Parity and use-effectiveness with the contraceptive sponge → P16 → Am J Obstet Gynecol */
Q172|P17|"Oct;155(4):796-801"/* Parity and use-effectiveness with the contraceptive sponge → P17 → Oct;155(4):796-801 */
Q172|P18|+1986-01-01T00:00:00Z/9/* Parity and use-effectiveness with the contraceptive sponge → P18 → +1986-01-01T00:00:00Z/9 */
Q172|P19|"10.1016/s0002-9378(86)80023-0"/* Parity and use-effectiveness with the contraceptive sponge → P19 → 10.1016/s0002-9378(86)80023-0 */
Q172|P1|"https://pubmed.ncbi.nlm.nih.gov/3020983/"/* Parity and use-effectiveness with the contraceptive sponge → P1 → https://pubmed.ncbi.nlm.nih.gov/3020983/ */
Q172|P22|Q22/* Parity and use-effectiveness with the contraceptive sponge → P22 → Verhütungsschwamm */
Q172|P23|Q6/* Parity and use-effectiveness with the contraceptive sponge → P23 → Effizienzmaße */
Q173|P15|"Edelman DA, North BB"/* Updated pregnancy rates for the Today contraceptive sponge → P15 → Edelman DA, North BB */
Q173|P16|"Am J Obstet Gynecol"/* Updated pregnancy rates for the Today contraceptive sponge → P16 → Am J Obstet Gynecol */
Q173|P17|"Nov;157(5):1164-5"/* Updated pregnancy rates for the Today contraceptive sponge → P17 → Nov;157(5):1164-5 */
Q173|P18|+1987-01-01T00:00:00Z/9/* Updated pregnancy rates for the Today contraceptive sponge → P18 → +1987-01-01T00:00:00Z/9 */
Q173|P19|"10.1016/s0002-9378(87)80284-3"/* Updated pregnancy rates for the Today contraceptive sponge → P19 → 10.1016/s0002-9378(87)80284-3 */
Q173|P1|"https://pubmed.ncbi.nlm.nih.gov/3318467/"/* Updated pregnancy rates for the Today contraceptive sponge → P1 → https://pubmed.ncbi.nlm.nih.gov/3318467/ */
Q173|P22|Q22/* Updated pregnancy rates for the Today contraceptive sponge → P22 → Verhütungsschwamm */
Q173|P23|Q6/* Updated pregnancy rates for the Today contraceptive sponge → P23 → Effizienzmaße */
Q174|P15|"Chvapil M, Droegemueller W"/* Collagen sponge in gynecologic use → P15 → Chvapil M, Droegemueller W */
Q174|P16|"Obstet Gynecol Annu"/* Collagen sponge in gynecologic use → P16 → Obstet Gynecol Annu */
Q174|P17|"10:363-73"/* Collagen sponge in gynecologic use → P17 → 10:363-73 */
Q174|P18|+1981-01-01T00:00:00Z/9/* Collagen sponge in gynecologic use → P18 → +1981-01-01T00:00:00Z/9 */
Q174|P1|"https://pubmed.ncbi.nlm.nih.gov/7024877/"/* Collagen sponge in gynecologic use → P1 → https://pubmed.ncbi.nlm.nih.gov/7024877/ */
Q174|P22|Q22/* Collagen sponge in gynecologic use → P22 → Verhütungsschwamm */
Q174|P23|Q3/* Collagen sponge in gynecologic use → P23 → Material des Verhütungsmittels */
Q175|P15|"Meyer U, Gerhard I, Runnebaum B"/* Benzalkonium chloride for vaginal contraception--the vaginal sponge → P15 → Meyer U, Gerhard I, Runnebaum B */
Q175|P16|"Geburtshilfe Frauenheilkd"/* Benzalkonium chloride for vaginal contraception--the vaginal sponge → P16 → Geburtshilfe Frauenheilkd */
Q175|P17|"Jul;50(7):542-7"/* Benzalkonium chloride for vaginal contraception--the vaginal sponge → P17 → Jul;50(7):542-7 */
Q175|P18|+1990-01-01T00:00:00Z/9/* Benzalkonium chloride for vaginal contraception--the vaginal sponge → P18 → +1990-01-01T00:00:00Z/9 */
Q175|P19|"10.1055/s-2008-1026298"/* Benzalkonium chloride for vaginal contraception--the vaginal sponge → P19 → 10.1055/s-2008-1026298 */
Q175|P1|"https://pubmed.ncbi.nlm.nih.gov/2391020/"/* Benzalkonium chloride for vaginal contraception--the vaginal sponge → P1 → https://pubmed.ncbi.nlm.nih.gov/2391020/ */
Q175|P22|Q22/* Benzalkonium chloride for vaginal contraception--the vaginal sponge → P22 → Verhütungsschwamm */
Q175|P23|Q3/* Benzalkonium chloride for vaginal contraception--the vaginal sponge → P23 → Material des Verhütungsmittels */
Q176|P15|"Psychoyos A, Creatsas G, Hassan E, Georgoulias V, Gravanis A"/* Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (Protectaid) containing sodium cholate → P15 → Psychoyos A, Creatsas G, Hassan E, Georgoulias V, Gravanis A */
Q176|P16|"Hum Reprod"/* Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (Protectaid) containing sodium cholate → P16 → Hum Reprod */
Q176|P17|"Jun;8(6):866-9"/* Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (Protectaid) containing sodium cholate → P17 → Jun;8(6):866-9 */
Q176|P18|+1993-01-01T00:00:00Z/9/* Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (Protectaid) containing sodium cholate → P18 → +1993-01-01T00:00:00Z/9 */
Q176|P19|"10.1093/oxfordjournals.humrep.a138156"/* Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (Protectaid) containing sodium cholate → P19 → 10.1093/oxfordjournals.humrep.a138156 */
Q176|P1|"https://pubmed.ncbi.nlm.nih.gov/7688380/"/* Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (Protectaid) containing sodium cholate → P1 → https://pubmed.ncbi.nlm.nih.gov/7688380/ */
Q176|P22|Q22/* Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (Protectaid) containing sodium cholate → P22 → Verhütungsschwamm */
Q176|P23|Q3/* Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (Protectaid) containing sodium cholate → P23 → Material des Verhütungsmittels */
Q177|P15|"Lethbridge DJ"/* Coitus interruptus. Considerations as a method of birth control → P15 → Lethbridge DJ */
Q177|P16|"J Obstet Gynecol Neonatal Nurs"/* Coitus interruptus. Considerations as a method of birth control → P16 → J Obstet Gynecol Neonatal Nurs */
Q177|P17|"Jan-Feb;20(1):80-5"/* Coitus interruptus. Considerations as a method of birth control → P17 → Jan-Feb;20(1):80-5 */
Q177|P18|+1991-01-01T00:00:00Z/9/* Coitus interruptus. Considerations as a method of birth control → P18 → +1991-01-01T00:00:00Z/9 */
Q177|P19|"10.1111/j.1552-6909.1991.tb01680.x"/* Coitus interruptus. Considerations as a method of birth control → P19 → 10.1111/j.1552-6909.1991.tb01680.x */
Q177|P1|"https://pubmed.ncbi.nlm.nih.gov/2005488/"/* Coitus interruptus. Considerations as a method of birth control → P1 → https://pubmed.ncbi.nlm.nih.gov/2005488/ */
Q177|P22|Q23/* Coitus interruptus. Considerations as a method of birth control → P22 → Coitus interruptus */
Q177|P23|Q2/* Coitus interruptus. Considerations as a method of birth control → P23 → Geschlecht */
Q178|P15|"Demir O, Ozalp M, Sal H, Aran T, Osmanagaoglu MA"/* Evaluation of the frequency of coitus interruptus and the effect of contraception counselling on this frequency → P15 → Demir O, Ozalp M, Sal H, Aran T, Osmanagaoglu MA */
Q178|P16|"J Obstet Gynaecol"/* Evaluation of the frequency of coitus interruptus and the effect of contraception counselling on this frequency → P16 → J Obstet Gynaecol */
Q178|P17|"Apr;41(3):453-458"/* Evaluation of the frequency of coitus interruptus and the effect of contraception counselling on this frequency → P17 → Apr;41(3):453-458 */
Q178|P18|+2021-01-01T00:00:00Z/9/* Evaluation of the frequency of coitus interruptus and the effect of contraception counselling on this frequency → P18 → +2021-01-01T00:00:00Z/9 */
Q178|P19|"10.1080/01443615.2020.1754370"/* Evaluation of the frequency of coitus interruptus and the effect of contraception counselling on this frequency → P19 → 10.1080/01443615.2020.1754370 */
Q178|P20|"Fertility control; general gynaecology"/* Evaluation of the frequency of coitus interruptus and the effect of contraception counselling on this frequency → P20 → Fertility control; general gynaecology */
Q178|P1|"https://pubmed.ncbi.nlm.nih.gov/32543257/"/* Evaluation of the frequency of coitus interruptus and the effect of contraception counselling on this frequency → P1 → https://pubmed.ncbi.nlm.nih.gov/32543257/ */
Q178|P22|Q23/* Evaluation of the frequency of coitus interruptus and the effect of contraception counselling on this frequency → P22 → Coitus interruptus */
Q178|P23|Q6/* Evaluation of the frequency of coitus interruptus and the effect of contraception counselling on this frequency → P23 → Effizienzmaße */
Q179|P15|"Woods JL, Hensel DJ, Fortenberry JD"/* Contraceptive withdrawal in adolescents: a complex picture of usage → P15 → Woods JL, Hensel DJ, Fortenberry JD */
Q179|P16|"J Pediatr Adolesc Gynecol"/* Contraceptive withdrawal in adolescents: a complex picture of usage → P16 → J Pediatr Adolesc Gynecol */
Q179|P17|"Aug;22(4):233-7"/* Contraceptive withdrawal in adolescents: a complex picture of usage → P17 → Aug;22(4):233-7 */
Q179|P18|+2009-01-01T00:00:00Z/9/* Contraceptive withdrawal in adolescents: a complex picture of usage → P18 → +2009-01-01T00:00:00Z/9 */
Q179|P19|"10.1016/j.jpag.2008.11.001"/* Contraceptive withdrawal in adolescents: a complex picture of usage → P19 → 10.1016/j.jpag.2008.11.001 */
Q179|P1|"https://pubmed.ncbi.nlm.nih.gov/19646669/"/* Contraceptive withdrawal in adolescents: a complex picture of usage → P1 → https://pubmed.ncbi.nlm.nih.gov/19646669/ */
Q179|P22|Q23/* Contraceptive withdrawal in adolescents: a complex picture of usage → P22 → Coitus interruptus */
Q179|P23|Q2/* Contraceptive withdrawal in adolescents: a complex picture of usage → P23 → Geschlecht */
Q180|P15|"Dude A, Neustadt A, Martins S, Gilliam M"/* Use of withdrawal and unintended pregnancy among females 15-24 years of age → P15 → Dude A, Neustadt A, Martins S, Gilliam M */
Q180|P16|"Obstet Gynecol"/* Use of withdrawal and unintended pregnancy among females 15-24 years of age → P16 → Obstet Gynecol */
Q180|P17|"Sep;122(3):595-600"/* Use of withdrawal and unintended pregnancy among females 15-24 years of age → P17 → Sep;122(3):595-600 */
Q180|P18|+2013-01-01T00:00:00Z/9/* Use of withdrawal and unintended pregnancy among females 15-24 years of age → P18 → +2013-01-01T00:00:00Z/9 */
Q180|P19|"10.1097/AOG.0b013e31829d8074"/* Use of withdrawal and unintended pregnancy among females 15-24 years of age → P19 → 10.1097/AOG.0b013e31829d8074 */
Q180|P1|"https://pubmed.ncbi.nlm.nih.gov/23921858/"/* Use of withdrawal and unintended pregnancy among females 15-24 years of age → P1 → https://pubmed.ncbi.nlm.nih.gov/23921858/ */
Q180|P22|Q23/* Use of withdrawal and unintended pregnancy among females 15-24 years of age → P22 → Coitus interruptus */
Q180|P23|Q2/* Use of withdrawal and unintended pregnancy among females 15-24 years of age → P23 → Geschlecht */
Q181|P15|"Döring GK"/* On the reliability of temperature method for contraception → P15 → Döring GK */
Q181|P16|"Dtsch Med Wochenschr"/* On the reliability of temperature method for contraception → P16 → Dtsch Med Wochenschr */
Q181|P17|"Jun 9;92(23):1055-61"/* On the reliability of temperature method for contraception → P17 → Jun 9;92(23):1055-61 */
Q181|P18|+1967-01-01T00:00:00Z/9/* On the reliability of temperature method for contraception → P18 → +1967-01-01T00:00:00Z/9 */
Q181|P19|"10.1055/s-0028-1103790"/* On the reliability of temperature method for contraception → P19 → 10.1055/s-0028-1103790 */
Q181|P1|"https://pubmed.ncbi.nlm.nih.gov/6024685/"/* On the reliability of temperature method for contraception → P1 → https://pubmed.ncbi.nlm.nih.gov/6024685/ */
Q181|P22|Q24/* On the reliability of temperature method for contraception → P22 → Temperaturmethode (Symptothermale Methode) */
Q181|P23|Q6/* On the reliability of temperature method for contraception → P23 → Effizienzmaße */
Q182|P15|"Marshall J"/* Cervical-mucus and basal body-temperature method of regulating births. Field trial → P15 → Marshall J */
Q182|P16|"Lancet"/* Cervical-mucus and basal body-temperature method of regulating births. Field trial → P16 → Lancet */
Q182|P17|"Aug 7;2(7980):282-3"/* Cervical-mucus and basal body-temperature method of regulating births. Field trial → P17 → Aug 7;2(7980):282-3 */
Q182|P18|+1976-01-01T00:00:00Z/9/* Cervical-mucus and basal body-temperature method of regulating births. Field trial → P18 → +1976-01-01T00:00:00Z/9 */
Q182|P19|"10.1016/s0140-6736(76)90732-7"/* Cervical-mucus and basal body-temperature method of regulating births. Field trial → P19 → 10.1016/s0140-6736(76)90732-7 */
Q182|P1|"https://pubmed.ncbi.nlm.nih.gov/59854/"/* Cervical-mucus and basal body-temperature method of regulating births. Field trial → P1 → https://pubmed.ncbi.nlm.nih.gov/59854/ */
Q182|P22|Q24/* Cervical-mucus and basal body-temperature method of regulating births. Field trial → P22 → Temperaturmethode (Symptothermale Methode) */
Q182|P23|Q6/* Cervical-mucus and basal body-temperature method of regulating births. Field trial → P23 → Effizienzmaße */
Q183|P15|"Frank E, White R"/* An updated basal body temperature method → P15 → Frank E, White R */
Q183|P16|"Contraception"/* An updated basal body temperature method → P16 → Contraception */
Q183|P17|"Nov;54(5):319-21"/* An updated basal body temperature method → P17 → Nov;54(5):319-21 */
Q183|P18|+1996-01-01T00:00:00Z/9/* An updated basal body temperature method → P18 → +1996-01-01T00:00:00Z/9 */
Q183|P19|"10.1016/s0010-7824(96)00187-4"/* An updated basal body temperature method → P19 → 10.1016/s0010-7824(96)00187-4 */
Q183|P1|"https://pubmed.ncbi.nlm.nih.gov/8934068/"/* An updated basal body temperature method → P1 → https://pubmed.ncbi.nlm.nih.gov/8934068/ */
Q183|P22|Q24/* An updated basal body temperature method → P22 → Temperaturmethode (Symptothermale Methode) */
Q183|P23|Q2/* An updated basal body temperature method → P23 → Geschlecht */
Q184|P15|"Porter JF"/* The rhythm method of contraception → P15 → Porter JF */
Q184|P16|"Reprod Fertil Suppl"/* The rhythm method of contraception → P16 → Reprod Fertil Suppl */
Q184|P17|"Apr;(22):91-105"/* The rhythm method of contraception → P17 → Apr;(22):91-105 */
Q184|P18|+1975-01-01T00:00:00Z/9/* The rhythm method of contraception → P18 → +1975-01-01T00:00:00Z/9 */
Q184|P1|"https://pubmed.ncbi.nlm.nih.gov/1058971/"/* The rhythm method of contraception → P1 → https://pubmed.ncbi.nlm.nih.gov/1058971/ */
Q184|P22|Q25/* The rhythm method of contraception → P22 → Kalendermethode */
Q184|P23|Q2/* The rhythm method of contraception → P23 → Geschlecht */
Q185|P15|"Bonnar J, Lamprecht V, O'Conner E"/* Alternatives to vaginal intercourse practiced during the fertile time among calendar method users in Ireland → P15 → Bonnar J, Lamprecht V, O'Conner E */
Q185|P16|"Adv Contracept"/* Alternatives to vaginal intercourse practiced during the fertile time among calendar method users in Ireland → P16 → Adv Contracept */
Q185|P17|"Jun-Sep;13(2-3):173-7"/* Alternatives to vaginal intercourse practiced during the fertile time among calendar method users in Ireland → P17 → Jun-Sep;13(2-3):173-7 */
Q185|P18|+1997-01-01T00:00:00Z/9/* Alternatives to vaginal intercourse practiced during the fertile time among calendar method users in Ireland → P18 → +1997-01-01T00:00:00Z/9 */
Q185|P19|"10.1023/a:1006599804380"/* Alternatives to vaginal intercourse practiced during the fertile time among calendar method users in Ireland → P19 → 10.1023/a:1006599804380 */
Q185|P1|"https://pubmed.ncbi.nlm.nih.gov/9288335/"/* Alternatives to vaginal intercourse practiced during the fertile time among calendar method users in Ireland → P1 → https://pubmed.ncbi.nlm.nih.gov/9288335/ */
Q185|P22|Q25/* Alternatives to vaginal intercourse practiced during the fertile time among calendar method users in Ireland → P22 → Kalendermethode */
Q185|P23|Q2/* Alternatives to vaginal intercourse practiced during the fertile time among calendar method users in Ireland → P23 → Geschlecht */
Q186|P15|"d'Arcangues C, Kennedy KI; Research Group on Methods for the Natural Regulation of Fertility"/* Periodic abstinence and calendar method use in Hungary, Peru, the Philippines, and Sri Lanka → P15 → d'Arcangues C, Kennedy KI; Research Group on Methods for the Natural Regulation of Fertility */
Q186|P16|"Contraception"/* Periodic abstinence and calendar method use in Hungary, Peru, the Philippines, and Sri Lanka → P16 → Contraception */
Q186|P17|"Oct;64(4):209-15"/* Periodic abstinence and calendar method use in Hungary, Peru, the Philippines, and Sri Lanka → P17 → Oct;64(4):209-15 */
Q186|P18|+2001-01-01T00:00:00Z/9/* Periodic abstinence and calendar method use in Hungary, Peru, the Philippines, and Sri Lanka → P18 → +2001-01-01T00:00:00Z/9 */
Q186|P19|"10.1016/s0010-7824(01)00252-9"/* Periodic abstinence and calendar method use in Hungary, Peru, the Philippines, and Sri Lanka → P19 → 10.1016/s0010-7824(01)00252-9 */
Q186|P1|"https://pubmed.ncbi.nlm.nih.gov/11747869/"/* Periodic abstinence and calendar method use in Hungary, Peru, the Philippines, and Sri Lanka → P1 → https://pubmed.ncbi.nlm.nih.gov/11747869/ */
Q186|P22|Q25/* Periodic abstinence and calendar method use in Hungary, Peru, the Philippines, and Sri Lanka → P22 → Kalendermethode */
Q186|P23|Q2/* Periodic abstinence and calendar method use in Hungary, Peru, the Philippines, and Sri Lanka → P23 → Geschlecht */
Q187|P15|"Kunjappu MJ"/* Pioneering studies of the 'morning-after' pill → P15 → Kunjappu MJ */
Q187|P16|"Yale J Biol Med"/* Pioneering studies of the 'morning-after' pill → P16 → Yale J Biol Med */
Q187|P17|"Jun;84(2):109-11"/* Pioneering studies of the 'morning-after' pill → P17 → Jun;84(2):109-11 */
Q187|P18|+2011-01-01T00:00:00Z/9/* Pioneering studies of the 'morning-after' pill → P18 → +2011-01-01T00:00:00Z/9 */
Q187|P20|"'morning-after' pill; diethylstilbestrol; emergency contraception; estrogenic compounds; ethinyl estradiol"/* Pioneering studies of the 'morning-after' pill → P20 → 'morning-after' pill; diethylstilbestrol; emergency contraception; estrogenic compounds; ethinyl estradiol */
Q187|P1|"https://pubmed.ncbi.nlm.nih.gov/21698041/"/* Pioneering studies of the 'morning-after' pill → P1 → https://pubmed.ncbi.nlm.nih.gov/21698041/ */
Q187|P22|Q26/* Pioneering studies of the 'morning-after' pill → P22 → Pille Danach */
Q187|P23|Q2/* Pioneering studies of the 'morning-after' pill → P23 → Geschlecht */
Q188|P15|"Grou F, Rodrigues I"/* The morning-after pill--how long after? → P15 → Grou F, Rodrigues I */
Q188|P16|"Am J Obstet Gynecol"/* The morning-after pill--how long after? → P16 → Am J Obstet Gynecol */
Q188|P17|"Dec;171(6):1529-34"/* The morning-after pill--how long after? → P17 → Dec;171(6):1529-34 */
Q188|P18|+1994-01-01T00:00:00Z/9/* The morning-after pill--how long after? → P18 → +1994-01-01T00:00:00Z/9 */
Q188|P19|"10.1016/0002-9378(94)90396-4"/* The morning-after pill--how long after? → P19 → 10.1016/0002-9378(94)90396-4 */
Q188|P1|"https://pubmed.ncbi.nlm.nih.gov/7802062/"/* The morning-after pill--how long after? → P1 → https://pubmed.ncbi.nlm.nih.gov/7802062/ */
Q188|P22|Q26/* The morning-after pill--how long after? → P22 → Pille Danach */
Q188|P23|Q2/* The morning-after pill--how long after? → P23 → Geschlecht */
Q189|P15|"Rudzinski P, Lopuszynska I, Pazik D, Adamowicz D, Jargielo A, Cieslik A, Kosieradzka K, Stanczyk J, Meliksetian A, Wosinska A"/* Emergency contraception - A review → P15 → Rudzinski P, Lopuszynska I, Pazik D, Adamowicz D, Jargielo A, Cieslik A, Kosieradzka K, Stanczyk J, Meliksetian A, Wosinska A */
Q189|P16|"Eur J Obstet Gynecol Reprod Biol"/* Emergency contraception - A review → P16 → Eur J Obstet Gynecol Reprod Biol */
Q189|P17|"Dec;291:213-218"/* Emergency contraception - A review → P17 → Dec;291:213-218 */
Q189|P18|+2023-01-01T00:00:00Z/9/* Emergency contraception - A review → P18 → +2023-01-01T00:00:00Z/9 */
Q189|P19|"10.1016/j.ejogrb.2023.10.035"/* Emergency contraception - A review → P19 → 10.1016/j.ejogrb.2023.10.035 */
Q189|P20|"Copper intrauterine device; Emergency contraception; Levonorgestrel; Postcoital contraception; Ulipristal acetate"/* Emergency contraception - A review → P20 → Copper intrauterine device; Emergency contraception; Levonorgestrel; Postcoital contraception; Ulipristal acetate */
Q189|P1|"https://pubmed.ncbi.nlm.nih.gov/37922775/"/* Emergency contraception - A review → P1 → https://pubmed.ncbi.nlm.nih.gov/37922775/ */
Q189|P22|Q26/* Emergency contraception - A review → P22 → Pille Danach */
Q189|P23|Q2/* Emergency contraception - A review → P23 → Geschlecht */
Q190|P15|"Batur P, Kransdorf LN, Casey PM"/* Emergency Contraception → P15 → Batur P, Kransdorf LN, Casey PM */
Q190|P16|"Mayo Clin Proc"/* Emergency Contraception → P16 → Mayo Clin Proc */
Q190|P17|"Jun;91(6):802-7"/* Emergency Contraception → P17 → Jun;91(6):802-7 */
Q190|P18|+2016-01-01T00:00:00Z/9/* Emergency Contraception → P18 → +2016-01-01T00:00:00Z/9 */
Q190|P19|"10.1016/j.mayocp.2016.02.018"/* Emergency Contraception → P19 → 10.1016/j.mayocp.2016.02.018 */
Q190|P1|"https://pubmed.ncbi.nlm.nih.gov/27261868/"/* Emergency Contraception → P1 → https://pubmed.ncbi.nlm.nih.gov/27261868/ */
Q190|P22|Q26/* Emergency Contraception → P22 → Pille Danach */
Q190|P23|Q2/* Emergency Contraception → P23 → Geschlecht */
Q191|P15|"Li RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, Ho PC, Ng EHY"/* Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial → P15 → Li RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, Ho PC, Ng EHY */
Q191|P16|"Lancet"/* Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial → P16 → Lancet */
Q191|P17|"Sep 9;402(10405):851-858"/* Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial → P17 → Sep 9;402(10405):851-858 */
Q191|P18|+2023-01-01T00:00:00Z/9/* Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial → P18 → +2023-01-01T00:00:00Z/9 */
Q191|P19|"10.1016/S0140-6736(23)01240-0"/* Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial → P19 → 10.1016/S0140-6736(23)01240-0 */
Q191|P1|"https://pubmed.ncbi.nlm.nih.gov/37597523/"/* Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial → P1 → https://pubmed.ncbi.nlm.nih.gov/37597523/ */
Q191|P22|Q26/* Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial → P22 → Pille Danach */
Q191|P23|Q6/* Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial → P23 → Effizienzmaße */
Q192|P15|"Glasier AF, Cameron ST, Fine PM, Logan SJ, Casale W, Van Horn J, Sogor L, Blithe DL, Scherrer B, Mathe H, Jaspart A, Ulmann A, Gainer E"/* Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis → P15 → Glasier AF, Cameron ST, Fine PM, Logan SJ, Casale W, Van Horn J, Sogor L, Blithe DL, Scherrer B, Mathe H, Jaspart A, Ulmann A, Gainer E */
Q192|P16|"Lancet"/* Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis → P16 → Lancet */
Q192|P17|"Feb 13;375(9714):555-62"/* Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis → P17 → Feb 13;375(9714):555-62 */
Q192|P18|+2010-01-01T00:00:00Z/9/* Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis → P18 → +2010-01-01T00:00:00Z/9 */
Q192|P19|"10.1016/S0140-6736(10)60101-8"/* Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis → P19 → 10.1016/S0140-6736(10)60101-8 */
Q192|P1|"https://pubmed.ncbi.nlm.nih.gov/20116841/"/* Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis → P1 → https://pubmed.ncbi.nlm.nih.gov/20116841/ */
Q192|P22|Q26/* Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis → P22 → Pille Danach */
Q192|P23|Q6/* Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis → P23 → Effizienzmaße */
Q193|P15|"Gemzell-Danielsson K, Berger C, Lalitkumar PG"/* Mechanisms of action of oral emergency contraception → P15 → Gemzell-Danielsson K, Berger C, Lalitkumar PG */
Q193|P16|"Gynecol Endocrinol"/* Mechanisms of action of oral emergency contraception → P16 → Gynecol Endocrinol */
Q193|P17|"Oct;30(10):685-7"/* Mechanisms of action of oral emergency contraception → P17 → Oct;30(10):685-7 */
Q193|P18|+2014-01-01T00:00:00Z/9/* Mechanisms of action of oral emergency contraception → P18 → +2014-01-01T00:00:00Z/9 */
Q193|P19|"10.3109/09513590.2014.950648"/* Mechanisms of action of oral emergency contraception → P19 → 10.3109/09513590.2014.950648 */
Q193|P20|"Emergency contraception pills; endometrium; follicular development; implantation; levonorgestrel; ovulation; ulipristal acetate"/* Mechanisms of action of oral emergency contraception → P20 → Emergency contraception pills; endometrium; follicular development; implantation; levonorgestrel; ovulation; ulipristal acetate */
Q193|P1|"https://pubmed.ncbi.nlm.nih.gov/25117156/"/* Mechanisms of action of oral emergency contraception → P1 → https://pubmed.ncbi.nlm.nih.gov/25117156/ */
Q193|P22|Q26/* Mechanisms of action of oral emergency contraception → P22 → Pille Danach */
Q193|P23|Q3/* Mechanisms of action of oral emergency contraception → P23 → Material des Verhütungsmittels */
Q194|P15|"Cameron ST, Li H, Gemzell-Danielsson K"/* Current controversies with oral emergency contraception → P15 → Cameron ST, Li H, Gemzell-Danielsson K */
Q194|P16|"BJOG"/* Current controversies with oral emergency contraception → P16 → BJOG */
Q194|P17|"Dec;124(13):1948-1956"/* Current controversies with oral emergency contraception → P17 → Dec;124(13):1948-1956 */
Q194|P18|+2017-01-01T00:00:00Z/9/* Current controversies with oral emergency contraception → P18 → +2017-01-01T00:00:00Z/9 */
Q194|P19|"10.1111/1471-0528.14773"/* Current controversies with oral emergency contraception → P19 → 10.1111/1471-0528.14773 */
Q194|P20|"Emergency contraception; levonorgestrel; postcoital contraceptive agents; ulipristal acetate"/* Current controversies with oral emergency contraception → P20 → Emergency contraception; levonorgestrel; postcoital contraceptive agents; ulipristal acetate */
Q194|P1|"https://pubmed.ncbi.nlm.nih.gov/28658565/"/* Current controversies with oral emergency contraception → P1 → https://pubmed.ncbi.nlm.nih.gov/28658565/ */
Q194|P22|Q26/* Current controversies with oral emergency contraception → P22 → Pille Danach */
Q194|P23|Q3/* Current controversies with oral emergency contraception → P23 → Material des Verhütungsmittels */